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ABBREVIATIONS 
 
Frequently used abbreviations are listed below; other abbreviations are defined within the text. 
 
ATP  adenosine triphosphate 
cAMP  cyclic andenosin monophosphate 
CDK cyclin-dependent kinase 
CKI cyclin-dependent kinase inhibitors 
cGMP cyclic guanosine monophosphate 
CREB cAMP responsive element-binding protein 
EGF epidermal growth factor 
ER endoplasmatic reticulum 
ERK extracellular signal regulated kinase 
GCK germinal centre kinase 
GDP guanosine diphosphate 
GTP guanosine triphosphate 
KRS kinase responsive to stress 
LATS large tumour surpressor 
MAPK mitogen-activated protein kinase 
MASK Mst3 and Sok related kinase 
MOB Mps one binder 
MST mammalian STE20-like 
NAD nicotinamiddinucleotide 
NDR nuclear Dbf2-related 
PAK p21 activated kinase 
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PKB protein kinase B 
SGK serum glucocorticoid kinase 
PRMT protein arginine methyltransferase 
SOK STE20 like oxidative stress response kinase 
SUMO small ubiquitin-related modifier  
STAT signal transducer and activator of transcription 
YSK yeast SPS1/STE20-related kinase 
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SUMMARY 
Protein modification is a common regulatory mechanism in order to transduce a signal from 
one molecule to another. One of the best-studied protein modifications is phosphorylation. 
The enzymes that are capable of transferring phosphate groups onto other proteins are called 
protein kinases. Depending on the acceptor group, kinases can be distinguished into tyrosine, 
serine/threonine and dual-specificity kinases. This work describes the characterisation of 
human and mouse NDR1 and NDR2 kinases, members of the AGC group of serine/threonine 
kinases. The NDR protein kinase family is highly conserved between yeast and human, and 
several members have been shown to be involved in the regulation of cell morphology and the 
control of cell cycle progression. For example, the yeast NDR kinases Sid2p 
(Schizosaccharomyces pombe) and Dbf2p (Saccharomyces cerevisiae) are central 
components of the septation-initiation network and the mitosis exit network, respectively. The 
closest yeast relatives Cbk1p and Orb6p, members of the regulation of Ace2p transcription 
and morphogenesis network and Orb6 signalling pathways, are implicated in the coordination 
of cell cycle progression and cell morphology. This study, as well as studies using worms and 
flies, provide evidence that not only NDR is conserved, but also the NDR signalling pathway 
and regulation. Similar to yeast, NDR kinase activation is regulated by phosphorylation at the 
activation segment phosphorylation site and the hydrophobic motif phosphorylation site. This 
phosphorylation is regulated by a conserved signaling module consisting of MOB proteins 
and a STE20–like kinase. Here we show that the STE20-like kinase MST3 activates NDR by 
phosphorylation specifically at the hydrophobic motif in vitro and in vivo. Furthermore, 
MOB1A binding is important for the release of autoinhibition and full kinase activation. The 
data also indicate that NDR is part of a feedback mechanism, which induces cleavage and 
nuclear translocation of MST3.  The data presented here also show that NDR1 and NDR2 are 
differentially expressed, but regulated in a similar manner. Mouse Ndr1 mRNA is mainly 
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expressed in spleen, thymus and lung, whereas Ndr2 mRNA is more ubiquitously expressed, 
with the highest levels in the gastrointestinal tract. Both, NDR1 and NDR2, are activated by 
S100B protein and okadaic acid stimulated phosphorylation; NDR1 and NDR2 are also 
indistinguishable in the biochemical assays used: membrane targetting, phosphorylation by 
MST3, and activation by MOB. Further, this work describes the generation and initial 
characterisation of a mouse model for NDR1 deficiency. Protein analysis using NDR1 
knockout mouse embryonic fibroblasts suggest a compensation of the loss of NDR1 by 
upregulation of NDR2 expression.  
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I. GENERAL INTRODUCTION 
 
1. MECHANISMS OF SIGNAL TRANSDUCTION 
(This first chapter gives a short overview about the current textbook knowledge signal 
transduction (see Gomperts et. al., 2002; Krauss et al., 1997) and serves as a general 
introduction to the thesis.)  
 
Multicellular organisms rely on coordinated interactions between organs and cells. In order to 
ensure a well-ordered course of events during development and in the mature organism, 
animals developed a variety of forms of intercellular signalling. Bioactive molecules (e.g. 
peptides, steroids, retinoids, nucleotides or amino acids) can be released from one type of cell, 
and provoke timely, coordinated responses in target cells. Depending on the range of 
signalling events, this can be classified as endocrine (long-range; signalling over long 
distances throughout the whole body), paracrine (short-range; signalling to neighbouring 
cells) and autocrine (self; sending cell can also be receiving cell) signalling. 
Communication between neighbouring cells can also occur via “gap junctions”. Gap junctions 
are channels which directly link two neighbouring cells and allow the direct exchange of 
metabolites or signalling molecules. Another form of cell-cell interaction is direct interaction 
of cells via cell surface proteins. Lastly, cells can also communicate via electrical processes 
and/or neurotransmitters.  
Typically, signals in a sender cell are initiated by a mostly external trigger signal, which is 
then transported or transduced to a target cell (which can be the sender cell itself). There, the 
signal is received by a receptor protein, and then subsequently converted into a sequence of 
biochemical or electrical reactions. Signalling pathways are often regulated by mechanisms, 
which allow the termination or attenuation of the signal. 
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Intercellular signalling occurs typically by the release of bioactive compounds, via diffusion 
or exocytosis, into the extracellular space. The molecules (ligands) either diffuse into target 
cells or bind to specific receptors at the cell surface. Alternatively, cell surface proteins can 
directly interact with each other. The binding of ligands induces conformational changes in 
the receptor protein, which result in a dimerisation/oligomerisation and enzymatic activation 
of the receptor, or the recruitment, association or release of other molecules/proteins or 
domains. For instance, ligand-induced oligomerisation of receptor tyrosine kinases such as 
PDGF (platelet derived growth factor) or ERB receptors results in an autophosphorylation and 
activation of the intracellular domain (Pawson et al., 2002); serine/threonine kinase receptors, 
such as the BMP (bone morphogenetic protein) or TGF (transforming growth factor) 
receptors, are activated by ligand binding driven heterodimerisation of type I and II receptors 
(Piek et al., 1999); and activation of NOTCH proteins by their ligands (JAGGED, DELTA or 
SERRATE) trigger the release of the intracellular domain by two steps of proteolytic cleavage 
(Lai, 2004). 
Components of the intracellular signalling are low molecular weight substances, so-called 
“second messenger” molecules, or proteins. Second messenger molecules are either stored or 
released from intracellular organelles (e.g. Ca2+), or can be created or removed by enzymatic 
reactions (e.g. cAMP, cGMP, inositoltrisphophate, phosphatidyl-inositol-phosphates or 
diacylglycerol). Their binding to effector molecules leads to the rapid and local activation or 
inhibition of signalling enzymes. 
There are various methods for the transduction of signals by proteins. For example, proteins 
can function as “adaptor proteins”. Adaptor proteins serve as “bridging molecules” between 
signalling components. These proteins play an important role in regulating the co-localisation 
of signalling components by creating a close proximity between proteins, and therefore enable 
an effective and specific transduction of signals. Adaptor proteins often contain specific 
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modular domains which recognise specific protein sequences or modifications. Src-homology 
2 (SH2) or phosphotyrosin-binding (PTB) domains recognise specific phospho-tyrosine-
containing protein sequences. SHC (Src-homology 2/α-collagen) contains both SH2 and PTB 
domains, which link the EGF (epidermal growth factor) receptor protein with the GRB2 
(growth factor receptor bound protein 2) adaptor protein (Downward, 1994; Tari and Lopez-
Berestein, 2001). SH3 domains recognise proline-rich sequences. For example, the SH3 
domain of CRK (CT10 regulator of kinase) interacts with the ABL (Abelson) tyrosine kinase 
(Donaldson et al., 2002); PDZ domains (Post-synaptic density/Discs-large/ZO1 domain) are 
modular protein interaction domains that are specialised for binding to short peptide motifs at 
the extreme carboxy termini of other proteins, although they can also have other modes of 
interaction. Their target proteins are frequently transmembrane receptors or ion channels. 
PDZ-containing proteins often result in the assembly of large protein complexes at specific 
subcellular localisations (Hung and Sheng, 2002). For example, erbin bridges the ERBB2 
receptor and G proteins such as RAS or RHO (Kolch, 2004). 
Proteins can also function as activator or inhibitor proteins, which signal by inducing 
conformational changes of themselves or of their target proteins. Differential expression of 
activator or inhibitor proteins can regulate the activity of target molecules. For example, 
CYCLINS and CKI’s regulate the cell cycle progression by specifically stabilizing or 
inducing an active or inactive conformation of CDK’s, which drive the cell forward to the 
next phase of the cell cycle (Li and Blow, 2001). 
Ligand binding can also induce conformational changes, which activate or inhibit signalling 
molecules. Seven-transmembrane domain receptors (also called serpentine receptors) such as 
the β-adrenergic receptor or the glucagon receptor are G-protein coupled receptors that cross 
the plasma membrane seven times. Upon ligand binding in the extracellular domain, the 
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intracellular domain changes into an active conformation and recruits and activates 
heterotrimeric G-proteins (Pierce et al., 2002).  
Binding of the second messenger ligands also controls the conformation of regulatory 
GTPases, which include monomeric and heterotrimeric GTPases. GTP binding induces an 
active conformation, whereas bound GDP stabilises the inactive conformation. Guanine 
nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and GDP 
dissociation factors (GDIs) can regulate the activity of the GTPases. In the active state, 
GTPases modulate effector protein: for example RAF kinase is recruited by active RAS·GTP, 
and adenylate cyclase activity is regulated by the α-subunits of heterotrimeric G-proteins 
(Bhattacharya et al., 2004). 
One of the most common ways of transducing signals to downstream components of 
signalling pathways is protein modification. Enzymes regulate the activity, localisation and/or 
affinity of downstream signalling molecules by posttranslational alteration of one or more 
amino acid residues via introducing a covalent bond with another chemical subunit. There is a 
wide variety of protein modifications; some of the most prominent of these are outlined in the 
next section. 
 
2. SIGNAL TRANSDUCTION BY PROTEIN MODIFICATIONS 
 
The regulation of proteins in the long term depends mostly on their expression levels. 
However, the complexity of multicellular organisms requires fast changes in enzymatic 
activities or binding affinities in order to react to environmental or intrinsic changes. One of 
the best-studied strategies of acute regulation is the use of posttranslational protein 
modifications. The covalent modification of proteins by removal or addition of chemical 
subunits alters the properties of the protein, or targets proteins to different subcellular 
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complexes. This chapter outlines the features of some of the most common modes of 
modification. 
 
2.1 PROTEOLYTIC CLEAVAGE 
The removal of peptide sequences by enzymatic cleavage can have multiple effects on 
proteins. Some proteins are synthesized as inactive precursors, so call proproteins that are 
activated by proteolysis. Caspases are one example of this. Procaspases reside as latent 
precursors in cells. Initiator caspases (e.g. caspase-2, -8, -9 or -10) are activated upon 
dimerisation, and then cleave and activate effector or executioner caspases (e.g. caspase-3 or -
7) (Boatright and Salvesen, 2003), which subsequently cleave their substrates. For example, 
caspase-mediated cleavage of ERK2 results inactivation of the kinase (Marchetti et al., 2004). 
In contrast, caspase cleavage of RAF kinase or ROCK1 results in a constitutively active 
kinase (Cornelis et al., 2005; Sebbagh et al., 2001). Proteolytic cleavage can alter not only 
enzyme activity: in several cases it also plays a role in the localisation of proteins. 
NOTCH proteins undergo several steps of proteolytic cleavage during the activation process. 
Processing of synthesized NOTCH in the trans-Golgi network by furin proteases is 
constitutive and necessary for signalling in mammals. Upon ligand binding, NOTCH is 
sensitised to cleavage of the extracellular domain by extracellular proteases from the 
ADAM/Kuzbanian family. This induces a further processing step by γ-secretases, which 
enables the NOTCH intracellular domain (NICD) to translocate to the nucleus. There, it 
associates with CBF-1 (CREB binding factor1) and MAM (mastermind), and leads to the 
activation of target genes (Schweisguth, 2004). 
 
2.2. GLYCOSYLATION 
The attachment of carbohydrates to proteins is called glycosylation. Glycosylation can occur 
on oxygen, nitrogen or carbon atoms of proteins. This modification mainly takes place while 
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the proteins are being transported from the ER through the Golgi apparatus to the plasma 
membrane. Glycosylation of cell surface proteins plays an important role in cell-cell 
communication, maintenance of the cell structure and self-recognition by the immune system. 
Carbohydrate modifications are also involved in protein transport in the secretory pathway, or 
the membrane linkage of proteins via glycosylphosphatidylinositol (GPI) anchors. For 
example, the importance of carbohydrate structures for self-recognition by the immune 
system is shown in the ABO blood group antigens: different glycosylation patterns of the 
antigen are recognised by antibodies (Morgan and Watkins, 2000). The modification of 
proteins in the secretory pathway is required for proper sorting of the proteins; e.g. a 
mannose-6-phosphate modification targets proteins to the lysosome (Scheiffele and Fullekrug, 
2000). The affinity of protein-protein interactions can also be regulated by glycosylation. The 
level of O-fucosylation of serine and threonine residues of the NOTCH EGF repeats 
determines the affinity for its ligand DELTA (Schweisguth, 2004).  
Cytoplasmic and nuclear proteins are also described as targets of glycosylation. O-GlcNAc 
modifications of serine residues are involved in numerous processes such as nuclear transport 
(e.g. nucleoporin), transcription (e.g. RNA polymerase II), macromolecular assembly 
processes (tau proteins, prions) or protein stability (p67) (Van den Steen et al., 1998). 
 
2.3. METHYLATION 
The methylation of proteins occurs on lysine and arginine residues or carboxy groups. 
Methylation often alters the affinity of proteins for each other. One of the most prominent 
cases of methylation is histone methylation. The lysine methylation of histones regulates the 
transcription of specific chromosomal loci. Histone methylation is often associated with the 
transcriptional repression of chromosomal regions: histone H3-K9 promotes the recruitment 
of HP1 (heterochromatin protein 1) and leads to the propagation of heterochromatin. H3-K27 
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methylation is recognized by the Polycomb repressor complex, which mediates repression at 
the gene level in euchromatic regions. In contrast, H3-K4 methylation impairs methylation of 
H3-K9, thereby keeping the chromatin in a transcriptionally active state (Sims 3rd et al., 
2003).  
Arginine methylation has also been shown to regulate protein-protein interactions. Recent 
studies have suggested that arginine methylation is involved in a variety of processes, 
including RNA processing, transcription and polyadenylation, regulation of cytoskeleton 
proteins, signal transduction and DNA repair (Boisvert et al., 2003). For instance, arginine 
methylation of STAT1 by the protein methyltransferase PRMT1 is required for the cellular 
interferon response (Mowen et al., 2001). 
The RAS protein can exemplify carboxymethylation. The CAAX motif of RAS is 
endoproteolytically cleaved after the attachment of the prenyl-group. Subsequent 
carboxymethylation of the cysteine creates a hydrophobic moiety, which allows binding to the 
membrane (Maurer-Stroh et al., 2003). Another example for carboxyl group methylation is 
the catalytic subunit of PP2A. The methylation of the C-terminal leucine is important for the 
association of the PR55/B regulatory subunit (Evans and Hemmings, 2000)  
 
2.4 ACETYLATION 
Proteins can be acetylated on amino-terminal residues or the ε-amino group of lysine residues. 
Amino-terminal acetylation occurs on the majority of eukaryotic proteins during the 
translation process. Some proteins require acetylation for activity or stabilisation, but for most 
proteins amino-terminal acetylation has no apparent biological significance (Polevoda and 
Sherman, 2002). Regulatory peptides and hormones are also acetylated at the amino terminus. 
This posttranslational modification is important for regulating the biological activity of 
peptides and hormones (e.g. α-melanocyte-stimulating factor) (Fu et al., 2002). The most 
 17
studied proteins that are acetylated are histones. Acetylation on lysine residues decreases the 
positive charge of histone tail structures, and therefore weakens the DNA-histone binding, 
which results in a greater accessibility for transcriptional complexes. Histone acetylation is 
regulated by histone acetylases (HATs) and histone deacetylases (HDACs) (Eberharter and 
Becker, 2002). Non-histone chromosomal proteins such as HMG (high mobility group) 
proteins are also subject to acetylation, which is thought to be important for their binding to 
distorted DNA (Ugrinova et al., 2001). Several transcription factors are also well-
characterised targets of protein acetylation. Acetylation can alter their DNA binding ability 
(e.g. in the cases of E2F1, p53, EKLF (erythroid Krueppel-like factor) or HNF-4 (hepatocyte 
nuclear factor)), their protein interactions (e.g. in the cases of c-JUN, TCF (T-cell factor) or 
HNF-4) or their localisation (HNF-4) (Polevoda and Sherman, 2002). Acetylation is also 
implicated in the regulation of nuclear import by modifying import factors such as 
RCH1/IMPORTIN-α (Bannister et al., 2000). In recent years, much effort has also been put 
towards understanding the role and regulation of α-TUBULIN acetylation. Acetylation is 
mostly associated with stable microtubule structures, and is thought to influence cell motility 
(Westermann and Weber, 2003).  
 
2.5. UBIQUITINATION 
Ubiquitination is a conserved, reversible, posttranslational modification that results in the 
covalent attachment of ubiquitin to the ε-amino group of a lysine residue on the target 
molecule. This multi-step process requires the coordinated activity of ubiquitin-activating 
enzymes (E1), ubiquitin-conjugating enzymes (E2) and ubiquitin ligases (E3) (Pickart, 2001). 
Polyubiquitin chains consisting of Lys48-Gly76 polymers target proteins for ATP-dependent 
proteolysis by the 26S proteasome, while Lys63-Gly76 chains modulate protein function or 
label proteins for destruction via non-proteasome-dependent mechanisms (Sun and Chen, 
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2004). In contrast, monoubiquitination has been linked to receptor endocytosis, lysosomal and 
peroxisomal degradation of proteins, virus budding, transcription, DNA repair or caspase 
recruitment or modulate protein function (Lee and Peter, 2003).   
 
2.6. SUMOYLATION 
Sumoylation is the reversible, posttranslational modification of proteins on lysine residues 
with the ubiquitin-like SUMO protein. The mechanisms of sumoylation and ubiquitination are 
similar. The SUMO conjugation pathway also involves the E1, E2 and E3 enzymes. SUMO 
acceptor sites contain a conserved ΨKXE (Ψ is a large hydrophobic amino acid) site. In 
contrast to ubiquitination, sumoylation has not been associated with protein degradation, but 
is also involved in the regulation of protein activity and localisation (Gill, 2004). Sumoylation 
is used to regulate protein translocation (e.g. RAN·GAP1 or adenoviral E1B), transcription 
(e.g. SP3, HSF1 and 2 or TEL), DNA replication and repair (e.g. PCNA or topoisomerase I) 
and chromosome segregation (Seeler and Dejan, 2003). 
 
2.7. PHOSPHORYLATION 
Protein phosphorylation involves the transfer of a phosphate group from an energetic 
phosphate donor (mostly ATP) to specific phosphoacceptor sites on a protein. The reaction is 
generally catalysed by protein kinases, but another mode of protein phosphorylation involving 
inositol-pyrophosphates has been described recently (York et al., 2004). Phosphorylation is a 
reversible protein modification. The dephosphorylation reaction is catalysed by protein 
phosphatases or can occur by hydrolysis. The phospho-status of proteins is tightly regulated 
by the relative activities of protein kinases and protein phosphatases. Protein phosphorylation 
occurs mostly on serine, threonine or tyrosine residues. However, protein phosphorylation has 
also been reported on histidine and aspartate residues. For example, the two-component 
systems in bacteria (e.g. Bacillus subtilis) consist of a His-Asp relay network that transfers 
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phosphate from histidine to aspartate. However, due to the chemical properties these 
modifications are very unstable (Oka et al., 2002; Wolanin et al., 2002). In mammals 
histidine kinases are also known for many years, but little is still known about their biological 
functions (Besant and Attwood, 2005). 
Protein phosphorylation is one of the best-studied protein modifications, and is involved in 
almost all cellular processes ranging from transcription, replication, translation, splicing and 
protein degradation to the regulation of cell cycle progression, cell morphology and many 
more. The modification of proteins with a phosphate group can alter protein localisation. For 
example, the localisation of the Forkhead transcription factor FKHRL1 (FOXO3a) is 
regulated by phosphorylation through PKB and SGK (Brunet et al., 2001; You et al., 2004). 
Via phosphorylation of serine and threonine residues, FKHRL1 transcription is modified or 
abolished and FKHRL1 translocates to the cytoplasm.  
Phosphorylation can also determine the localisation of proteins to specific protein complexes. 
Phosphorylation of the scaffolding molecule DOK-R by c-SRC leads to the co-recruitment of 
the SRC family kinase inhibitory kinase CSK to the EGF receptor, and results in an 
attenuation of EGF signalling (Van Slyke et al., 2005). Phosphorylation of CREB by protein 
kinase A allows the recruitment of the coactivator protein CBP (CREB-binding protein) and 
enables transcription at CRE sites (Cardinaux et al., 2000).  
Phosphorylation signals are often used by adaptor proteins to link signalling proteins to each 
other in order to regulate signalling cascades or biological responses (Cherezova et al., 2002). 
For example, SH2 or PTB domains are used to bind specific phospho-tyrosine residues of 
target molecules.  
The dimerisation of proteins can also be regulated by phosphorylation. For example, tyrosine 
phosphorylation STAT5 induces the formation of protein dimers, which allows subsequent 
translocation of the dimer to the nucleus, where it modulates the expression of target genes 
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(Imida and Leonard, 2000). Another effect of phosphorylation is the change of the 
electrostatic potential of proteins: phosphorylation adds a negative charge to proteins, which 
can result in the decrease or increase in protein affinities. For example, phosphorylation of the 
C-terminal domain (CTD) of RNA polymerase II is important for the promoter to release the 
polymerase. Unphosphorylated RNA polymerase is preferentially bound to the promoter. 
After initiation of transcription, kinases such as CDK7 phosphorylate the CTD and release the 
polymerase from the initiation complex (Prelich, 2002).  
Phosphorylation can influence protein stability. Phosphorylation of β-CATENIN on Ser21, 
Thr102 and Thr112 by casein kinase II destabilises the protein by targeting it to the ubiquitin-
proteasome pathway (Bek et al., 2005). But phosphorylation can also have a stabilizing effect 
on proteins. After activation, RHO-associated coiled-coil forming kinase (ROCK I) 
phosphorylates the GTPase-deficient RHO E on Ser11 and stabilises the protein (Riento et al., 
2005). 
Protein phosphorylation is also a common way of altering enzyme activities. The 
phosphorylation of enzymes can alter their structure towards an active or inactive 
conformation. For example, the phosphorylation of type 1 and type 2 phosphatases on their C-
terminal regulatory domain is reported to inhibit the phosphatase activity (Brautigan, 1995). 
In contrast, phosphorylation of the regulatory subunit of ATP-Mg-dependent protein 
phosphatase inhibitor-2 on Thr72 by MAPK or GSK3 results in an activation of the 
phosphatase (Wang et al., 1995). Inactivation of glycogen-synthase is associated with a 
multiple phosphorylation of the enzyme (Nielsen and Wojtaszewski, 2004). Protein kinases 
are not only performing phosphorylation, they are a class of enzymes which is regulated by 
phosphorylation. Phosphorylation of kinases is essential for their activity. However, in some 
cases phosphorylation of regulatory domains also has an inhibitory role. For example, CDK4 
is activated by activation segment phosphorylation, but inhibited by phosphorylation on 
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Tyr17 (Ekkholm and Reed, 2000). Protein kinases often form signalling cascades where one 
kinase transduces a signal by phosphorylation and activation of another protein kinase. For 
example, MAPKs are activated by a conserved kinase subfamily, the MAPK kinases 
(MAPKK), which are in turn phosphorylated and activated by MAPKK kinases (Schaeffer 
and Weber, 1999). This thesis describes the phosphorylation and activation of NDR by an 
upstream kinase in detail in the results section. 
 
2.8.  OTHER MODIFICATIONS 
Apart from the modifications listed above, many more modifications have been described. For 
example, adenylation is an important step in the ubiquitin transfer cascade for the ubiquitin-
like protein NEDD8 (Walden et al., 2003). Prenylation, myristoylatation palmitoylation, 
farnesylation and geranyl-geranyl modifications are lipid modifications which help proteins 
associate with membranes (Magee and Seabra, 2005). Sulfatation of tyrosine residues in 
selectin increases its binding affinity to sialyl-Lewis X antigen (Van den Steen et al., 1998). 
Deamidation of proteins is thought to serve as a molecular clock for protein turnover, ageing 
and development using the intrinsic instability of asparagines and glutamine residues 
(Robinson and Robinson, 2001a,b). Biotinylation of proteins increases their affinity to the cell 
surface of monocytes and granulocytes (Storm et al., 1996). Formylation occurs mostly as 
modification of the initiator methionine in bacteria (Ramesh et al., 2003). Vitamin K-
dependent proteins require carboxylation of glutamyl residues for their biological activity as 
regulators of bone morphogenesis, haemostasis and growth (Berkner and Pudota, 1998). 
ADP-ribosylation of proteins is known to be involved in the modulation of the immune 
response (e.g. modification of the human neutrophil protein (HNP1)) (Corda and Di Girolamo, 
2002); and poly-ADP-ribosylation plays an important role in DNA repair (Oei et al., 2005). 
Oxidative stress marks itself by oxidation and hydroxylation of proteins. However, there are a 
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few more modifications, e.g. pyroglutamylation, selenocysteine and selenomethionine, but a 
detailed coverage of all of them is not the aim of this study. This study mainly focuses on the 
effect of phosphorylation and protein binding on NDR kinase activity and function. 
 
2.9. THE CONCEPT OF ‘SIGNALLING PATHWAYS’  
Protein modifications and protein-protein interactions are the basis for most signaling 
pathways. Signalling pathways transduce an extrinsic and/or intrinsic signal via consecutive 
signalling events (protein modifications, complex formation, second messenger binding etc.) 
to downstream effectors in order to change a transcriptional or physiological output. This 
section exemplifies the concept of signaling pathways using the PI3K/PKB and the 
JAK/STAT signalling pathway.  
2.9.1. THE PI3K/PKB KINASE SIGNALLING PATHWAY 
Upon stimulation with growth factors such as PDGF, EGF or IGF-1 the corresponding growth 
factor receptors (PDGFR, ErbB, or IGF1-R) homo- and/or hetero dimerise and get activated 
by autophosphorylation (Tallquist et al., 2004; Roskoski, 2004, Adams et al., 2004). The 
phosphorylated receptor tyrosine kinase recruits phosphoinositide 3-phosphat-kinase (PI3K) 
to the receptor, either directly or via the phosphorylation and recruitment of adaptor 
molecules such as insulin receptor substrate (IRS) proteins or SHC/GRB2/GAB (Wymann 
and Marone, 2005). The recruitment of PI3K results in the increase of phosphoinositol-3,4,5-
trisphosphate (PtdIns(3,4,5)P3) levels at the membrane.  The opposing player for 
PtdIns(3,4,5)P3 production is the 3’-phosphoinositide phosphatase PTEN (phosphatase and 
tensin homologue deleted on chromosome 10) (Sulis and Parson, 2003). Increasing levels of 
PtdIns(3,4,5)P3 result in the recruitment of several phosphoinositide binding domain (eg. 
pleckstrin homology domain) containing proteins to cellular membranes (Cozier et al., 2004). 
Within those PKB and its activation segment upstream kinase PDK1 (phosphoinositide 
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dependent kinase) are recruited to the membrane, which facilitates phosphorylation of PKB 
by PDK1 (Meier and Hemmings, 1998). Furthermore, membrane recruited PKB is 
phosphorylated at the C-terminal hydrophobic motif phosphorylation site by mTOR/rictor 
(Sarbassov et al., 2005) or DNA-PK (Feng et al., 2004). The C-terminal hydrophobic motif 
phosphorylation is impeded by the binding of inhibitory proteins such as CTMP1 (C-terminal 
modulator protein) or TRB3 (tribble homologue 3) (Maira et al., 2001; Du et al., 2003), 
which therefore prevent activation of PKB. Furthermore, PKB also is negatively regulated by 
protein phosphatase 2A, which is able to dephosphorylate and inactivate the kinase 
(Andjelkovic et al., 1996).  Activated PKB itself transduces the signal to several downstream 
components of the signalling pathway by phosphorylation. Phosphorylation of target 
molecules such as FOXO transcription factor, IκB kinase, hTERT, p21CIP p27KIP, PDE3B, 
PFK2, RAC, eNOS , NUR77, IRS-1, TSC2, GSK3, CHFR, MDM2, MYT1, CREB, BRCA-1, 
B-RAF or C-RAF results in multiple cellular responses encompassing protein synthesis, cell 
metabolism, cell proliferation and cell survival (Brazil and Hemmings, 2001; Brazil et al. 
2004; Hay, 2005).  However, this is only a simplified presentation of the PI3K/PKB signaling 
pathway, the real picture is still under development. Many more molecules have been 
identified (eg. Actin, Periplakin, JIP1, POSH or ERK1/2) and likely will be identified, which 
bind to PKB or affect PKB activity (Brazil et al., 2004). Similarly, bioinformatic approaches 
as well as peptide library screens just point out the potential multitude of PKB substrates 
(Obata et al., 2000; Obenauer et al., 2003). (For illustration of the PI3K/PKB signalling 
pathway see Figure 1 of Brazil et al., 2004). 
2.9.2 THE JAK/STAT SIGNALLING PATHWAY 
The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway is 
another well studied pathway that transduces signals of cytokines and growth factors in order 
to alter the transcriptional response of the cell.  Cytokines such as interferons and interleukins 
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bind to their receptors and induce multimerisation of receptor subunits (O’Shea et al., 2002). 
This allows the activation and transphosphorylation of two neighbouring receptor associated 
JAKs, which subsequently phosphorylate STATs. This phosphorylation can be assisted STAT 
interacting proteins (StIP), which serve as adaptors (Aaronson and Horvath, 2002). 
Phosphorylated STATs dimerise through the interaction of SH2 domains and are translocated 
to the nucleus, where they alter the transcription of target genes such as MYC, NOS (nitrogen 
oxide synthase), p21CIP, NMI (N-Myc interacting protein), BCL2-Xi (B cell lymphoma 2 Xi) 
or SOCS (suppressor of cytokine signalling) (Rawlings et al., 2004). SOCS itself is a negative 
regulator of the JAK/STAT signaling pathway, which modulate the signal intensity in a 
negative feedback loop. SOCS binds to phosphotyrosin residues at the receptor and inhibits 
STAT recruitment. Furthermore SOCS recruits E3-ligases which target JAKs and receptors 
for ubiquitination and subsequent degradation by the proteasome (Alexander, 2002). Other 
negative regulators of the JAK/STAT pathway are tyrosine phosphatases such as SHP-1 (SRC 
homology region 2 containing phosphatase), which reverse the activation of JAKs by 
dephosphorylation of the kinase. (Rawlings et al., 2004).  STAT proteins are also negatively 
regulated by the binding of protein inhibitors of activated STATs (PIAS), which prevent the 
binding of STATs to DNA. Furthermore PIAS is reported to have E3 conjugase activity 
which results in the sumoylation of STATs (Rogers et al., 2003).  This again, only gives a 
simplified view on the JAK/STAT signalling pathway, an few more molecules have been 
described to affect this signalling pathway (e.g. STAM (signal transducing activator 
molecule), PKCδ or IMPORTIN α-5) (Rawlings et al., 2004). (For illustration of the JAK-
STAT signaling pathway see Figure 1 of Rakesh and Agrawal, 2005). 
In general, almost every step of signalling cascades is regulated by multiple modes to ensure 
the correct signal intensity and output. This includes cross talks of different signalling 
cascades and feedback regulatory loops, which contribute to the complexity of cellular signal 
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transduction observed in cells and organisms. Here we describe first steps towards the 
characterisation of the MOB/NDR signaling pathway, namely the identification of its 
upstream kinase MST3.  
 
 
3. PROTEIN KINASES 
 
Protein phosphorylation is one of the most widespread and well-studied signalling 
mechanisms in eukaryotes, and is involved in the control of many, if not all, cellular processes. 
The extent of protein phosphorylation is reversibly controlled by the activity of protein 
kinases and protein phosphatases, the ‘Yin and Yang’ of protein phosphorylation (Hunter, 
1995).  
Comparisons of the protein kinase complements (‘kinomes’) of yeast, worm, fly and human 
revealed that many kinase families are conserved from yeast to human. These kinases mediate 
mainly unicellular functions. However, metazoan-specific kinase families and groups 
(tyrosine kinase and tyrosine kinase-like) exist. This expansion during metazoan evolution is 
most likely due to the increased complexity of signalling in multicellular organisms in order 
to control cell-cell communication, development and differentiation (Manning et al., 2002a).  
The eukaryotic protein kinases are classified into several groups: AGC (containing cAMP-
dependent protein kinase (PKA), cGMP-dependent protein kinase (PKG), and protein kinase 
C (PKC)), CAMK (Ca2+/calmodulin-dependent protein kinase), CK1 (casein kinase 1), 
CMGC (containing cyclin-dependent kinase (CDK), mitogen-activated protein kinase 
(MAPK), glycogen synthase kinase 3 (GSK3) and Cdc2-like kinase (CLK) families), STE 
(homologues of yeast sterile 7, 11 and 20-like kinases), TK (tyrosine kinase), TKL (tyrosine 
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kinase-like), RGC (receptor guanylate cyclase), ‘Atypical’, the ‘Other’ group, the worm-
specific Fer and the yeast Hal group of protein kinases (Manning et al., 2002a). 
3.1 THE HUMAN KINOME 
The human kinome consists of AGC, STE, CK1, CMGC, TK, TKL, Atypical and ‘the Other’ 
groups of protein kinases. Despite the fact that that the human kinome contains 518 kinases 
compared to 454 worm, 239 fly and 130 yeast kinases, only 13 kinase families are unique for 
humans. This indicates that most of the large-scale divergence of the kinase families had 
already occurred in their most recent common ancestor (Manning et al., 2002a). The 
conservation of protein kinase families between different organisms allows us to transfer 
conclusions gained by studying lower organisms to the mammalian systems. This work makes 
extensive use of this conservation and describes a conserved interaction between STE20-like 
kinases and NDR kinases. The conservation of protein kinases not only allows vertical 
transfers of information between organisms, but also horizontal transfers between members of 
kinase families and groups. A common feature of almost all protein kinases (except several 
Atypical protein kinases) is the structure of their catalytic domain.  
 
3.2. STRUCTURE OF PROTEIN KINASES 
The superfamily of eukaryotic protein kinases (ePKs) shares a conserved catalytic domain. 
This conservation is marked by a high degree of similarity in their primary structure, which is 
thought to result in a similar tertiary structure (Hanks and Hunter, 1995). The primary 
structure of the catalytic domain can be further divided into twelve subdomains which contain 
regions of higher homology (Hanks and Quinn, 1991). Subdomains I-IV form the smaller N-
terminal lobe, which is responsible for the binding of Mg2+·ATP. The N-terminal lobe 
consists of a five-stranded antiparallel β-strand: subdomain I – a β-strand-turn-β-strand with a 
conserved glycine-rich loop – is important for anchoring ATP to the protein; subdomain II – a 
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β-sheet with an α-helical extension – contains the invariant catalytic lysine which interacts 
with and stabilises the α- and β-phosphates of ATP; subdomain III – a large α-helix – 
contains a glutamate residue which stabilizes the interaction of the catalytic lysine with ATP; 
subdomain IV is also a β-strand. Subdomain V contains a hydrophobic β-strand and chain that 
connects the two lobes of the catalytic domains, which anchor ATP to the kinase and are 
important for substrate recognition. The larger C-terminal lobe consists mainly of α-helical 
structures encompassing subdomains V-VII and is involved in substrate binding and catalysis: 
it consists of the α-helical part of subdomain V; subdomain VIA which is a large α-helix; two 
hydrophobic β-strands connected by the so-called catalytic loop which form subdomain VIB 
and contain important residues (D-X-K-X-X-N motif) for the catalysis of the phosphate 
transfer to the substrate; and subdomain VII also has a β-strand-loop-β-strand structure 
containing the DFG motif which plays a role in orientating the γ-phosphate of ATP by 
chelating the Mg2+ which bridges the β- and γ-phosphate of ATP. Subdomain VIII contains a 
chain encompassing the so-called T- or activation loop, followed by the APE motif which has 
an important function in stabilising the large lobe of the kinase; a large α-helix forms 
subdomain IX and encompasses residues responsible for substrate recognition; the α-helix 
and the helix loop helix structure of subdomains X and XI, respectively, conclude the large 
lobe of the kinase (Hanks and Quinn, 1991). Most protein kinases share this primary structure 
similarity. However, several protein kinases of the ‘Atypical’ group are known that lack this 
sequence similarity, but several of them are shown to have structural similarities (Manning et 
al., 2002b).  
 
3.3 REGULATION OF SERINE/THREONINE KINASES 
A common regulatory element of protein kinase activity is phosphorylation of the kinase 
activation segment. Phosphorylation on additional phosphorylation sites can stabilize the 
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kinases in an active or inactive conformation. Kinase activity is often also regulated by 
additional regulatory elements such as binding to coactivators or inhibitory proteins. For 
example, CYCLINS bind to one side of the catalytic cleft of CDKs and induce a large 
conformational change in the T-loop of the kinase (Jeffrey et al., 1995). In contrast, binding 
of the inhibitor protein p27KIP1 to the cyclin A-CDK2 complex rearranges the amino lobe of 
the kinase and interacts with the catalytic cleft by mimicking ATP binding (Russo et al., 
1996). Also, the localisation of serine/threonine kinases plays an important role in the 
activation process of protein kinase. For example, adaptor molecules such as NOD1 mediate 
the interaction with RIP (receptor interacting protein)-like interacting caspase-like apoptosis-
regulatory protein kinase (RICK) and IκB kinase (IKK) and form specific signalling modules 
(Inohara et al., 2000). Several lines of evidence suggest that cellular membranes are an active 
compartment for kinase activation and phosphorylation. For example, the binding of GTP-
bound GTPases such as RAS, RHO or RAC results in a membrane recruitment and activation 
of RAF, ROCK or PAK kinases, respectively (Wennerberg and Der, 2004). Several kinases 
are recruited to cellular membranes by their lipid-binding domain. For example, PKC is 
activated by membrane recruitment induced by binding to diacylglycerol (DAG) or phorbol 
esters (Brose and Rosenmund, 2002). PKB (also termed AKT) is translocated to the 
membrane by binding of the pleckstrin homology (PH) domain to phosphatidylinositol 3,4,5-
trisphosphate lipid molecules, which leads to the subsequent phosphorylation and activation 
of the kinase (Brazil and Hemmings, 2001; Brazil et al., 2004). This study characterizes the 
activation of NDR protein kinase by binding to coactivator protein MOB and by membrane 
targeting mediated hydrophobic motif phosphorylation of the kinase mediated by a STE20-
like kinase.  
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4. THE STE20 GROUP OF PROTEIN KINASES 
 
The STE20 group of protein kinases is related to the budding yeast Ste20p (sterile 20) protein. 
In mammals, this group comprises the p21-activated kinases (PAKs) and the germinal centre 
kinases (GCKs).   
 
4.1. GENERAL FEATURES OF STE20-LIKE KINASES 
The STE20 group of protein kinases is implicated in the regulation of apoptosis, cell shape 
and cell motility. The STE20 group kinases show conservation within their kinase domains, 
but are structurally extremely diverse in their noncatalytic domain. PAK-I contains an N-
terminal SH3 domain, an autoinhibitory domain, a CDC42/RAC-1-binding domain and a 
Cool/Pix binding motif (a region which is important for recruitment to focal adhesions) and 
the C-terminal kinase domain. The N terminus of PAK-II subfamily kinases contains a 
CDC42/RAC-1 binding domain as well, but this shows a higher affinity to CDC42 than to 
RAC-1. The GCK kinases have their kinase domain at their N terminus. GCK-I kinases have 
several prolin-rich repeats, a citron homology domain and a conserved C-terminal extension. 
A C-terminal autoinhibitory sequence and a dimerisation domain are characteristic of GCK-II 
kinases; the C terminus of GCK-III kinases is short and does not contain defined domains. 
The C terminus of GCK-IV kinases contains a citron homology domain; GCK-V kinases have 
an AT1-46 homology domain. GCK-VI kinases have a conserved C-terminal region of 
unknown function; the special feature of GCK-VII kinases is a myosin light chain domain 
adjacent to the kinase domain, and a C-terminal calmodulin-binding domain. GCK-VIII 
kinases contain a long central conserved region of unknown function (Dan et al., 2001). 
Several of the STE20 group kinases (PAK2, HPK1 (haematopoetic progenitor kinase) and 
MLK3 (mixed lineage kinase) are thought to function as MAP kinase kinase kinase kinases 
 30
(MAP4K). Many STE20 group kinases, such as the GCK-VIII kinases, also function as MAP 
kinase kinase kinases (MAP3K) (Dan et al., 2001). Interestingly, STE20 group kinases are 
also involved in the regulation of apoptosis: several of them are cleaved by caspases. This 
study describes a newly discovered interaction between MST3, a STE20 group kinase 
subfamily kinase, and NDR kinases. 
 
4.2. THE MAMMALIAN STE20-LIKE FAMILY OF PROTEIN KINASES 
Mammalian STE20-like kinases (MST) are members of the STE20 group of serine/threonoine 
kinases, relatives of the yeast sterile 20 (Ste20p). Their closest relatives in budding/fission 
yeast, Cdc15p and Kic1p/Nak1p, are components of the mitosis exit network 
(MEN)/septation initiation network (SIN) or regulation of Ace2p and morphogenesis (RAM) 
network. 
MST kinases belong to the germinal centre kinase (GCK) subfamilies II (MST1, MST2) and 
III (MST3, MST4 (MASK) and YSK1 (SOK1)). They share a common domain structure, a 
very short N terminus followed by the catalytic domain and a C-terminal regulatory domain. 
MST kinases (apart from YSK1) are reported have one or two caspase cleavage sites adjacent 
to their kinase domain. The C terminus of GCK-II kinases contains a dimerisation domain and 
a nuclear export sequence (NES). The C terminus of GCK-III kinases is less conserved, but at 
least MST3 is also known to bear a C-terminal NES. Figure 1 shows the domain structure of 
MST kinases.Cleavage of the kinases by caspases results in an increased activity and a 
nuclear translocation of the N-terminal part of the kinase (Lee et al., 2001; Ura et al., 2001; 
Dan et al., 2002; Huang et al., 2002). 
MST kinases are implicated in the regulation of apoptosis (De Souza et al., 2004) and cell 
migration (Preisinger et al., 2004). MST1 is known to be responsible for apoptotic 
phosphorylation of histone 2B (Cheung et al., 2003). The phosphorylation of histones is 
associated with a condensation of the chromatin and DNA fragmentation (Cheung et al., 
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2003). Furthermore, MST1 activity causes cardiomyopathy by inducing cardiac myocyte 
apoptosis (Yamamoto et al., 2003) and induces eosinophil apoptosis (De Souza et al., 2002). 
MST1 and MST2 are both activated and cleaved in response to chemical stress or heat shock 
(Taylor et al., 1996). However, no direct upstream activators of MST1 or MST2 are known so 
far, but RAS association domain family protein 1A (RASF1A), novel RAS effector 1A 
(NORE1A) and RAS keep MST1 kinase in a moderately active form and might be involved 
in recruiting the kinase to the site of activation; in agreement membrane recruitment of MST1 
or NORE1A results in activation of the kinase (Praskova et al., 2004). Similarly, MST2 
kinase activation and dimerisation is inhibited by RAF-1 kinase and decreases the sensitivity 
to programmed cell death (O’Neill et al., 2004). 
 
Figure 1. Domain organisation of mammalian STE20-like kinases. 
The catalytic domain (CD), dimerisation domain (DD), nuclear localisation signal (NLS) and nuclear 
export sequence (NES) are highlighted by boxes. The amino acid number of the catalytic domain, 
activation segment phosphorylation site and caspase cleavage site are indicated. 
Hippo, the MST1/2 orthologue in Drosophila melanogaster, couples cell proliferation and 
cell death.(Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu 
et al., 2003). 
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MST3 is also thought to play a role in the induction of apoptosis (Huang et al., 2002). 
Interestingly, MST3 shows an unusual cofactor preference and is autophosphorylated in the 
presence of Mg2+, Mn2+, Co2+ and Zn2+ (Schinkmann and Blenis, 1997; Lu et al., 2005).  
MST4 and YSK1 bind to GM130, a Golgi-matrix protein, and have functions in cell motility 
and polarisation (Preisinger et al., 2004). MST4 shows apoptosis-inducing properties, but is 
also thought to affect prostate cancer progression and cell transformation (Lin et al., 2001; 
Dan et al., 2002; Sung et al., 2003). Activation of YSK1 requires oxidant stress and high 
levels of Ca2+ (Pombo et al., 1997). However, the signalling and function of GCK-III kinases 
in worms, flies and mammals has been rather poorly studied, so far.    
Recent studies in yeast, flies and human indicate that MST kinases are part of a conserved 
signalling module, together with NDR family kinases and MOB proteins (Mps one binder). 
This study shows for the first time that human MST3 activates an NDR kinase by 
hydrophobic motif phosphorylation. 
 
5. THE AGC GROUP OF PROTEIN KINASES 
 
The AGC group of protein kinases include the protein kinase B (PKB), glucocorticoid 
receptor kinase (GRK), dystrophia myotinica protein kinase (DMPK), nuclear Dbf2 related 
(NDR), microtubule-associated protein kinase (MAST), ribosomal protein S6 kinase (RSK), 
protein kinase A (PKA), phosphoinosited-dependent kinase 1 (PDK1), protein kinase C 
(PKC), protein kinase G (PKG), protein kinase N (PKN), RSK-like (RSKL) and yet another 
novel kinase (YANK) family kinases (Manning et al., 2002b). 
 
5.1 GENERAL FEATURES OF AGC-GROUP KINASES 
AGC group kinases share similar structural features. Two structural lobes form the catalytic 
domain, with the ATP binding site in between. Phosphorylation of the activation segment 
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phosphorylation site bridges the α-C helix with the catalytic and Mg2+ positioning loops and 
stabilizes the active conformation. Most AGC kinases are phosphorylated by PDK1 at their 
activation segment (Biondi, 2004).   
Another feature of all AGC kinases, except PDK1, is the C-terminal hydrophobic motif. This 
C-terminal region folds back onto the catalytic domain of the kinase and binds to a 
hydrophobic pocket in the small lobe of the kinase (Biondi, 2004). Most of the AGC kinases 
are regulated by phosphorylation of the hydrophobic motif, which results in an order to 
disorder transition of the α-C and α-B helices, stabilizing the active conformation of the 
kinase. However, a few kinases, such as PRK2, have constitutively ordered α-C and α-B 
helices, where the phosphorylation is mimicked by an aspartate mutant and, additionally, 
stabilizing amino acid residues (Yang et al., 2002; see also results section). The N terminus of 
AGC group kinases also contains a regulatory domain, such as the PH domain (in the case of 
PKB), cAMP (in the case of PKA) or cGMP (in the case of PKG) binding domain, Ca2+ 
binding domain or phorbol ester binding sites (in the case of PKC). These N-terminal 
domains are often responsible for recruitment of the kinases to their sites of phosphorylation 
and activation. These studies describe the regulation of NDR family kinases, which differ 
from other AGC group kinases in several respects.  
 
5.2 THE NDR KINASE FAMILY 
The NDR kinase family comprises the fission yeast kinases SID2 and ORB6, the budding 
yeast kinases DBF2, DBF20 and CBK1, the Caenorhabitis elegans kinases SAX-1 and LATS 
(T20F10.1), the Drosophila melanogaster kinases TRC and WARTS, and the mammalian 
kinases NDR1, NDR2, LATS1 and LATS2. Within the AGC group of protein kinases, NDR 
kinase shows some special features regarding structure, function and regulation (Tamaskovic 
et al., 2003b). 
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5.2.1.  STRUCTURE OF NDR PROTEIN KINASES 
A special feature of NDR kinases is their specific domain organisation. NDR kinases have an 
N-terminal regulatory S100B and MOB association (SMA) domain, which binds to S100B 
and/or MOB co-activator proteins (Millward et al., 1998: Bichsel et al., 2004). Adjacent to 
the SMA domain is the catalytic domain, which contains an insert between subdomains VII 
and VIII. This insert contains a basic sequence which resembles the peptide substrate 
sequence of NDR and probably acts as a pseudosubstrate or autoinhibitory sequence (AIS) 
(Bichsel et al., 2004; see also results section). Furthermore, NDR kinases contain two major 
regulatory phosphorylation sites: the activation segment phosphorylation site (Ser281 in 
NDR1); and a C-terminal hydrophobic motif phosphorylation site (Thr444 in NDR1). Figure 
2 shows the domain organization of NDR family kinases. LATS kinases have an elongated N 
terminus compared to NDR kinases. It contains glutamine- and proline- (flies) or proline-rich 
(human LATS) stretches. 
  
Figure 2. Domain organization of the human NDR protein kinases. 
The catalytic domain (CD), S100B and MOB association (SMA) domain, autoinhibitory sequence 
(AIS), and the hydrophobic motif (HM) are highlighted by boxes. The amino acid number of the 
catalytic domain, activation segment phosphorylation site and hydrophobic motif phosphorylation site 
are indicated. 
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5.2.2.  FUNCTIONS OF NDR PROTEIN KINASES 
NDR protein kinases are highly conserved kinases, known in organisms ranging from plants 
and fungi to euplotes and animals. This section introduces some of the best-characterized 
NDR kinases. The conservation of NDR kinases and NDR signalling pathways is illustrated 
in table 1. 
Table 1: NDR kinase signalling pathways 
a) The LATS pathway 
Organism Saccharomyces 
cerevisiae 
Saccharomyces 
pombe 
Caenorhabditis 
elegans  
Drosophila 
melanogaster 
Homo sapiens 
NDR 
kinase 
DBF2, DBF20 SID2 WARTS/T20F10.1 WARTS/LATS LATS1/WARTS,
LATS2/KPN 
Upstream 
kinase 
CDC15 SID1+CDC7 (F14H12.4a) HIPPO MST1/KRS2, 
MST2/KRS1 
Coactivator MOB1 MOB1 (F38H4.10)  
(F09A5.4d) 
(T12B3.4) 
DMOB1/MATS MOB1A,(B), 
(MOB3A,B,C) 
Scaffold NUD1 CDC11+SID4 (CBG02143) 
 
SALVADOR hWW45/ 
SAV1 
GTPase TEM1 SPG1 (RAB family 
GTPase) 
(RAB family 
GTPase) 
(RAB family 
GTPase) 
b) The NDR pathway 
Organism Saccharomyces 
cerevisiae 
Saccharomyces 
pombe 
Caenorhabditis 
elegans  
Drosophila 
melanogaster 
Homo sapiens 
NDR kinase CBK1 ORB6 SAX-1 TRI-
CORNERED 
NDR1,2 
Upstream 
kinase 
KIC1 NAK1 (GCK-1) (RE38276p) MST3, 
(MST4, YSK1)
Coactivator MOB2 MOB2 (T12B3.4) 
(F38H4.10)  
(F09A5.4d)  
DMOB1/MATS 
DMOB2, 
DMOB3, 4 
MOB1A,B, 
MOB2 
(MOB3A,B,C) 
Scaffold PAG1/TAO3 MOR2/CPS15 SAX-2 FURRY (AF4p12) 
Interactor HYM1 MO25 (Y53C12A.4) (DMO25) (MO25α,β) 
Methyl-
transferase 
(HSL7) SKB1 (C34E10.5) (CAPSULEEN) PRMT5 
 
The table indicates the conservation of components of the LATS and NDR signalling 
pathways from yeast to mammals. Orthologous proteins are in bold. However, evidence for 
an involvement of some of the conserved components in LATS/NDR kinase signalling is still 
missing, as indicated by the brackets. Slashes indicate synonymous names. 
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5.2.2.1.FUNGAL NDR KINASES 
The budding yeast NDR family kinases DBF2 and DBF20 are components of the mitosis exit 
network (MEN). Mutations of DBF2 cause cells to arrest in anaphase because of an elongated 
spindle and a large “dumbbell” morphology (Johnston et al., 1990). DBF2 activity and 
localisation are regulated in a cell cycle-dependent manner. Active DBF2 is localised to the 
spindle pole bodies in anaphase (Toyn and Johnston, 1994; Visintin and Amon, 2001). The 
MEN plays an important role in the inactivation of mitotic CDKs and the completion of 
cytokinesis (Bardin and Amon, 2001). 
The NDR kinase CBK1 is a central component of the regulation of ACE2 transcription and 
morphogenesis (RAM) network (Nelson et al., 2003). CBK1 mutants grow as large cell 
aggregates and have round cell morphology (Racki et al., 2000). Furthermore, the apical 
growth, mating projection formation and bipolar budding pattern is altered in CBK1 mutants 
(Bidlingmaier et al., 2001). Similar to DBF2, CBK1 shows a cell cycle-dependent localisation 
(Colman-Lerner et al., 2001; Weiss et al., 2002). CBK1 is required for the appropriate 
localisation of the ACE2 transcription factor, which is required for the expression of cyclin3 
(CLN3), glucanase (SCW11) and chitinase (CTS1) (O’Conallain et al., 1998; Colman-Lerner 
et al., 2001; Laabs et al., 2004). CBK1 also controls the polarized apical growth and mating 
projection formation in an ACE2-independent manner (Colman-Lerner et al., 2001). 
The MEN corresponding network in fission yeast is the septation initiation network (SIN). 
The NDR kinase of the SIN is SID2 (Bardin and Amon, 2001), which is involved in the 
coordination of mitosis exit and cytokinesis (McCollum and Gould, 2001). SID2 is cell cycle-
regulated in terms of activation and localisation and is required for actinomyosin ring 
constriction and septum formation after chromosome separation (Balasubramanian et al., 
1998; Sparks et al., 1999; Bardin and Amon, 2001). 
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The orthologous pathway of the RAM is the ORB6 signalling pathway. ORB6 regulates cell 
morphology and cell cycle progression. ORB6 mutants are spherical and do not have a bipolar 
growth pattern, which is associated with disorganised microtubule and actin cytoskeleton 
networks. Furthermore, entry in mitosis is accelerated (Verde et al., 1998). ORB6 delays the 
onset of mitosis by regulating CDC2 activity. Similar to CBK1, ORB6 kinase activity and 
localisation is regulated in a cell cycle-dependent manner (Verde et al., 1998). 
 
5.2.2.2.WORM NDR KINASES 
In Caenorhabditis elegans, two NDR kinases are known: a so far uncharacterised WARTS 
kinase, and SAX-1 protein kinase. SAX-1 mutants show morphological alterations in 
chemosensory and mechanosensory neurons. The neurons show reduced cell spreading and 
increased neurite outgrowth as well as a dentritic branching and tiling phenotype (Zallen et al., 
2000; Gallegos and Bargmann, 2004). Usually mechanosensory PML neurons undergo phases 
of active growth and maintenance growth. These growth phases are tightly regulated by cell-
cell signalling. The lack of growth inhibition in the SAX-1 signalling pathway causes an 
overlap of neighbouring dendrites (Gallegos and Bargmann, 2004). 
 
5.2.2.3.FLY NDR KINASES  
Drosophila melanogaster has two NDR family kinases, the WARTS (WTS) kinase and 
TRICORNERED (TRC). WARTS is an orthologue of human LATS kinase. WARTS was 
identified in a screen for overproliferation mutants that are lethal in early developmental 
stages (Justice et al., 1995; Xu et al., 1995) and is a tumour suppressor in flies. WARTS 
mutant cells have an aberrant cell shape and clones are round or spherical. Furthermore, 
WARTS is thought to regulate apoptosis by regulating DIAP (Drosophila inhibitor of 
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apoptosis) protein levels via regulating the transcriptional activity of YORKIE (YKI), a 
transcriptional coactivator protein (Huang et al., 2005b). 
TRICORNERED (TRC) kinase is about 70% identical to human NDR kinase. TRC mutations 
are organismal lethal. Clonal knockouts of TRC of cuticular structures such as wing hairs, 
bristles, lateral extensions of the arista or the larval denticle show a splitting and branching 
phenotype of these cellular extensions (Geng et al., 2000). Furthermore, TRC is proposed to 
interact with the actin cytoskeleton, because cytochalasin D or latrunculin A, inhibitors of 
actin polymerisation, partially phenocopy the TRC mutants. However, TRC does not affect 
actin polymerisation or bundling itself, but is important for the fine regulation of actin 
bundles and is thought to be a part of a morphogenetic checkpoint (Geng et al., 2000). Similar 
to the worm NDR kinase, TRC clonal mutants in sensory neurons show a dentritic branching 
and tiling phenotype. TRC mutants have excessive terminal branching, and homologous 
dentrites overlap due to a failure in repulsion (Emoto et al., 2004). 
 
5.2.2.4.MAMMALIAN NDR KINASE 
Four NDR family kinases exist in mice and humans: LATS1(hWARTS) and LATS2(KPM), 
as well as NDR1 and NDR2. LATS1 kinase, as is its Drosophila orthologue WARTS, is a 
tumour suppressor (St. John et al., 1999). Mice lacking LATS develop soft tissue sarcomas 
and ovarian stromal cell tumours, mammary gland development is impaired, they are infertile 
and growth is retarded (St. John et al., 1999). Similar to their yeast relatives, the activity and 
localisation of LATS are regulated during the cell cycle. Interestingly, LATS1 is localised to 
the centrosome in interphase cells and translocates to the spindle during metaphase and 
anaphase and to the midbody in telophase (Nishiyama et al., 1999). LATS1 is reported to 
restrict cell cycle progression and to promote apoptosis by regulating cyclin A and B as well 
as BAX levels (Yang et al., 2001; Xia et al., 2002). Furthermore, phosphorylated LATS1 
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interacts directly with CDC2 and inhibits its activity (Tao et al., 1999). LATS1 also ensures 
genomic integrity and cytokinesis by regulating mitotic cell cycle progression and inhibiting 
LIMK1 (Iida et al., 2004; Yang et al., 2004).  
LATS2 kinase is also implicated in restriction of proliferation and promotion of apoptosis 
(Kamikubo et al., 2003). LATS2 inhibits G1/S transition via downregulation of 
cyclinE/CDK2 activity (Li et al., 2003). Interestingly, the localisation to centrosomes and 
phosphorylation of LATS2 by AURORA-A shows a cell-cycle dependency similar to what is 
known from NDR family kinases in lower organisms (Toji et al., 2004). Taken together, both 
LATS1 and LATS2 control cell proliferation and apoptosis, but there might also be LATS1- 
or LATS2-specific functions.  
In contrast to the LATS kinases, very little is known about the mammalian NDR1 and NDR2 
kinases. Both Ndr1 (chromosome 6p21) and Ndr2 (chromosome 12p11) are located in regions 
that have been described as cancer amplicons (Manning et al., 2002a). Ndr1 mRNA is 
consistently upregulated in ductal carcinoma in situ, with intraductal necrosis and bad 
prognosis regarding progression to invasive tumours compared to DCIS without intraductal 
necrosis (Adeyinka et al., 2002). Human Ndr2 is upregulated in the highly metastatic non-
small cell lung cancer cell line NCI-H460 (Ross et al., 2000). The murine Ndr2 gene was 
found to be interrupted in two independent B-cell lymphomas generated by retroviral 
insertional mutagenesis (Suzuki et al., 2002).  
Furthermore, Ndr2 mRNA has been found upregulated in the mouse amygdala during fear 
memory consolidation. It is also worth noting that NDR2 expression in PC12 cells results in 
decreased cell spreading and alterations in neurite outgrowth (Stork et al., 2004). This points 
to common functions of worm, fly and mammalian NDR kinases in controlling neuronal 
morphology. 
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Recently, NDR1 and NDR2 have also been identified in HIV-1 viral particles. The viral 
protease cleaves off the C-terminal hydrophobic motif of NDR1 and NDR2 kinases, which 
leads to an inhibition of NDR kinase activity, indicating that NDR kinase might affect the 
viral lifecycle (Devroe et al., 2005). 
Recent data from our laboratory using NDR-deficient mouse embryo fibroblasts and stable 
cell lines overexpressing NDR kinase also indicate a role of NDR in the regulation of cell 
cycle progression, genomic integrity and cell death (Tamaskovic et al., in prep.). 
 
5.2.3. REGULATION OF NDR PROTEIN KINASES (part of a review in 
preparation for Nature Reviews Molecular Cell Biology) 
A common regulatory element of kinase activity is phosphorylation. NDR kinases, like other 
AGC group kinases, contain two major regulatory phosphorylation sites: the activation 
segment (AS) phosphorylation site (Ser281 for human NDR1); and the hydrophobic motif 
(HM) phosphorylation site (Thr444 in human NDR1). In contrast to other AGC group kinases, 
where PDK1 is the AS kinase (Biondi, 2004), the NDR kinase activation segment is regulated 
by autophosphorylation, whereas the hydrophobic motif is targeted by an upstream kinase 
(Tamaskovic et al., 2003a). The importance of HM phosphorylation for AGC group kinases is 
well illustrated by the structure of activated PKB (Yang et al., 2002). Phosphorylation results 
in a structural ordering of the α-C helix. This enables an interaction of the helix with the 
activation segment phosphorylation site, which restructures the activation segment in an 
active conformation. Phosphorylation and activation of NDR and LATS kinase can be 
induced by treatment of cells with okadaic acid, a potent inhibitor of phosphatase 2A (PP2A) 
(Millward et al., 1999). Mimicking this phosphorylation by replacing the HM of NDR with 
the PIFtide sequence (the HM phospho mimic derived from PRK2), results in a constitutively 
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active NDR kinase (Stegert et al., 2004; this study). Furthermore, PP2A negatively regulates 
the yeast MEN network (Wang and Ng, 2005). 
In the past few years, studies in yeast and flies have demonstrated that STE20-like kinases 
genetically interact with and phosphorylate NDR kinases. CDC15 in budding yeast is required 
for phosphorylating and activating the NDR kinases DBF2 (Mah et al., 2001). Drosophila 
Hippo, an MST1/2 orthologue, phosphorylates WARTS, a LATS orthologue. Furthermore, 
human MST1 and MST2 phosphorylate LATS1 and LATS2 in vitro (Chan et al., 2005). 
MST3 is the first STE20-like kinase which has been shown to specifically phosphorylate the 
NDR kinase hydrophobic motif, but not the activation segment, providing a mechanism for 
the interaction of STE20-like kinases with NDR kinases (see results section). The localisation 
of NDR kinase and STE20-like kinase is critical for NDR kinase activation, and provides a 
tool to coordinate cellular events in a temporal and spatial manner (Visintin and Amon, 2001; 
Hergovich et al., 2005; see also results section). Interestingly, STE20-like kinases are also 
activated by PP2A inhibition (Kakeya et al., 1998; Praskova et al., 2004; see also results 
section). The close collaboration between NDR family kinases and MST kinases points to a 
common role of these kinases in the regulation of cell cycle progression, apoptosis and 
morphology. 
Another mode of regulation of NDR kinases is the binding of a coactivator to the N terminus 
of the kinase. MOB proteins were shown to genetically and physically interact with NDR 
kinases in yeast, flies and man. MOB proteins bind to the N-terminal S100B and MOB 
association domain (SMA) of NDR kinase (Bichsel et al., 2004). In yeast MOB proteins are 
important for the activation of NDR kinases (Hou et al., 2000, 2002, 2004; Mah et al., 2001; 
Weiss et al., 2002). In budding and fission yeast there are two MOB proteins, MOB1 and 
MOB2 proteins, which show a specific binding to DBF2/SID2 and CBK1/ORB6 respectively. 
In contrast, in flies and humans DMOB1(MATS) and hMOB1 proteins bind and activate both 
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NDR and LATS kinases (Bichsel et al., 2004; Devroe et al., 2004; He et al., 2005a; Lai et al., 
2005), whereas MOB2 binds preferentially to NDR1/2 kinase (Bothos et al., 2005; He et al., 
2005a). So far, little is known about the other MOB proteins, but genetic evidence indicates 
that they also play a role in NDR kinase regulation (He et al., 2005a). The binding of MOB1 
releases NDR kinases from autoinhibition mediated by the AIS within the kinase domain 
insert (Bichsel et al., 2004; see also results section). The binding of MOB proteins is 
dependent on the interaction of its negatively charged surface with the basic-hydrophobic N 
terminus of NDR kinases (Stavridi et al., 2003; Bichsel et al., 2004; Ponchon et al., 2004). 
However, the exact binding mode and affinity differs between different MOB proteins 
(Devroe et al., 2004; He et al., 2005a). MOB1 protein from okadaic acid-treated cells show a 
higher affinity to NDR kinases than MOB1 from untreated cells, indicating that 
posttranslational modifications of MOB proteins might also have an impact on their affinity to 
NDR kinase (Bichsel et al., 2004). Interestingly, a MOB relative phocein is reported to 
interact with the PP2A B’’’-subunits straitin, zinedin and SG2NA (Baillat et al., 2001; 
Moreno et al., 2001). Therefore, MOB protein binding to PP2A might explain the low NDR 
kinase activity in unstimulated cells. (Millward et al., 1999; Stegert et al., 2004; see also this 
study).  
Furthermore, MOB proteins are thought to activate the kinase by the disruption of an 
inhibitory self-association of the kinase molecules (Hou et al., 2004). MOB proteins are also 
important for NDR localisation (Luca et al., 2001; Weiss et al., 2002; Hou et al., 2004). 
Fission yeast MOB1 is required for spindle pole and division site localisation of Sid2p, which 
is thought to enable the kinase to regulate cytokinesis (Hou et al., 2004). Budding yeast 
MOB2 and CBK1 are interdependent in terms of localisation (Weiss et al., 2002) to the 
nucleus and cortical sites. Interestingly, the localisation of human NDR1 and NDR2 and 
LATS1 and LATS2 to cellular membranes by membrane targeting results in a constitutive 
 43
activation of the kinase (Hergovich et al., 2005; Hergovich unpub. results). Recruitment of 
MOB proteins to cellular membranes co-recruits NDR and results in full phosphorylation and 
activation of the kinase (Hergovich et al., 2005). Inducible membrane recruitment of NDR 
kinase via MOB also provides evidence that HM phosphorylation is dependent on MST 
kinases (see results section).  
However, it is as yet unclear what drives the localisation of NDR or MOB to cellular 
membranes in vivo. MOB and STE20-like kinases are common element of both NDR and 
LATS kinase activation. Other components of the pathway might be specific for either NDR 
or LATS. 
S100B proteins, EF- hand calcium binding proteins, also bind to the N terminus of NDR 
kinases and stimulate the autophosphorylation activity of NDR kinases in a calcium (Ca2+)-
dependent manner (Millward et al., 1998; Stegert et al., 2004; Tamaskovic et al., 2003a). 
Furthermore, experiments using the calcium-chelator BAPTA-AM indicate that 
phosphorylation at the activation segment as well as at the hydrophobic motif are calcium 
dependent (Tamaskovic et al., 2003a). However, it is not known whether LATS kinases are 
also dependent on calcium and bind to S100 proteins.  
FURRY proteins are specific for the NDR kinase signalling pathway. The yeast FURRY 
proteins PAG1/MOR2 physically interact and are important for the activation of the yeast 
NDR kinases CBK1/ORB6 (Du and Novick, 2002; Hirata et al., 2002). The worm and fly 
FURRY proteins (Sax-2 and FURRY) show a strong genetic interaction with NDR kinases 
SAX-1 and TRC (Cong et al., 2001; Emoto et al., 2004; Gallegos and Bargmann, 2004; He et 
al., 2005b). In addition, TRC physically interacts with, and requires, FURRY for activation 
(Emoto et al., 2004; He et al., 2005b). A human homologue of FURRY, AF4p12, is fused to 
mixed lineage leukaemia (MLL) in leukaemia patients (Hayette et al., 2005). FURRY is 
thought to function as a scaffolding protein (Du and Novick, 2002; He et al., 2005b), but 
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might also exhibit some transcriptional activity (Hayette et al., 2005). The scaffolding 
proteins of the LATS kinases are SALVADOR proteins. SALVADOR proteins (called 
hWW45 in humans) contain two WW domains and bind to LATS kinases (Tapon et al., 2002). 
However, SALVADOR is less conserved than FURRY, and there is no clear orthologue in 
yeast. The scaffolding proteins in the MEN and SIN networks are NUD1 and SID4, together 
with CDC11 (Bardin and Amon, 2001; see also table 1). 
MEN and SIN networks also comprise the GTPases TEM1 or SPG1, RAS family GTPases 
which are most closely related to RAB GTPases. TEM1 regulates the activation of CDC15 at 
the spindle pole bodies (Molk et al., 2004). So far, no activating GTPase interaction is known 
for mammalian STE20-like kinases. In contrast to the MEN and SIN networks, no GTPase 
has been identified for the RAM network or the ORB6 signalling pathway. However, the 
STE20-like kinases of these signalling module were shown to genetically and physically 
interact with the MO25 proteins, HYM1p and MO25 (Dorland et al., 2000; Bidlingmaier et 
al., 2001; Bogomolnaya et al., 2004; Kanai et al., 2005). The mammalian MO25 proteins 
interact with STRAD proteins, a STE20-like pseudokinase and LKB1 (Baas et al., 2004; 
Boudeau et al., 2004) and functions as a scaffold, or adaptor, protein (Milburn et al., 2004). 
The Drosophila MO25 does not appear to interact genetically with the NDR kinase TRC, 
indicating that MO25 might not regulate NDR in flies (He et al., 2005a). However, further 
studies, including mutants and phenotypes of the upstream kinase, are required to exclude this 
possibility.  
In fission yeast, the NDR kinase ORB6 also directly interacts with the methyltransferase 
SKB1, an orthologue of human PRMT5. SKB1 influences the intracellular localisation of 
ORB6 to cellular tips and exacerbates the phenotype of ORB6 mutants (Wiley et al., 2003). 
Interestingly, human NDR1 was found in a transcriptional complex together with FCP1, a 
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PRMT5 interactor, indicating a potential collaboration of PRMT5 with human NDR kinases 
(Amente et al., 2005). 
Several reports have suggested that there is an interaction between LATS and NDR kinase 
pathways, indicating that LATS might partially control NDR activation and/or localisation 
(Weiss et al., 2002; He et al., 2005a; Kanai et al., 2005). A feedback mechanism, whereby 
active NDR induces cleavage of its upstream kinase MST3, might be used to regulate the 
signal intensity (see results section). Similarly, LATS kinases activate caspases and induce 
apoptosis (Ke et al., 2004), which is likely to induce cleavage of MST1/2. 
In HIV-1 NDR kinase activation itself is inhibited by proteolytic cleavage mediated by the 
viral protease (Devroe et al., 2005). Truncation of NDR2 at the cleavage site also alters its 
subcellular localisation (Devroe et al., 2005).  
The multiple modes of regulation reflect the tight control of NDR and LATS kinase activity 
in vivo and suggest a spatial and temporal activation of these kinases. 
 
 
6. AIMS OF THIS STUDY 
 
The aim of this study was to gain further insights into the function and regulation of 
mammalian NDR kinases. This study reports the identification and cloning of human Ndr2 
and mouse Ndr1 and Ndr2. It shows expression patterns of mouse Ndr1 and Ndr2 mRNA. 
The main part of this work covers the regulation and activation of NDR protein kinase by 
phosphorylation and binding of the coactivator proteins S100B and MOB1A. The study 
demonstrates that activation of NDR is a multi-step process involving autophosphorylation at 
the activation segment, hydrophobic motif phosphorylation by mammalian STE20-like kinase 
3 (MST3), and release of autoinhibition by MOB1A. Furthermore, it provides evidence that 
NDR kinase is involved in a feedback mechanism which regulates the cleavage of MST3. 
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This suggests a potential role of NDR in the regulation of apoptosis. Therefore, this study 
proposes a general mechanism for the interaction of STE20-like kinases and NDR kinases: 
hydrophobic motif phosphorylation. 
To address the function of NDR kinases in mammals, NDR1 knockout mice were generated. 
The initial characterisation of the NDR1 deficiency is described in the third part of the results 
section. However, NDR1 mice show only a mild or late-onset phenotype. Data from mouse 
embryonic fibroblasts (MEFs) provide evidence that ablation of NDR1 kinase is partly 
compensated by NDR2 upregulation.   
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Summary 
 
NDR protein kinases are a family of AGC group kinases that are involved 
in the regulation of cell division and cell morphology. We describe the cloning 
and characterisation of the human and mouse NDR2, a second mammalian 
isoform of NDR protein kinase. NDR1 and NDR2 share 86% amino acid identity 
and are highly conserved between human and mouse. However, they differ in 
expression pattern: mouse Ndr1 is expressed mainly in the spleen, lungs and 
thymus, whereas mouse Ndr2 shows highest expression in the gastrointestinal 
tract. NDR2 is potently activated in cells following treatment with the protein 
phosphatase 2A inhibitor okadaic acid, which also results in phosphorylation of 
the activation segment residue Ser-282 and the hydrophobic motif residue Thr-
442. We show that Ser-282 becomes autophosphorylated in vivo, whereas Thr-
442 is targeted by an upstream kinase. This phosphorylation can be mimicked by 
replacing the hydrophobic motif of NDR2 with a PRK2-derived sequence, 
resulting in a constitutively active kinase. Similar to NDR1, the 
autophosphorylation of NDR2 protein kinase was stimulated in vitro by S100B, 
an EF-hand Ca2+-binding protein of the S100 family, suggesting that the two 
isoforms are regulated by the same mechanisms. Further, we show a 
predominant cytoplasmic localisation of ectopically expressed NDR2.  
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Introduction 
 
The NDR protein kinase family is a member of the AGC group of 
serine/threonine kinases, which includes cAMP-dependent kinase, cGMP-dependent 
kinase, protein kinase B and protein kinase C (1). The human NDR protein kinase is 
highly conserved and is expressed almost ubiquitously (2). The closest members of 
the mammalian NDR protein kinase family which come from lower organisms, TRC, 
SAX-1, Cbk1p and Orb6p, are all involved in the control of cell morphology. The 
Drosophila NDR kinase TRC regulates the integrity of epidermal cell extensions, 
such as sensory bristles, arista and wing hairs, by affecting the actin cytoskeleton, and 
is thought to form a part of a putative morphogenetic checkpoint (3). SAX-1 is the 
Caenorhabditis elegans NDR protein kinase and is reported to play an important role 
in the regulation of neuronal cell shape and neurite initiation (4). The relatives of 
NDR protein kinase in Saccharomyces cerevisiae and Schizosaccharomyces pombe, 
Cbk1 and Orb6, are also essential for normal morphogenesis, cell polarity and 
coordinating cell morphology with the cell cycle (5-8).  
NDR protein kinase and its relatives have a conserved structure consisting of 
an N-terminal S100B/calmodulin binding site, a catalytic kinase domain containing an 
insertion between subdomains VII and VIII (encompassing, in the case of NDR, a 
nonconsensus nuclear localisation signal and the activation loop phosphorylation site), 
and a C-terminal regulatory domain (2,9,10). The human NDR1 protein has been 
shown to become autophosphorylated on Ser-281 and activated when S100B binds in 
a Ca2+-dependent manner. The C-terminal regulatory phosphorylation site Thr-444 is 
phosphorylated in vivo by an upstream kinase, so far unidentified (11). This 
phosphorylation within the hydrophobic motif, which is an event typical of the 
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regulation of many AGC-group kinases, mediates kinase activity and protein stability 
(12,13). Some kinases, such as PRK2, have an Asp residue instead of a Ser or Thr 
residue, and a mutation of the hydrophobic phosphorylation site to an Asp has been 
shown to result in a constitutively active hydrophobic motif for several kinases 
(14,15). 
Here, we describe the characterisation of a second isoform of NDR protein 
kinase, termed NDR2, and show that mNdr1 is widely expressed, whereas mNdr2 is 
mainly expressed in the gastrointestinal tract of mice. NDR2 becomes activated in 
vivo following phosphorylation of three conserved sites, Thr-75, Ser-282 and Thr-442. 
Further, an NDR2-PIFtide chimera, which contains the PRK2 hydrophobic motif 
(PIFtide), is constitutively active. In vitro, the Ca2+ binding protein S100B stimulates 
activation of NDR2 and autophosphorylation on Thr-75, Ser-282 and Thr-442. 
 
Experimental Procedures 
PCR and Molecular cloning ⎯ BLAST searches of the NCBI database were 
performed to identify NDR-related sequences. The Ndr2 cDNA was assembled by 
PCR screening using a Marathon-ReadyTM human brain cDNA library (Clontech) 
following standard protocols (16). The mouse Ndr1 cDNA was cloned from a mouse 
λZAPII (Stratagene) cDNA library; the mouse Ndr2 cDNA was cloned using a 3’ 
mEST (GeneBank accession number AA277870) and subcloning the 5’ end from a 
mouse brain cDNA library (Clontech) using PCR. Sequences of all clones were 
obtained using an ABI PRISM 3700 DNA Analyzer (Applied Biosystems) using 
custom synthesised primers, and compared to the appropriate genomic databases 
(Ensembl and Celera). Sequence analysis was performed using Seqweb 1.2 (Genetics 
Computer Group, Inc.). 
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 Plasmids ⎯ Mammalian expression vectors encoding HA and GST-epitope 
tagged hNDR1  described previously (2). Expression vectors for HA-hNDR2 and 
GST-NDR2 were constructed in a similar way. GFP-Ndr2 was constructed by 
amplifying the Ndr2 cDNA with primers 5’-CGGGATCCGGTACCATGGCAATG-
ACGGCAGGGACTAC-3’ and 5’-CGGGATCCCTTCATTCATAACTTCCCAGC-
3’ using Pfu polymerase (Promega). The PCR product was then digested using 
BamHI and cloned into pEGFP-C1 (Clontech). HA-NDR2-PIFtide was constructed 
by amplifying NDR2 cDNA with primers 5’-CTTCCAAGCTTAGTCGACATGGC-
TTACCCATACGATGTTCCAGATTACGCTTCGGCAATGACGGCAGGGACTA-
CAACAACC-3’ and 5’-CGGGATCCTCACCAGTCGGCGATGTAGTCGAAGTC-
GCGGAACATCTCCTGCTCCTCTTTGTAGTCCGGTTCTGTGGTTATT-3’ using 
Pfu polymerase (Promega). The PCR product was then digested using BamHI and 
SalI and cloned into pCMV5. All plasmids were confirmed by sequence analysis.
 RNA Extraction and Real-time RT-PCR ⎯ Tissues of three 129SvPas mice 
were isolated and subjected to RNA extraction using Trizol Reagent (Invitrogen) and 
the RNeasy 96 kit (Qiagen). Reverse transcription reactions were performed using the 
GeneAmpRNA PCR kit according to the manufacturer’s instructions (Applied 
Biosystems). Real-time quantitative PCR analysis was performed using an ABI Prism 
7700 Sequence Detector. Specific primers and probes for each gene were designed 
using Primer Express 2.0 software. Amplicon sizes were 67 bp for mNdr1 and 98 bp 
for mNdr2. TaqMan PCR reactions were performed for mNdr1, mNdr2 and 18S 
rRNA according to the user manual. Details of primers and probes are available on 
request. Relative quantifications were performed by comparing the corrected Ct value 
of each tissue to the corrected Ct value of the brain, as described in the ABI PRISM 
7700 user bulletin number 2. 
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Bacterial Expression and Kinase Assay of Human GST-fused NDR2 ⎯ 
Expression of pGEX-2T_NDR2 species in the BL21-DE3 (pRep4) E. coli strain and 
in vitro kinase assays [autophosphorylation in presence or absence of 100 µM CaCl2 
and 10 µM bovine S100B (Sigma)] were performed, as described previously for 
NDR1 (11). 
Cell Culture and HA-NDR2 Kinase Assay ⎯ Culture and transfection of 
COS-1 and COS-7 cells, and measurement of kinase activity of HA-NDR2 variants 
were as described previously for HA-NDR1 (9). 
Western Blotting ⎯ Immunodetection of NDR2 phosphorylated on Thr-75, 
Ser-282 or Thr-442 was as previously described (11). 
Mass Spectrometry ⎯ Analysis of the phosphorylation sites of GST-NDR2 
was performed according to Tamaskovic et al. (11). 
Immunofluorescence Microscopy ⎯ Exponentially growing cells were plated 
on coverslips and transfected the next day with indicated constructs using Fugene 6 
(Roche) as described by the manufacturer. After 24 h of transfection, cells were 
washed with PBS and fixed in 3% paraformaldehyde/2% sucrose in PBS at pH 7.4 for 
10 min at 37°C. They were then permeabilised using 0.2% Triton X-100 in PBS for 2 
min at room temperature. All subsequent steps were carried out at room temperature. 
Coverslips were rinsed twice with PBS and incubated for 1 h with anti-HA Y11 
(Santa Cruz) diluted in PBS containing 1% BSA/1% goat serum. After three 1-min 
washes in PBS, goat anti-rabbit FITC (Sigma) was used as the secondary antibody. 
DNA was counterstained with 4 µg/ml Hoechst (Sigma). Coverslips were then 
inverted into 5 µl Vectashield medium (Vector Lab). Images were obtained with an 
Eclipse E800 microscope using a CoolPix950 digital camera (Nikon) and processed 
using Adobe Photoshop 6.0 (Adobe Systems Inc.). Only cells with intact nuclei were 
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included in the statistical evaluation. Cells expressing GFP-NDR2 were fixed and 
then stained for DNA without permeabilisation and antibody incubation steps. 
 
 
Results 
Conservation of NDR Kinases ― BLAST searches of the NCBI database identified 
the human KIAA0965 clone (GeneBank accession number AB023182/ hj06174s1) as 
a partial cDNA with significant homology to human NDR1 protein kinase. We 
determined the sequences of hNdr2, mNdr1 and mNdr2 cDNAs, and the 
corresponding mouse genes. The deduced amino acids sequences were compared and 
aligned to the known sequences of hNDR1, D. melanogaster NDR TRC, C. elegans 
NDR SAX-1 and S. cerevisiae Cbk1 (Fig.1). The human and mouse NDR1 sequences 
show 99% identity, the NDR2 sequences 97%, and NDR1 and NDR2 show an 
identity of 86%, the identity to fly, worm and yeast NDR kinases are 68%, 67% and 
47% respectively, indicating an extremely high sequence conservation during 
evolution. Human and mouse NDR2 are 464 amino acids long, with a predicted mass 
of 54 kDa. Gene mapping indicates that hNdr1 and mNdr1, as well as hNdr2 and 
mNdr2, are located on orthologous regions: hNdr1 maps to 6p21 (17), and hNdr2 to 
12p12.3. The corresponding mouse genes map to 17B1 and 6G2-G3. In addition, 
pseudogenes of Ndr2 were found on chromosomes 1D and 8A1.2 of the mouse 
genome. The human and mouse genes consist of 14 exons, with conserved intron-
exon boundaries. Exon 1 is a non-coding exon containing 5’ UTR, exon 2 contains the 
start codon, and the stop codon is located in exon 14 (data not shown). 
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Fig. 1. Amino acid sequence alignment of Homo sapiens, Mus musculus, Drosophila 
melanogaster, Caenorhabditis elegans and Saccharomyces cerevisiae NDR. The NDR 
amino acid sequences were aligned using Seqweb 1.2. Identical amino acids are shaded in 
yellow and similar residues in red. Dots represent gaps inserted to bring the sequences into 
alignment. The NDR phosphorylation sites Thr74, Ser 281 and Thr 444 are indicated with 
arrows and numbered according to hNDR1. The predicted NLS is indicated. 
 
Tissue-specific Expression of Ndr1 and 2 ― TaqMan real-time PCR analysis 
was used to examine the differential expression of mNdr1 and mNdr2 in mouse 
tissues obtained from three different mice (Fig. 2). The expression of 18S rRNA was 
used as a reference gene to correct for RT-PCR efficiency of each sample. The 
highest expression levels of mNdr1 were observed in the spleen, lungs, thymus, brain 
and fat tissue, whereas mNdr2 expression was mainly found in the large and small 
intestine, as well as in the stomach and testes. Assuming similar PCR efficiency for 
both reactions, mNdr2 appears to be the predominantly expressed isoform in mice. 
These data indicate tissue-specific functions of NDR1 and NDR2 in mammals. 
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Fig. 2. Relative mRNA expression levels of mNdr1 (A) and mNdr2 (B) determined by 
quantitative real-time PCR. The expression levels of mNdr1 and mNdr2 are shown. RNA 
samples from three mice were collected and reverse transcribed. Each value was normalised 
against the expression of 18S RNA and compared to the relative expression of mNdr1 or 
mNdr2 in the brain. 
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Regulation of NDR2 Kinase Activity ― Comparison of the NDR2 and NDR1 
sequences showed that NDR2 contains three conserved phosphorylation sites 
corresponding to the described NDR1 phosphorylation sites Thr-75, Ser-281 and Thr-
444 (10). NDR2 mutants were created, in which Thr-75, Ser-282 or Thr-442 were 
replaced by an alanine, and a kinase-dead mutant K119A was also made. The protein 
kinase activity of each of these mutants was measured following treatment of 
transfected Cos1 cells with 1 µM okadaic acid (OA), or solvent alone, for 1 h. HA-
NDR2-WT was potently stimulated (∼10-fold) by OA (Fig. 3). All three 
phosphorylation site mutants (T75A, S282A and T442A) displayed reduced basal 
activity and could not be stimulated by OA treatment. The K119A mutation reduced 
basal activity to almost undetectable levels and, as expected, abolished the activation 
by OA. Western blot analysis of the regulatory phosphorylation site mutants T75A, 
S282A, T442A and wild type with phospho-specific antibodies, which recognise the 
phospho-epitopes Ser-282P and Thr-442P, showed that NDR2 became 
phosphorylated on Ser-282 in wild type, T442A and T75A, and that this 
phosphorylation increased after OA treatment in the wild type and T442A, but not in 
the mutant T75A. The kinase-dead K119A mutant did not become phosphorylated on 
Ser-282, indicating that Ser-282 is an autophosphorylation site.  
Thr-442 became phosphorylated upon OA treatment in NDR2 wild type, as well as in 
the S282A, T75A and K119A mutants, suggesting that Thr-442 is phosphorylated 
independently of NDR2 activity and is therefore targeted by an upstream kinase (Fig. 
3). These results confirmed that phosphorylation on both the activation segment 
phosphorylation site Ser-282 and the regulatory hydrophobic motif phosphorylation 
site Thr-442 are required for NDR2 activation. In addition, NDR2 activity also 
depends on the presence of Thr75 in the N-terminal regulatory domain. 
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Fig. 3. NDR2 kinase activity and phosphorylation status of NDR kinase mutants. A, 
COS-1 cells expressing either wild-type HA-NDR2 or the indicated mutants were treated for 
1 h with 1 µM okadaic acid (OA) or with solvent alone. HA-tagged NDR kinase variants were 
then immunoprecipitated (100 µg of cell-free protein extracts) with 12CA5 monoclonal 
antibody and assayed for kinase activity using a peptide substrate as described under 
“Experimental Procedures”. Bars represent the mean ± S.D. of triplicate 
immunoprecipitations. B, An aliquot (100 µg protein) of 12CA5-immunoprecipitated proteins 
from transfected COS-1 cells was immunoblotted with 12CA5 to verify similar expression 
levels of each HA-NDR2 construct (top panel). For the analysis of phosphorylation status, 
12CA5-immunoprecipitated HA-NDR2 variants (100 µg protein) were analysed by 
immunoblotting with phosphospecific antibodies directed against phosphorylated Ser-282 or 
phosphorylated Thr-442 (middle and bottom panels, respectively).  
 
Constitutive Active NDR2 ― The phosphorylation of Ser/Thr residues can be 
mimicked by the substitution with Asp or Glu for several kinases (14). However, we 
have recently shown that T444D or T444E mutations have only a very moderate 
effect (1.5- to 2-fold activation) on NDR1 kinase activity (10). Previous studies with 
PKB showed that the active state of the N-lobe hydrophobic groove, which is 
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dependent on an ordered αC-helix, could also be achieved by substituting the 
hydrophobic motif of PKB with the constitutive active hydrophobic motif of PRK2 
(PIFtide) (15).  
 
Fig. 4. NDR2-PIFtide chimera is constitutively active. A, COS-1 cells expressing either 
wild-type HA-NDR2 or the HA-NDR2-PIFtide chimera were treated for 1 h with 1 µM OA or 
with solvent alone. HA-tagged NDR kinase variants were then immunoprecipitated (100 µ g 
of cell-free protein extracts) with 12CA5 monoclonal antibody and assayed for kinase activity 
using a peptide substrate as described under “Experimental Procedures”. Bars represent the 
mean ± S.D. of triplicate immunoprecipitations. B, For the analysis of phosphorylation status, 
12CA5-immunoprecipitated HA-NDR2 variants (100 µg protein) were analysed by 
immunoblotting with phosphospecific antibodies directed against phosphorylated Thr-442, 
phosphorylated Ser-282 or phosphorylated Thr-442 (top and middle panels, respectively). An 
aliquot (100 µg protein) of 12CA5-immunoprecipitated proteins from transfected COS-1 cells 
was immunoblotted with 12CA5 to verify similar expression levels of each HA-NDR2 
construct (bottom panel). 
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Based on the similarities between AGC group kinases, we created an NDR2-PIFtide 
chimera, aiming to generate an active kinase. Indeed, the NDR2-PIFtide had a more 
than 20-fold elevated basal kinase activity, and even increased activity compared with 
OA-stimulated NDR2 (Fig. 4A). Phosphorylation site analysis showed increased 
Ser282 phosphorylation in the NDR2-PIFtide chimera, suggesting increased 
autophosphorylation activity (Fig. 4B).  
Therefore, we have shown that substitution of the hydrophobic motif of NDR2 with 
the PIFtide sequence results in a constitutively active NDR2 kinase, describing for the 
first time a constitutively active variant of the NDR protein kinase. 
 Activation of NDR2 by S100B ― The sequence conservation between NDR1 
and NDR2 also encompasses the previously defined S100B-binding domain of NDR1 
(see Fig. 1). Therefore, the in vitro effect of Ca2+/S100B on NDR2 activity was 
investigated. Ca2+/S100B increased the rate of NDR2 autophosphorylation 
approximately 2-fold after a 4-h incubation (Fig. 5A) and stimulated specific NDR 
activity approximately 4-fold in a concentration-dependent manner (Fig. 5B). This 
indicates that NDR2 activation by Ca2+/S100B also occurs by the mechanism reported 
for NDR1 (9,11). After in vitro incubation of GST-NDR2 in the presence or absence 
of Ca2+/S100B, the proteins were digested with trypsin and the resultant mixture 
analysed by ESI-MS-MS in a –79 precursor scan (18). This technique measures the 
mass to charge ratio (m/z) of all peptide species liberating a single phosphate group 
after fragmentation. Five (NDR2-derived) phospho-peptides were identified in both 
samples (the GST-NDR2 and the GST-NDR2/Ca2+/S100B), corresponding to the 
phosphorylation sites Thr-75, Ser-282 and Thr-442 (Fig. 5C). These results 
demonstrate that S100B proteins regulate NDR2 by a mechanism similar to that 
reported for NDR1 (11). 
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Fig. 5. Ca2+/S100B promotes the auto- and transphosphorylation of GST-NDR2. A, An 
aliquot (1 µg) of purified GST-NDR2 wild type (~0.5 µM) was autophosphorylated for the 
indicated time periods in vitro without further additions (filled circle) or in the presence of 
100 µM CaCl2 and 10 µM bovine S100B (open circle) as indicated. B, An aliquot (1 µg) of 
purified GST-NDR2 was autophosphorylated at 30°C for 2 h in the absence or presence of 
increasing concentrations of S100B. C, Mapping of NDR2 in vitro autophosphorylation sites. 
An aliquot (10 µg) of GST-NDR2 was autophosphorylated for 2 h in the absence or presence 
of 100 µM CaCl2 and 10 µM bovine S100B. After separation by SDS-PAGE, GST-NDR2 
was excised and processed by tryptic cleavage for MS analysis of phosphopeptides by 
precursor ion scanning of m/z –79. Phosphopeptides whose m/z could be assigned to NDR2-
derived phosphopeptides are labelled P1-P5. Some peptides were detected in several charged 
states [M-2H]2-, [M-3H]3-, etc. Peptide P1/P3 results presumably from a trace of chymotryptic 
contamination of the trypsin preparation, because it overlaps with P2 and terminates with an 
aromatic residue. Asterisks denote an abundant double-charged, nonphosphorylated NDR2 
peptide (379-392) with m/z 862. 
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Localisation of NDR2 ― To examine the subcellular localisation of NDR2, COS-7 
and HeLa cells were transfected with either N-terminally GFP-tagged NDR2 (GFP-
NDR2) or HA-NDR2 and processed for indirect immunofluorescence (Fig. 6A; data 
not shown). A statistical analysis showed that both proteins were detected mainly in 
the cytoplasm of both COS-7 cells and HeLa cells under these experimental settings 
(Fig. 6B). Similar results were also obtained when U2-OS cells were studied (data not 
shown). Thus, in marked contrast to the localisation pattern described for NDR1 (2), 
NDR2 was not predominantly localised to nuclear structures. For unknown reasons, 
NDR2 was found to be mainly cytoplasmic, even though it contains the same NLS as 
NDR1 (see Fig.1). 
 
 
Fig. 6. NDR2 localises mainly to cytoplasmic structures. A, COS-7 cells expressing GFP-
NDR2 (upper panels) or HA-NDR2 (lower panels) were processed for immunofluorescence 
using either no antibody (upper right) or anti-HA Y11 (lower right). Anti-HA antibody was 
visualised using anti-rabbit FITC (green). Corresponding DNA stains (blue; left panels). B, 
HeLa (light) and COS-7 (dark) cells expressing GFP-NDR2 were processed for 
immunofluorescence and GFP signals were scored as either mainly nuclear (N), nuclear and 
cytoplasmic (N/C) or predominantly cytoplasmic (C). The blotted numbers represent at least 
two independent experiments (±SD). A minimum of 150 cells was counted per experiment. 
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Discussion 
 In this study, we describe the cloning and characterisation of the NDR2 
protein kinase, a second isoform of mammalian NDR protein kinase. The extremely 
high conservation of NDR protein kinases throughout the eukaryotic world indicates 
that this kinase is subject to a very high evolutionary pressure. Mouse and human 
NDR kinases also show a conserved gene organisation of 14 exons. It is likely that the 
kinases are components of a conserved signalling pathway (1). This has already been 
shown genetically for one component of the pathway, the FURRY/MOR2/PAG1 
protein, the mutation of which results in similar phenotypes in D. melanogaster, S. 
pombe and S. cervisiae, as reported for NDR kinase mutations (19-21). There is no 
information on the function of the human FURRY protein. 
Our results show that NDR2 is regulated by multi-site phosphorylation similar 
to many of the AGC family of protein kinases. Mutation of one or both 
phosphorylation site residues Ser-282 and Thr-442 of NDR2 led to an almost total 
loss of kinase activity, indicating that both residues are essential for kinase activity. 
This is not surprising, as similar observations have been made for other AGC-group 
kinases. Recent structural studies of PKB have delineated a mechanism by which 
multi-site phosphorylation brings about structural changes involving both disorder to 
order transitions of the alpha B and C helices, and ordering of the activation segment, 
concomitant with converting the kinase to a fully 1000-fold activated enzyme (13,15). 
Significantly, NDR2 becomes phosphorylated on three residues in vitro. The major 
site, Ser-282, which is conserved among all AGC group kinases, is an essential part of 
the activation segment of the kinase. The second site, Thr-75, is located within the 
S100B-binding domain and the third site, Thr-442, which is also conserved in the 
AGC-group superfamily, is located outside the kinase domain in a region enriched 
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with hydrophobic amino acid residues (“hydrophobic motif”). In vivo mutation of the 
phosphorylation site residues Ser-282 and Thr-442 of NDR2 ablated kinase activity 
and blocked activation. In wild-type NDR2, both residues were phosphorylated upon 
OA stimulation, whereas in the kinase-dead mutant K119A only the hydrophobic 
motif phosphorylation site Thr-442 was phosphorylated, indicating that the kinase 
activity of NDR2 is required only for phosphorylation of Ser-282. Therefore, NDR2 is 
phosphorylated by an upstream kinase at the C-terminal hydrophobic site in OA-
stimulated COS-1 cells. However, we cannot rule out the possibility that Thr-442 
autophosphorylation observed in vitro also contributes to the overall phosphorylation 
at this residue in vivo. Autophosphorylation on the activation segment residue has also 
been reported for other AGC kinases such as PKA and PKCδ (22,23). This indicates 
that autophosphorylation is an alternative mechanism of activation of the few AGC 
kinases that are not targeted by PDK1 (for review, see Ref. 24). The specificity of 
activation of AGC-group kinases is likely to be mediated by the phosphorylation of 
the hydrophobic motif residue. For the NDR kinases, some significant clues indicate 
that upstream kinases are members of the STE20 family. For example, the upstream 
kinase of Dbf2p has been identified as Cdc15p, one of the budding yeast STE20-like 
kinases (25), and the fission yeast STE20-like kinase Pak1p/Shk1p has been reported 
to interact genetically with Orb6p (8). The identification of this so far unknown 
upstream kinase for NDR will provide important information about the physiological 
regulation of the NDR protein kinase, which in turn could provide hints about the 
conditions under which this tightly controlled kinase is activated in vivo.  
As demonstrated for PKB, the PIFtide sequence leads to an ordered and, 
therefore, fully active hydrophobic motif, concomitant with an activation of the kinase 
(15). The similarities within the AGC group kinases in sequence similarity and mode 
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of activation enabled us to create a constitutive active NDR2 by substituting the C-
terminus of NDR2 with the PIFtide sequence. The NDR2-PIFtide showed an even 
higher activity than the OA-stimulated kinase. This is probably due to an intrinsic 
stimulation of the autophosphorylation activity by keeping the kinase in the active 
state, which is also reflected by the increased Ser-282 phosphorylation in the NDR2-
PIFtide. The constitutive active kinase will probably prove to be a valuable tool for 
the identification of downstream targets of NDR2 protein kinase.  
The in vivo significance of the phosphorylation at Thr-74 in NDR1 and Thr-75 
in NDR2 is so far unclear. This threonine is within the identified S100B-binding 
domain of NDR protein kinase and its mutation is critical for NDR protein kinase 
activity. This might be due to a missing phosphorylation event, or this residue may be 
structurally important for the NDR-S100B interaction. Nevertheless, recent data show 
that Thr75 is not directly involved in the binding of S100B, indicating that the 
phosphorylation modulates the affinity between the two proteins (26). Conservation 
of the kinase also encompasses the S100B-binding domain, and the mechanism of in 
vitro activation by S100B appears to be identical for NDR1 and NDR2. The 
homology between the mammalian, fly, worm and yeast NDR kinases suggests that 
this mode of activation will be similar in all organisms. 
The subcellular localisation of NDR2 was rather surprising, considering the 
high sequence similarity between NDR1 and NDR2. Whereas NDR1 was reported to 
be mainly nuclear (2), we detected NDR2 predominantly localised to cytoplasmic 
structures in our experimental settings. This might reflect different functions and/or 
substrate specificities of NDR1 and NDR2 within subcellular compartments.  
Most importantly, the two mammalian isoforms differ mainly in their tissue- 
and cell type-specific expression patterns. It is striking that mNdr2 is mainly 
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expressed in highly proliferative tissues with high cellular turnover, such as the 
stomach, and the large and small intestines. Interestingly, hNdr1 has recently been 
found to be upregulated in highly necrotic and progressive ductal carcinoma in situ, as 
well as in some melanoma cell lines (9,27). Significantly, hNdr2 is upregulated in the 
highly metastatic non-small cell lung cancer cell line NCI-H460 (28), suggesting a 
potential role of NDR protein kinase in the regulation of cancer cell morphology and 
migration.  
The major outstanding task for the future will be the full delineation of the 
novel highly conserved NDR signalling pathway. Of considerable importance is the 
question of the identification of the predicted agonist and receptor that initiate kinase 
activation. The answer may then help us understand how NDR contributes to the 
regulation of cell morphogenesis and proliferation, and how these signals are 
disrupted in transformed cells. Mouse knockout studies may reveal whether the 
observed differences in tissue-specific expression and subcellular localisation of 
NDR1 and NDR2 reflect differences in their functions. 
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Abstract 
NDR protein kinases are involved in the regulation of cell cycle progression and 
morphology. NDR1/NDR2 protein kinases are activated by phosphorylation of 
the activation loop phosphorylation site Ser281/Ser282 and the hydrophobic 
motif phosphorylation site Thr444/Thr442. Autophosphorylation of NDR is 
responsible for phosphorylation on Ser281/Ser282, whereas Thr444/Thr442 is 
targeted by an upstream kinase. Here we show that MST3, a mammalian STE20-
like protein kinase, is able to phosphorylate NDR protein kinase at 
Thr444/Thr442. In vitro, MST3 selectively phosphorylated Thr442 of NDR2, 
resulting in a 10-fold stimulation of NDR activity. MOB (Mps one binder) 1A 
protein further increased the activity, leading to a fully active kinase. In vivo, 
Thr442 phosphorylation after OA stimulation was potently inhibited by 
MST3KR, a kinase-dead mutant of MST3. Knockdown of MST3 using short 
hairpin constructs abolished Thr442 hydrophobic motif phosphorylation of NDR 
in HEK293F cells. We conclude that activation of NDR is a multi-step process 
involving phosphorylation of the hydrophobic motif site Thr444/2 by MST3, 
autophosphorylation of Ser281/2 and binding of MOB1A. 
 
Introduction 
The NDR and LATS family of serine/threonine protein kinases participate in the 
regulation of cell cycle progression and cell morphology (14, 42, 52). These kinases 
share a conserved N-terminal regulatory domain that interacts with MOB (3, 6, 32, 
49) and S100B proteins (30). The conserved catalytic (kinase) domain has an 
insertion of 30 amino acids between subdomains VII and VIII, containing the 
activation segment phosphorylation site Ser281/Ser282 and, in the case of mammalian 
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NDR1 and NDR2, an autoinhibitory sequence (3). The C-terminal regulatory domain 
encompasses the regulatory hydrophobic motif phosphorylation site Thr444 (31). 
Recent data have shown that NDR1 and NDR2 protein kinase activities are stimulated 
by Ca2+/S100B- and MOB1-binding induced autophosphorylation on S281/S282 in 
vitro and in vivo (3, 30). Phosphorylation of the hydrophobic motif phosphorylation 
site T444/T442 is required for maximal activation, and involves an upstream kinase 
(41, 43). 
Genetic evidence suggests that STE (Sterile) 20-like protein kinases function as 
upstream kinases of the NDR family. For example, one of the budding yeast STE20-
like kinases, Cdc15p, phosphorylates Dbf2p (27), and the fission yeast STE20-like 
kinase Pak1p/Shk1p genetically interacts with Orb6p (48). Furthermore, the STE20-
like kinase Kic1p functionally interacts with Cbk1p, the closest relative of NDR from 
Saccharomyces cerevisiae (32), and the Drosophila melanogaster STE20-like kinase 
HIPPO phosphorylates WARTS/LATS kinase (16, 19, 33, 44, 50). The closest 
mammalian homologues of Kic1p and HIPPO are the mammalian STE20-like protein 
kinases MST1/KRS2, MST2/KRS1, MST3, MST4/MASK and SOK/YSK, which are 
involved in the regulation of cell morphology, proliferation and apoptosis (7, 9, 21, 24, 
37). This group of kinases contains an N-terminal kinase domain as well as an 
autoinhibitory C-terminal regulatory domain. Their activities are regulated by 
phosphorylation and proteolytic cleavage by caspases in response to stress and 
apoptotic stimuli (10, 18, 22, 36). Phosphorylation of MST1, for example, increases 
its activity several-fold and influences its subcellular localisation (22). Furthermore, 
the kinase-dead mutants of MST kinases are known to be inhibitors of MST kinase 
function in vivo (45).  
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There is evidence that several MST kinases promote apoptosis in response to stress 
stimuli and caspase activation. MST1, for example, can induce apoptosis and nuclear 
condensation in BJAB, 293T and COS-1 cells (15, 45, 46), and MST1 activity 
correlates with eosinophil apoptosis (8). Expression of MST3 in HEK293 cells leads 
to DNA fragmentation and apoptosis (18). YSK1 is activated at initial stages of 
necrotic cell death (34). In contrast, MST4 regulates cell growth and proliferation in 
HeLa and Phoenix cells (24). MST4 and YSK1 are localised to the Golgi apparatus, 
and the latter kinase is shown to be involved in processes such as cell migration, 
presumably by linking protein transport events with cellular processes such as cell 
adhesion or polarisation of the cytoskeleton (37).   
Our recent work has revealed that recruitment of the MOB/NDR complex to the 
plasma membrane results in phosphorylation on Ser281 and Thr444, and activation of 
the kinase (17). To clarify and elucidate the role of STE20-like kinases in regulating 
the activity of the NDR kinases, we performed in vitro and in vivo experiments with 
MST3, the closest relative of Kic1p from humans. We provide evidence that MST3 
can function as an NDR upstream kinase by phosphorylating the hydrophobic motif 
and thus stimulating kinase activity.  
 
MATERIALS AND METHODS 
Cell culture. COS-7 cells and HEK293F were maintained in Dulbecco’s modified 
Eagle’s medium containing 10% foetal calf serum, 100 units/ml penicillin, and 100 
µg/ml streptomycin, and manipulated them as described previously (17).  
Antibodies. α-P-Ser-282 and α-P-Thr-442 antibodies have been described 
previously (41). 12CA5 (HA) and 9E10 (myc) monoclonal antibody hybridoma 
supernatants were used for detection of HA-NDR, HA-MST3 and myc-MST3 variants. 
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Anti-GST antibodies (G7781) were purchased from Sigma. Polyclonal α-HA Y11 
antibodies were purchased from Santa Cruz. α-MST3 antibodies were purchased from 
BD Biosciences. α-NDR-NT peptide antibody was raised against the synthetic 
peptide DEEKRLRRSAHARKETEF-LRLKRTRLGL, corresponding to amino acids 
60 to 86 of NDR2, as described previously (17), and a rat monoclonal α-α-tubulin 
(YL1/2) producing hybridoma cell line was obtained from ATCC. 
Plasmids. DNA constructs used for transfection were purified from E. coli 
XL1Blue using Qiafilter Maxiprep kit (Qiagen) according to the manufacturer’s 
protocol. All DNA constructs were verified by DNA sequencing using an ABI PRISM 
3700 DNA Analyzer (Applied Biosystems) and custom-synthesized primers. 
Mammalian expression vector pCMV5, encoding HA-tagged NDR2 HA-MST3 and 
HA-MST3KR, has been described previously (18, 41). The myc-C1-MOB1A has 
been described previously (17). Bacterial expression constructs for pSHP-NDR2 wild 
type and mutants and pGEX-2T-MOB1A have been described previously (3). 
BamHI-flanked MST3 cDNA constructs were obtained by deleting the internal 
BamHI site using the QuickChange site-directed mutagenesis protocol (Stratagene) 
and the appropriate primers (primer sequences are available upon request) and 
subsequent amplification using primers 5’- CGCGGATCCATGGCTCACTCCCCG-
GTG-3’ and 5’-CGCGGATCCAAAGGAATTTCAGTGGGATG-3’. The resulting 
PCR product was subcloned as BamHI-BamHI into pcDNA3.0-myc (KpnI-
MEQKLISEEDL-BamHI), pEGFP-C1 and pEBG2T.  
A 16-amino-acid co-polymer of glutamic acid and glycine was added to the N-
terminus of MST3 using PCR. The linker-MST3 fragment was amplified using 
primers 5’-AACTGCAGGAAGGTGAGGGCGAAGGTGAGGGCGAAGGTGAGG-
GCGAAGGTGAGGGCATGGCTCACTCCCCG-3’ and 5’-GCTCTAGATCAGTG-
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GGATGAAGTTCC-3’. The PstI-XbaI fragment was subcloned into pCMV5. To 
create a pCMV5-HA-NDR2-MST3 fusion construct, HA-tagged NDR2 was amplified 
using primers 5’- CTTCCAAGCGCTTAGTCGACATGGCTTACCCATACGATGT-
TCCAGATTACGCTTCGGCAATGACGGCAGGGACTACAACAACC-3’ and 5’-
AACTGCAGTAACTTCCCAGCTTTCATGTAGG-3’ and subcloned as an HindIII-
PstI fragment into pCMV5 (linker-MST3). The myc-C1-MOB1A has been described 
previously (17). 
The pTER-shMST3 vectors were cloned using the HindIII-BglII digested pTER 
vector (47) and the following oligonucleotides: 5’–GATCCCGGCATTGACAATC-
GGACTCTTCAAGAGAGAGTCCGATTGTCAATGCCTTTTTGGAAA-3’ and 5’-
AGCTTTTCCAAAAAGGCATTGACAATCGGACTCTCTCTTGAAGAGTCCGA-
TTGTCAATGCCGG-3’ for shMST3. 
Western blotting and immunoprecipitation. Cell lysis buffer (IP buffer) 
contained 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 10% glycerol, 1 
mM Na3VO4, 20 mM β-glycerol phosphate, 1 µM microcystin, 50 mM NaF, 0.5 mM 
phenylmethylsulfonyl fluoride, 4 µM leupeptin and 1 mM benzamidine. To detect 
HA-NDR, SHP-NDR, HA-MST3 and myc-MST3, samples were resolved by 10% or 
12% SDS-PAGE and transferred to polyvinylidene difluoride membranes. Membranes 
were blocked in TBST (50 mM Tris-HCl pH 7.5, 150 mM NaCl and 0.05% Tween 20) 
containing 5% skimmed milk powder and then probed overnight at 4°C with the 
following antibodies: anti-GST 12CA5 α-HA, 9E10 α-myc, α-Thr-442P or α-Ser-
282-P, α-NDR-NT, α-MST3 and α-α-tubulin YL1/2. Bound antibodies were detected 
using horseradish peroxidase-linked secondary antibodies and ECL. For 
immunoprecipitations, HEK293F or COS-7 cells transfected with HA-MST3 wild 
type, HA-MST3-KR or HA-NDR2 variants were harvested as described above. Cell 
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lysates (0.5 mg protein) were precleared with protein A- or G-Sepharose and mixed 
subsequently for 3 h at 4°C with α-HA 12CA5 antibody prebound to protein A-
Sepharose. The beads were then washed twice with IP buffer, once with IP buffer 
containing 1 M NaCl, once again with IP buffer, and twice with 20 mM Tris-HCl pH 
7.5 containing 4 µM leupeptin and 1 mM benzamidine. Samples were then subjected 
to kinase assays and/or were resolved by 10% SDS-PAGE. HA-MST3, HA-MST3KR 
and HA-NDR2 variants were detected by western blotting using α-HA 12CA5 
monoclonal antibodies. 
Bacterial expression of human GST-fused MOB1A and human SHP-fused 
NDR2. XL-1 Blue E. coli was transformed with the pGEX-2T-MOB1A plasmid. 
Mid-logarithmic phase cells were induced using 0.1 mM isopropyl β-D-
thiogalactopyranoside overnight at 20°C. Bacterial lysis buffers contained 20 mM 
Tris-HCl pH 8.5, 10 mM 2-mercaptoethanol, 1% NP-40, 0.5 M NaCl and ‘complete’ 
proteinase inhibitor cocktail (Roche). Bacteria were disrupted using a French press in 
the presence of 1 mg/ml lysozyme and protease inhibitors, and the fusion proteins 
were purified on glutathione-Sepharose. SHP-NDR2 wild type and mutant plasmids 
were transformed into XL-1 Blue E. coli as described for GST-hMOB1A and protein 
purified on Ni-NTA-Sepharose. 
NDR protein kinase assays. Transfected COS-7 cells were washed once with ice-
cold phosphate-buffered saline and harvested 24 or 48 h after transfection in 1 ml of 
ice-cold phosphate-buffered saline containing 1 mM Na3VO4 and 20 mM β-glycerol 
phosphate before lysis in 500 µl IP buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 
1% Nonidet P-40, 10% glycerol, 1 mM Na3VO4, 20 mM β-glycerol phosphate, 1 µM 
microcystin, 50 mM NaF, 0.5 mM phenylmethylsulfonyl fluoride, 4 µM leupeptin, 
and 1 mM benzamidine). Lysates were centrifuged at 20,000 g for 20 min and 
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duplicate aliquots (250 µg) of the supernatant were precleared with protein A-
sepharose for 1 h and mixed for 3 h at 4°C with α-HA 12CA5 antibody prebound to 
protein A-sepharose. The beads were then washed twice with IP buffer, once for 10 
min with IP buffer containing 1 M NaCl, again for 10 min with IP buffer, and twice 
with 20 mM Tris-HCl pH 7.5 containing 4 µM leupeptin and 1 mM benzamidine. 
Thereafter, the beads were resuspended in 30 µl of buffer containing 20 mM Tris-HCl 
pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 100 µM [γ-32P] ATP (~1,000 cpm/pmol), 
1 µM cAMP-dependent protein kinase inhibitor peptide, 4 µM leupeptin, 1 mM 
benzamidine, 1 µM microcystin and 1 mM NDR substrate peptide (KKRNRRLSVA). 
After a 60-min incubation at 30°C, the reactions were processed as previously 
described (43). 
Purified recombinant SHP-NDR2 wild type and mutants (1 µg) were pre-
autophosphorylated or prephosphorylated for 60 min in the presence of HA-MST3 or 
HA-MST3KR (immunoprecipitated from 500 µg lysates of untreated and OA-treated 
HEK293F cells) in 30 µl of buffer containing 20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
1 mM dithiothreitol, 100 µM ATP, 1 µM cAMP-dependent protein kinase inhibitor 
peptide, 4 µM leupeptin, 1 mM benzamidine and 1 µM microcystin. Aliquots of 10 µl 
of the supernatant containing SHP-NDR or mutants were removed. One aliquot was 
assayed for activity using our standard conditions (reaction mixture of 30 µl 
containing 20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 100 µM [γ-
32P] ATP [~1,000 cpm/pmol], 1 µM cAMP-dependent protein kinase inhibitor peptide, 
4 µM leupeptin, 1 mM benzamidine, 1 µM microcystin and 1 mM NDR substrate 
peptide). After incubation for 30 min at 30°C, the reactions were processed and kinase 
activity determined as described for the HA-NDR kinase assay. The second aliquot 
was resolved by 10% SDS-PAGE and analysed for phosphorylation and amount of 
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protein using α-T-442-P and α-S-282-P antibodies by western blotting or Coomassie 
staining, respectively. 
Time course analyses of hydrophobic motif phosphorylation and activity of SHP-
NDR2 variants (1 µg) in the presence or absence of GST-MOB1A and in the presence 
or absence of GST-MST3 from untreated or OA-treated HEK293F cells were 
performed using our kinase assay standard conditions, as described above. Kinase 
assays were stopped after 0, 15, 30, 60, 90 and 120 min by adding 3 µl of 0.5 M 
EDTA. The reactions were processed and kinase activity was determined as described 
for the HA-NDR kinase assay. Phosphorylation of NDR was detected by western 
blotting, as described above. 
Localisation of MST3 and NDR2. Exponentially growing cells were plated on 
coverslips and transfected the next day with the indicated constructs using Fugene 6 
(Roche) as described by the manufacturer. After transfection for 24 h, cells were 
washed with PBS and fixed in 3% paraformaldehyde/2% sucrose in PBS at pH 7.4 for 
10 min at 37°C. They were then permeabilised using 0.2% Triton X-100 in PBS for 2 
min at room temperature. All subsequent steps were carried out at room temperature. 
Coverslips were rinsed twice with PBS and incubated for 1 h with α-HA Y11 (Santa 
Cruz) and α-myc 9E10 diluted in PBS containing 1% BSA/1% goat serum. After 
three 1-min washes in PBS, goat anti-rabbit FITC (Sigma) and goat anti-mouse Texas 
Red (Sigma) were used as secondary antibodies. DNA was counterstained with 4 
µg/ml Hoechst (Sigma). Coverslips were then inverted into 5 µl Vectashield medium 
(Vector Lab). Images were obtained using an Eclipse E800 microscope and a 
CoolPix950 digital camera (Nikon) and processed using Adobe Photoshop 6.0 (Adobe 
Systems Inc). Only cells with intact nuclei were included in the statistical evaluation. 
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Cells expressing GFP-MST3 were fixed and then stained for DNA without 
permeabilisation and antibody incubation steps. 
Cell fractionation. To separate cytosolic and membrane-associated proteins, cells 
were subjected to S100/P100 fractionation as follows: cells were collected in PBS and 
incubated for 20 min at 4°C in S100/P100 buffer (20 mM Tris, 150 mM NaCl, 2.5 
mM EDTA, 1 mM EGTA, 1 mM benzamidine, 4 µM leupeptin, 0.5 mM PMSF, 1 µM 
microcystin and 1 mM DTT at pH 7.5), homogenised by passage through a 26G 
needle (Beckton Dickinson) and nuclei were removed by centrifugation for 2 min at 
1,000 g at 4°C. The supernatant was then centrifuged at 100,000 g for 60 min at 4°C. 
Equal amounts of protein from the supernatant (S100; cytoplasmic fraction) and the 
pellet (P100; membrane fraction) were analysed by SDS-PAGE followed by 
immunoblotting. 
 
RESULTS 
Catalytic domain conservation of STE20-like kinases. We compared the substrate-
binding pockets (26) of the human MST kinases to the budding yeast relatives Kic1p 
and Cdc15p, which have previously been reported to be upstream regulators of Cbk1p 
and Dbf2p (27, 32). All of the kinases showed very high conservation of their 
catalytic domain. MST3, YSK1 and MST4, as well as MST1 and MST2, have 
identical residues in their substrate-binding pockets, indicating similar substrate 
specificities (Fig. 1A). We also compared the hydrophobic motifs of the budding 
yeast Cbk1p and Dbf2p with human NDR kinases. The hydrophobic motifs of 
hNDR1 and hNDR2 as well as LATS1 and LATS2 show a significant similarity to 
corresponding regions in the yeast kinases (Fig. 1B). To test our hypothesis that a 
mammalian STE20-like (MST) kinase is the hydrophobic motif kinase of NDR 
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protein kinases, we performed in vitro kinase assays using MST3, the closest relative 
of the yeast Kic1p-Cbk1p pathway. For this study we used NDR2 because it was 
easier to produce recombinant full-length protein. 
 
Fig. 1. Conservation of yeast and human STE20-like kinases. A. Dendrogram and 
sequences surrounding the substrate binding pocket of the Saccharomyces cerevisiae STE20-
like kinases Kic1p and Cdc15p, and the human mammalian STE20-like kinases MST3, YSK1, 
MST4, MST1 and MST2 (28). Identical residues are shaded in black, similar residues in grey. 
Residues determining the substrate-binding pocket are indicated with asterisks and shaded in 
dark grey. B. Dendrogram and hydrophobic motif sequences of the human NDR kinase 
family. Identical and similar residues are shaded as above. 
 
Activation and hydrophobic motif phosphorylation of NDR protein kinase by 
MST3. We expressed HA-MST3wt and the kinase-dead HA-MST3KR in HEK293F 
cells and treated them with 1 µM okadaic acid (OA) for 1 h (MST3+; MST3KR+) or 
solvent control (MST3; MST3KR). The HA-tagged MST3 kinase variants were 
immunoprecipitated with the α-HA 12CA5 monoclonal antibody and incubated with 
SHP-NDR2 and catalytically inactive SHP-NDR2KD for 1 h at 30°C. Subsequently, 
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the beads with bound MST3 were removed and the supernatants containing the SHP-
NDR proteins were analysed for activity and phosphorylation status using α-Ser282-P 
and α-Thr442-P specific phospho-antibodies. Kinase assays were carried out for 30 
min with the NDR substrate peptide (29). (We had previously established that 
activated MST3 does not significantly phosphorylate the NDR substrate peptide). 
 
Fig. 2. Activation and hydrophobic motif phosphorylation of NDR2 by MST3. A. Wild 
type recombinant SHP-NDR2 was pre-incubated for 60 min with or without 
immunoprecipitated HA-MST3 or HA-MST3KR from untreated and OA-treated (+) 
HEK293F cells. The activity of SHP-NDR2 was determined using the NDR kinase substrate 
peptide. The results shown are means ± S.D. of assays carried out in duplicate, and are 
representative of two independent experiments. Samples from each pre-incubation were also 
analysed for phosphorylation by western blotting using α-P-T442 and α-P-S282 antibodies. 
HA-MST3wt and HA-MST3KR were quantified by western blot analysis using the α-HA 
12CA5 monoclonal antibody. B. Phosphorylation of kinase-dead NDR2 by MST3. Kinase-
dead NDR2K119A was incubated for 60 min with or without immunoprecipitated HA-MST3 or 
HA-MST3KR from untreated and OA-treated (+) HEK293F cells. Samples were analysed by 
western blotting as in A. 
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Significantly, pre-incubation with non-stimulated MST3 only led to a two-fold 
activation of NDR2, while pre-incubation with OA-activated MST3 resulted in a 10-
fold increase in NDR2 activity. This result reflected an increase in phosphorylation of 
both the activation segment phosphorylation site Ser282 and the hydrophobic motif 
phosphorylation site Thr442 (Fig. 2A). Analysis of the phospho-status of the kinase-
dead NDR2 revealed that MST3 phosphorylates NDR2 on Thr442, but not on Ser282 
(Fig. 2B). Results from the same experiments performed with the kinase-dead 
MST3KR confirmed that phosphorylation, as well as activation of NDR2, depends on 
MST3 activity. Significantly, our results also show that OA treatment of HEK293F 
cells promotes the activation of MST3 in a similar way to that previously found for 
NDR (31). 
Mechanism of NDR activation by MST3 and MOB1. Next, we sought to define 
the role of the MOB proteins in regulating NDR activity. Previously, we and others 
had demonstrated that NDR1 and NDR2 are activated by MOB proteins (3, 11). We 
performed NDR kinase assays in the presence and absence of MOB1A and MST3 
using GST-MOB1A and SHP-NDR2 expressed in E. coli, as well as OA-stimulated (1 
µM for 1 h) and non-stimulated GST-MST3 expressed in HEK293F cells. Proteins 
were affinity purified on glutathione-Sepharose (GST-MOB1A and GST-MST3) and 
Ni-NTA-Sepharose (SHP-NDR2), respectively. We performed time-course kinase 
assays (0-90 min) with various combinations of the proteins employing the NDR 
substrate peptide. NDR2 alone showed only a moderate increase in kinase activity 
over the time course (Fig. 3A). Addition of MOB1A resulted in a three- to four-fold 
increase in kinase activity compared with NDR2 alone during the time course (Fig. 
3A). Addition of activated MST3 led to a rapid initial increase in kinase activity that 
reached a maximum after 30 min and remained approximately constant for the 
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remainder of the time course (Fig. 3A). Addition of activated MST3 together with 
MOB1A resulted in a 20-fold higher NDR activity (Fig. 3A), suggesting that both 
MOB1A and MST3 kinase are required for full kinase activation. Non-stimulated 
MST3 kinase had no significant effect on NDR2 kinase activity either in the presence 
or absence of MOB1A (data not shown), indicating that activation of MST3 is crucial 
for NDR activation. However, the Thr442 phosphorylation obtained with wild-type 
NDR2/MOB1A suggests a minor contribution of hydrophobic motif phosphorylation 
by NDR2 itself in vitro, as previously reported (41). 
 To obtain more detailed information about NDR2 activation by MST3 and MOB1A, 
we performed in vitro activation and phosphorylation time courses with kinase-dead 
and MOB binding-deficient NDR2 mutants (3). The SHP-NDR2 mutants were 
expressed and purified as described above for wild-type SHP-NDR2. As expected, the 
MOB1 binding-deficient mutant NDR2Y32A was not activated by MOB1A and 
showed only a basal activity similar to wild-type NDR2 (Fig. 3B). Addition of 
activated MST3 resulted in a five- to six-fold increase in NDR activity to levels 
similar to those observed with wild type NDR2 (Fig 3A, B). The activation profiles 
and phospho-blots of the NDR2Y32A mutant in the presence of MOB1A showed 
patterns similar to the corresponding profiles and blots of wild type NDR2 in the 
absence of MOB1A (Fig. 3A, B). The kinase-dead mutant showed the same degree of 
Thr442 phosphorylation in the presence and absence of MOB1A, indicating that 
MOB1A does not affect phosphorylation of NDR by MST3. 
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Fig. 3. Analysis of NDR2 activation and hydrophobic motif phosphorylation by MST3 
and MOB1A. A. Activation and phosphorylation of wild-type NDR2. NDR2 SHP-NDR2 
was incubated with GST-MOB1A (?), GST-MST3 from OA-stimulated HEK293F cells (▲), 
both (•) or alone (Ο) using our standard NDR kinase assay conditions. B. Activation and 
phosphorylation of kinase-dead and MOB binding-deficient NDR2. SHP-NDR2 (Ο), SHP-
NDR2/GST-MOB1A (?), SHP-NDR2/MOB1A/MST3+ (•), SHP-NDR2K119A/MOB1A/ 
MST3+ (▲), SHP-NDR2Y32A ( ), SHP-NDR2Y32A/MOB1A/ MST3+ (∆) were incubated 
using standard NDR kinase assay conditions. C. Activation and phosphorylation of the 
NDR2-AIS mutant. SHP-NDR2 (Ο), SHP-NDR2-AIS ( ), SHP-NDR2-AIS/GST-MOB1A 
(▲), SHP-NDR2-AIS/MST3+ (?), SHP-NDR2-AIS/GST-MOB1A/MST3+ (•) were 
incubated using standard NDR kinase assay conditions. At the time points indicated, NDR 
kinase activity was assayed with the NDR substrate peptide; results are expressed as specific 
activity. Results shown are means ± S.D. of assays carried out in duplicate and representative 
of two independent experiments. Error bars are only shown when larger than the size of the 
symbols. NDR hydrophobic motif phosphorylation was determined at each time point by 
western blotting using the α-P-T442 antibody.  
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The Thr442 phosphorylation obtained with the wild type NDR2/MOB1A/MST3+ and 
NDR2Y32A/MOB1A/MST3+ assays were similar, indicating that MOB1A promotes an 
active conformation and release of autoinhibition of the kinase. In agreement with 
these data, the NDR2-AIS (autoinhibitory sequence) mutant (3) that is released from 
autoinhibition showed an increase in basal activity; addition of MOB1A resulted in a 
further two-fold increase in NDR-AIS activity (Fig. 3C). Incubation of NDR2-AIS 
with MST3+, and NDR2-AIS with MOB1A and MST3+ resulted in very similar 
activation profiles, indicating that release of autoinhibition and hydrophobic motif 
phosphorylation are sufficient for full kinase activation (Fig. 3C). We conclude that 
activation of NDR2 is a multi-step process involving phosphorylation of the 
hydrophobic motif site Thr444/2 by MST3, autophosphorylation of Ser281/2 and 
binding of MOB1A.   
NDR hydrophobic motif site phosphorylation by MST3 in vivo. To examine the 
role of MST3 in NDR activation in vivo, we performed cotransfection experiments 
with HA-NDR2, myc-MST3 and myc-MST3KR using COS-7 cells. Analysis of the 
phosphorylation of NDR revealed a small but significant increase in Thr442 
phosphorylation in cells expressing MST3 and NDR2 compared with cells expressing 
NDR2 alone (Fig. 4A). The extent of NDR2 phosphorylation was less than that 
obtained after OA stimulation, as shown by the α-P-Thr442 (Fig. 4A). Cells 
expressing the kinase-dead variant MST3KR and NDR2 showed a reduction in 
Thr442 phosphorylation (Fig. 4A). Inhibition of Thr442 phosphorylation by the 
kinase-dead MST3KR indicates that the mutant protein acts as an inhibitor of Thr442 
phosphorylation mediated by endogenous MST3 (see below). Evidence in support of 
this hypothesis comes from the inhibition of OA-induced phosphorylation of the 
NDR2 hydrophobic motif by cotransfection with MST3KR, which resulted in 70% 
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lower NDR activity and Thr442 phosphorylation (Fig. 4B). Ser282 phosphorylation 
was largely unchanged (Fig. 4B). This indicates that MST3KR acts as an inhibitor of 
Thr442 phosphorylation. The reduced phosphorylation was also reflected by 
decreased NDR activity.  
 
Fig. 4. NDR activation and phosphorylation by MST3 in vivo. A. The effect of 
cotransfection of MST3 on NDR2 phosphorylation. COS-7 cells were cotransfected with 
myc-MST3, kinase-dead myc-MST3KR and HA-NDR2. OA-treated cells transfected with 
HA-NDR2 were used as a control for NDR2 phosphorylation. All proteins migrated at the 
expected molecular mass. Cell lysates were immunoblotted with α-P-T442, α-P-S282, α-HA 
and α-myc. B. Inhibition of NDR2 activation and hydrophobic motif phosphorylation by 
MST3KR. COS-7 cells expressing HA-NDR2, wild-type myc-MST3 and myc-MST3KR in 
various combinations were treated for 1 h with 1 µM OA or with solvent alone. HA-tagged 
NDR kinase variants were then immunoprecipitated (100 µg of cell-free protein extracts) with 
α-HA 12CA5 monoclonal antibody and assayed for kinase activity using the NDR peptide 
substrate. Bars represent the mean ± S.D. of triplicate immunoprecipitates and are 
representative of two independent experiments. All cell lysates were immunoblotted with α-
P-T442, α-P-S282, α-HA 12CA5 and α-myc. 
Taken together, our data indicate that MST3 can act in vivo as an NDR hydrophobic 
motif kinase. We tested this hypothesis further using NDR2-MST3 fusion proteins. 
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To create the NDR2-MST3 fusion protein, a linker of 16 amino acids composed of an 
alternating copolymer of glutamate and glycine was linked to the NDR2 C-terminus 
and fused to MST3 in frame, as described for ERK2-MEK1 fusions (39). HA-tagged 
NDR2-MST3, NDR2KD-MST3 and NDR2-MST3KR fusion proteins were expressed 
in HEK293F cells and analyzed for kinase activity and phosphorylation (FIG. 5). The 
immunoprecipitated NDR2-MST3 fusion protein was 50- to 100-fold more active 
than NDR2 from non-stimulated HEK293F cells. The activity was even higher than 
the previously described constitutively active NDR2-PIF variant (FIG. 5) (41). The 
NDR-PIF variant contains the PRK2 hydrophobic motif (EEQEMFRDFDYIADW 
fused at amino acid 434), which has an Asp residue instead of a Thr or Ser residue, 
and is able to stabilize the kinase in an active conformation, as described for PKB (51). 
Control fusions with kinase-dead NDR2 were inactive in the kinase assay, indicating 
that MST3 did not affect the activity measurements. Analysis of the NDR variants 
with phospho-specific α-P-T442 antibodies showed that NDR2-MST3 and NDR2KD-
MST3, but not NDR2-MST3KR, are phosphorylated on the hydrophobic motif 
phosphorylation site without OA stimulation, suggesting that the interaction is direct. 
Similar results were obtained with NDR1-MST3 fusion proteins (data not shown). 
Activation and phosphorylation of NDR by endogenous MST3. Membrane 
targeting of NDR leads to phosphorylation and activation of the kinase (17). 
Constitutive membrane targeting of NDR or MOB using the Lck 
myristoylation/palmitoylation motif (MGCVCSSN), or inducible membrane targeting 
using the C1-domain derived from PKCα (amino acids 26 to 126), results in an 
increase of hydrophobic motif phosphorylation and NDR activity (17). 
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Fig. 5. Activity of NDR2-MST3 fusion proteins. HA-tagged variants of NDR2, NDR2-
MST3, NDR2KD-MST3, NDR2-MST3KR and NDR2-PIF in the pcDNA3.1 vector were 
expressed in HEK293F. The NDR kinase variants were then immunoprecipitated (100 µg of 
cell-free protein extracts) with α-HA 12CA5 monoclonal antibody and kinase activity assayed 
using the NDR peptide substrate. Bars represent the mean ± S.D. of triplicate 
immunoprecipitates and are representative of two independent experiments. Additionally, all 
immunoprecipitates were subjected to SDS-PAGE and western blotting using α-HA 12CA5, 
α-P-S282 and α-P-T442 antibodies. All NDR variants migrated at the expected molecular 
weight. 
 To further establish the in vivo role of MST3 in regulating endogenous NDR, we 
transfected HEK293F cells with a myc-C1-MOB1A chimera and different MST3 
constructs designed to manipulate the levels of the upstream kinase. The cells were 
stimulated, after 24 h starvation, with 100 ng/ml TPA or solvent control for 15 min, 
and hydrophobic motif phosphorylation of endogenous NDR was determined using α-
P-Thr442 antibodies (Fig. 6A). TPA treatment promoted recruitment of NDR to the 
membrane and promoted phosphorylation of endogenous NDR. Overexpression of 
HA-MST3 increased the phosphorylation of Thr442 in unstimulated and stimulated 
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cells. Knockdown of MST3 protein (Fig. 6A) led to almost complete inhibition of 
NDR2 phosphorylation.  
 
Fig. 6. Phosphorylation of endogenous NDR by endogenous MST3. A. Myc-C1-MOB1A 
was expressed in HEK293F cells transfected with either pcDNA3.1-HA-MST3, pcDNA3.1-
HA-MST3KR or pTER-shMST3. Two days after transfection, the cells were starved for 24 h 
and then stimulated for 15 min with TPA (100 ng/ml) prior to harvesting. All cell lysates were 
subjected to SDS-PAGE and immunoblotted with α-P-T442, α-NDR-NT, α-MST3, α-myc 
and α-α-tubulin control. B. Phosphorylation and activation of NDR2 by endogenous MST3. 
HA-NDR2 was expressed in HEK293F cells and transfected with either pcDNA3.1 myc-C1-
MOB1A and/or pTER-shMST3. Two days after transfection, the cells were starved for 24 h 
and subsequently stimulated for 10 min with TPA (100 ng/ml) prior to harvesting. HA-NDR2 
was immunoprecipitated with α-HA 12CA5 monoclonal antibody and assayed for kinase 
activity using the NDR peptide substrate. Bars represent the mean ± S.D. of duplicate 
immunoprecipitates and are representative of two independent experiments. All cell lysates 
were subjected to SDS-PAGE and immunoblotted with α-P-T442, α-HA, α-MST3, α-myc 
and α-α-tubulin control. 
Furthermore, our results show that MST3KR also inhibits phosphorylation of 
endogenous MST3. The results show a clear correlation between MST3 levels and 
hydrophobic motif phosphorylation of NDR following TPA-induced membrane 
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recruitment of C1-tagged-MOB1A, indicating that MST3 is indeed a physiological 
regulator of NDR in vivo. To investigate the effects of MST3 on NDR kinase activity, 
we used the inducible membrane targeting method described above. We transfected 
HEK293F cells with HA-NDR2, myc-C1-MOB1A and pTER-shMST3, and 
determined the activation of NDR and hydrophobic motif phosphorylation (Fig. 6B). 
After incubation with TPA for 10 min, the activation of NDR was significantly 
diminished (~50%) in samples cotransfected with pTER-shMST3. The activation was 
only partially inhibited because we were unable to achieve full knockdown of MST3. 
In agreement with our results obtained with endogenous NDR, Thr442 
phosphorylation of HA-NDR2 showed a clear dependence on MST3, indicating that 
membrane recruitment of the NDR/MOB complex is crucial for NDR activation and 
phosphorylation by MST3. 
Activation and phosphorylation of MOB1-binding deficient NDR2. To obtain 
further insights into the role of MOB1 in the activation process of NDR, we examined 
its activation and phosphorylation following OA treatment using the MOB1-binding 
deficient mutant NDR2Y32A (3). Despite the fact that NDR2Y32A was phosphorylated 
on Thr442 to the same extent as wild-type NDR2, activation of the kinase was only 
two- to three-fold compared with 30-fold for the wild-type control (Fig. 7). This result 
shows that MOB1 binding is required for full activation and correlates well with the 
results obtained in vitro, arguing that MST3 functions as an upstream kinase and that 
MOB1 releases autoinhibition.  
 
. 
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 Fig. 7. Activation and phosphorylation of MOB1-binding deficient NDR2. HEK293F 
cells were transfected with HA-tagged NDR2 and NDR2Y32A and variants and stimulated for 1 
h with 1 µM OA or solvent prior to harvesting. The NDR kinase variants were then 
immunoprecipitated (100 µg of cell-free protein) with  α-HA 12CA5 monoclonal antibody 
and assayed for kinase activity using the NDR peptide substrate. Bars represent the mean ± 
S.D. of duplicate immunoprecipitates and are representative of two independent experiments. 
Additionally, all lysates were subjected to SDS-PAGE and immunoblotted using α-P-T442, 
α-P-S282, and α-HA 12CA5 antibodies. 
Colocalisation of MST3 and NDR. We examined the intracellular 
localisation of GFP-MST3, HA-MST, HA-MST3KR and myc-NDR2 in COS-7 cells. 
MST3 has previously been shown to localise predominantly to cytoplasmic structures 
(18), but translocates to the nucleus upon caspase cleavage. We confirmed the 
localisation of full-length MST3 in our experimental conditions with two different 
epitope tags (GFP and HA) (Fig. 8A). To evaluate whether NDR2 and MST3 localise 
to similar cytoplasmic structures, we co-expressed MST3 and NDR2 in COS-7 cells. 
Examination by confocal microscopy demonstrated a largely overlapping localisation 
of MST3 and NDR2 to cytoplasmic and membrane structures (Fig. 8B), indicating 
that these proteins are indeed able to interact in vivo.   
 92
   
Fig. 8. Co-localisation of NDR2 and MST3 in COS7 cells. A. Localisation of MST3. COS-
7 cells expressing GFP-MST3 (upper panels), HA-MST3-wt (middle panel) or HA-MST3KR 
(lower panels) were processed for immunofluorescence using either no antibody (upper right) 
or α-HA Y11 (lower right). Anti-HA antibody was visualised using anti-rabbit FITC (green) 
and DNA stained with 1 µM TO-PRO-3 iodide (Molecular Probes Inc) (blue; left panels). B. 
Colocalisation of NDR2 and MST3. COS-7 cells expressing HA-MST3 and myc-NDR2 were 
processed for immunofluorescence using α-HA Y11 and α-myc 9E10. α-HA Y11 antibody 
was visualised using anti-rabbit FITC (green), anti-myc antibody was visualised using anti-
mouse Texas Red (red). Representative pictures of HA-MST3 and myc-NDR2 localisation are 
shown. 
We further investigated whether the proteins form a stable complex. As expected, 
employing the myc-C1-MOB1A construct, TPA stimulation led to recruitment of HA-
NDR2 to the membrane fraction, thereby activating and phosphorylating NDR2 at the 
hydrophobic motif (see also Hergovich et al., 2005). 
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 Fig. 9. Fractionation of HA-NDR and MST3 after membrane recruitment of myc-C1-
MOB1A. HEK293F cells were transfected with the HA-NDR2 and myc-C1-MOB1A 
constructs indicated and subjected to S100/P100 fractionation (S, cytoplasm; P, membrane), 
before immunoblotting with α-T444-P, α-HA 12CA5, α-MST3 and α-myc antibodies. 
However, the distribution of endogenous MST3 was unchanged in these conditions 
(Fig. 9). The major population of MST3 was cytoplasmic, but a significant portion 
was associated with the membrane. Further, MST3 was apparently not detected in 
HA-NDR2 immunoprecipitates (data not shown). This indicates that MST3 and 
NDR2 did not form a stable complex under our conditions, and that membrane 
recruitment of the NDR/MOB1 complex is crucial for NDR phosphorylation by 
MST3 in vivo.  
NDR promotes cleavage of MST3. It has been reported that members of the MST 
family are frequently cleaved following caspase activation (10, 18, 20, 36). Based on 
our initial observations (data not shown) that most of the wild-type MST3 protein was 
efficiently cleaved but the kinase-dead MST3KR was only cleaved to a minor degree 
in samples harvested 36 h after transfection in COS-7 cells, we asked whether MST3 
cleavage depends on the activity of full-length MST3 and whether this regulation 
involves NDR (Fig. 10A). We co-transfected COS-7 cells with kinase-dead MST3KR 
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Fig. 10. NDR promotes cleavage of MST3 in COS-7 cells. A. Induction of MST3 cleavage 
by overexpression of catalytically active NDR2. Lysates of COS-7 cells transfected as 
indicated with myc-MST3KR, HA-NDR2, HA-NDR2KD and HA-NDR2-PIF were harvested 
after 36 h and subjected to western blotting using α-HA and α-myc antibodies. B. 
Localisation of NDR2-MST3 fusion proteins. COS-7 cells expressing HA-NDR-MST3 
(upper panel) or HA-NDR2KD-MST3 (lower panel) were processed for immunofluorescence 
24 h after transfection using α-HA Y11 (right panels). α-HA antibody was visualised using 
anti-rabbit FITC (green). Corresponding DNA stains (blue; left panels). Representative 
pictures of HA-NDR2-MST3 and HA-NDR2KD-MST3 localisation are shown. 
alone or together with HA-tagged NDR2, NDR2KD and NDR2-PIF. Co-transfection 
of wild-type NDR2 and NDR2-PIF resulted in significantly higher cleavage of 
MST3KR than in cells transfected with only MST3KR, whereas co-transfection of 
MST3KR with kinase-dead NDR2 had no detectable effect on the cleavage of full-
length MST3KR (Fig. 10A). This indicates that cleavage of MST3 can be induced by 
NDR activity. This is also clearly reflected by the localisation of NDR-MST3 fusion 
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proteins. MST3 was shown recently to contain both a nuclear localisation signal 
(NLS; amino acids 278-294) and an export signal (NES) located in the C-terminal 
region (amino acids 335-386) downstream of the kinase domain. The NES is cleaved 
off (residue 314) after caspase activation, which leads to nuclear translocation of the 
kinase (23). In COS-7 cells, NDR2-MST3 fusion proteins showed both nuclear and 
cytoplasmic localisation, whereas an NDR2KD-MST3 fusion was localised almost 
exclusively in the cytoplasm (Fig. 10B). Our results indicate that NDR can function in 
a regulatory feedback loop controlling MST3 cleavage. 
   
Discussion 
We provide evidence that MST3 functions as a hydrophobic motif kinase of NDR 
protein kinase and our current model for NDR regulation is summarised in Fig. 11. 
This is the first demonstration that a STE20-like kinase specifically phosphorylates 
the hydrophobic motif (Thr442), and not the activation segment phosphorylation site, 
of NDR. We have established that NDR2 is phosphorylated by activated MST3 (see 
below) specifically on the hydrophobic motif, leading to an approximately 10-fold 
activation of the kinase. MST3KR mutants were not able to activate or phosphorylate 
Thr442, demonstrating that MST3 kinase activity was necessary for NDR activation. 
Based on the catalytic domain conservation of mammalian STE20-like kinases and 
yeast STE20-like kinases, it is likely that the mechanism of NDR family kinase 
phosphorylation by STE20-like kinases is conserved, similar to many of the 
components of this signalling network (42). The mechanism of regulation of NDR 
kinases reported in yeast and flies, for example the Cdc15p-Dbf2p and Kic1p-Cbk1p 
interactions in S. cerevisiae, or the HIPPO-WARTS interaction in D. melanogaster, is 
probably through hydrophobic motif phosphorylation. We propose that NDR2 
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hydrophobic motif phosphorylation functions in a manner analogous to the reported 
disorder-to-order conformational transitions described for PKB (51). A similar 
disorder-to-order transition mechanism is probable for the other NDR-related kinases. 
It will be interesting to investigate whether other members of the STE20 group of 
protein kinases function as hydrophobic motif kinases for other AGC kinases. 
 
Fig. 11. Model of NDR protein kinase activation by multisite phosphorylation. MOB and 
activated MST are required for full phosphorylation and activation of NDR. MOB binding 
stimulates auto- and transphosphorylation of NDR by releasing autoinhibition, whereas MST3 
phosphorylation at the hydrophobic motif results in an active conformation of the kinase. The 
kinase complex is negatively regulated by PP2A or PP2A-related phosphatase. Activated 
NDR kinase in turn promotes cleavage of MST3. 
Previous results have revealed that MOB proteins play a critical role in the activation 
of several NDR kinase homologues. Mob1p has been shown to be required for the 
activation and phosphorylation of Dbf2p by Cdc15p (27), and Mob2p is required for 
Cbk1p function (6, 49). Recent studies have shown that human MOB proteins interact 
with NDR1 and NDR2 (3, 11). MOB1A binding induces the release of autoinhibition 
and thus stimulates autophosphorylation at the activation segment phosphorylation 
site of NDR kinase (3). Here we provide the first evidence for a functional interaction 
between mammalian STE20-like kinase, MOB1A protein and NDR2 kinase. In vitro, 
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all three proteins, MST3, MOB1A and NDR2, are required for full kinase activity. 
MOB1A binding is essential for the release of NDR autoinhibition, thus stimulating 
auto- and transphosphorylation activity. As expected, the NDR2-AIS mutant showed 
full activation in the presence of activated MST3, independent of MOB1A binding, 
supporting the proposed mechanism. Additionally, we provide evidence that the 
functional interaction between MST3 and NDR2 occurs in vivo. Cotransfection of 
MST3 and NDR2 in COS-7 cells resulted in an increase in Thr442 phosphorylation, 
whereas cotransfection of MST3KR and NDR2 reduced phosphorylation of the 
hydrophobic motif. Nevertheless, these in vivo changes were lower than those 
observed after activation of the kinase with OA. This indicates that activation of the 
pathway is tightly controlled and/or that other upstream regulatory components and 
proper localisation also play an important role.   
Targeting of NDR to the membrane provides further evidence for the importance of 
sub-cellular localisation in the activation mechanism. Membrane targeting of NDR 
results in increased hydrophobic motif phosphorylation as well as activation of the 
kinase (17). Here, we show that the degree of Thr442 phosphorylation clearly depends 
on MST3 activity. Hydrophobic motif phosphorylation of endogenous NDR is 
increased by overexpression of HA-MST3 and diminished by expression of kinase-
dead MST3KR or RNA interference using short hairpin constructs targeting 
endogenous MST3. Furthermore, activation of membrane-targeted HA-NDR2 is 
significantly reduced in cells transfected with pTER-shMST3. However, our results 
suggest that the interaction between NDR2 and MST3 is likely to be transient. 
Recruitment of NDR to the membrane via myc-C1-MOB1 resulted in phosphorylation 
of the kinase. MST3 was not co-recruited, but a significant portion of MST3 was 
already associated with the membrane. This indicates that the interaction between 
 98
MST3 and NDR2 is not stable, similar to the interaction reported between MST1/2 
and the NDR-relative LATS1/WARTS (5, 20). However, it has also been reported for 
other kinase substrate interactions that the affinity for their substrate is weak (4) and 
below the detection limit of immunoprecipitation (34). We propose that membrane 
recruitment of NDR is an essential part of the NDR activation mechanism and that the 
phosphorylation of NDR by MST3 occurs at the membrane. However, future 
experiments will have to address the question of what signals are responsible for 
membrane recruitment of the NDR/MOB complex in vivo. It is also possible that 
NDR is targeted to the membrane to phosphorylate proteins specifically localised to 
this region of the cell. 
MST3 purified from OA-treated cells showed significantly more activity in the cell-
free assays compared with the enzyme isolated from untreated cells. This indicates 
that MST3 activity is regulated by phosphorylation that can be initiated by treating 
cells with the PP2A inhibitor OA. This indicates that activation of the kinase cascade 
is likely to be tightly controlled in vivo. The mechanism of MST3 regulation has not 
yet been fully elucidated, but the available results provide an explanation for the 
dramatic effects of OA on NDR activity. Previously, we found that MOB1A binding 
to NDR is apparently facilitated by treatment of cells with OA (3). We conclude that 
PP2 or a PP2A-type phosphatase negatively regulates both kinases and MOB1A 
function; the key issue in the future will be to understand the regulation of the 
phosphatase in this signalling network.  
Significantly, we provide the first evidence that cleavage of MST3 can, at least 
partially, be induced by NDR in a regulatory feed back loop. NDR2 overexpression 
can induce cleavage of MST3 and MST3KR, whereas the kinase-dead NDR2K119A had 
no effect on cleavage. This indicates an involvement of NDR in the promotion of 
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cleavage. Interestingly, caspases-3, 7, 8 and 9 are processed in cancer cells infected 
with an adenovirus expressing the human LATS2 kinase, a close relative of NDR. 
Further, it was shown that the Drosophila melanogaster WARTS kinase, together 
with the STE20-like kinase HIPPO, regulates the levels of DIAP1 (Drosophila 
inhibitor of apoptosis) (16, 19, 33, 44, 50). Mammalian IAP proteins are known 
inhibitors of caspase activation (25, 40), but also play a role in signal transduction and 
cell cycle regulation (1, 38).  
Our results provide a molecular mechanism for the interaction and regulation of 
STE20-like kinases with NDR kinases, which is likely to be conserved from yeast to 
mammals. MST3 functions as a hydrophobic motif kinase that promotes NDR 
activation in a MOB protein-dependent mechanism (Fig. 11). Our earlier studies (31) 
also illustrate the importance of PP2A or PP2A-like protein phosphatase in negatively 
regulating this signalling pathway. Genetic studies with yeast, worms and flies have 
shown that many of the components of the NDR signalling pathway are highly 
conserved, such as the scaffold protein Pag1p (mor2p, sax-2, FURRY), the STE20-
like kinase Kic1p (gck-1), the adapter protein Hym1p (dMO25), the activator protein 
Mob2p (dMOB proteins), and the transcription factor Ace2p (Krueppel-like 
transcription factor) (42). Based on the conserved protein components, the NDR 
signalling pathway is more closely related to the signalling pathway established for 
Cbk1p than to Dbf2p (which appears to be more closely related to LATS). Our work 
on the human orthologues indicates that conservation is also maintained with the 
mammalian counterparts of some of these proteins. However, despite the high 
conservation of the proteins, the processes they regulate are likely to differ due to 
species variation between yeast (e.g. regulation of chitinase expression) and higher 
organisms. Further work is required to fully elucidate the functions of these different 
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proteins. However, the involvement of the yeast NDR kinases in the MEN (mitotic 
exit network) and RAM (regulation of Ace2p transcription and morphogenesis) 
network (42) raises the possibility of a cell-intrinsic regulation of NDR activity, 
which might explain why all attempts (growth hormones, oxidative stress, UV, 
ceramide, fluoride, serum) to identify a ligand/hormone or endogenous stimuli have, 
so far, failed (2). 
Significant insights into the physiological roles of NDR kinases have been obtained 
using yeast, worm and fly genetic screens. Early studies from yeast found that NDR 
family kinases play a significant role in the regulation of actin and tubulin 
cytoskeletal organisation during polarised growth and cytokinesis, and are central 
components of the mitotic exit network (42). Worm NDR regulates cell spreading and 
neurite outgrowth of chemosensory neurons (52). The fly NDR is reported to be 
important for the integrity of cellular outgrowths such as wing hairs and bristles (14). 
Recently, it has been shown that NDR kinase activity plays an important role in the 
regulation of dendritic branching and tiling in worms and flies (12, 13). These results 
predict that mammalian NDR also plays a significant role in the control of cell 
division and morphogenesis. Identification of NDR-specific substrates will help to 
define the physiological roles of this conserved signalling pathway.  
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Abstract 
 
 
NDR protein kinases are a conserved family of Ser/Thr kinases that play pivotal 
roles in regulating cell cycle progression and cell morphology. Genetic and 
biochemical data revealed that NDR kinases are part of a conserved signalling 
module consisting of MOB and mammalian STE20-like protein kinases. These 
studies address the question of functional implications of human NDR kinases 
using NDR1 knockout mice. We report that NDR1-knockout mice are viable and 
do not show any apparent morphological abnormalities. However, aged NDR1 
knockout mice showed incidences of hepatis peliosis and lymphomas as well as 
enlarged seminal vesicles. 
 
Introduction 
The NDR family of serine/threonine kinases are members of the AGC group of 
serine/threonine kinase which are implicated in the regulation of cell cycle 
progression and cell morphology. In Saccharomyces cerevisiae there are three NDR 
kinases: Dbf2p and the redundant Dbf20p kinase are members the mitotic exit 
network (MEN), a signalling module which coordinates the inactivation of cyclin-
dependent kinases and cytokinesis at the end of mitosis (23, 27); and Cbk1p is 
important for polarized growth, cell separation and daughter-cell-specific gene 
activation (5, 6, 35). In Saccharomyces pombe there are two NDR kinase family 
members: the Dbf2p orthologue and member of the MEN-analogous septation 
initiation network (SIN) Sid2p; and Orb6p, a Cbk1p orthologue, which is likewise 
required for the maintenance of cell polarity. In Caenorhabditis elegans there are two 
NDR kinase family members: the tumour suppressor-like protein 1K868, which has 
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not yet been characterised; and SAX-1, which has been reported as having an 
important role in regulating dendritic branching and tiling as well as cell spreading 
and neurite outgrowth of chemosensory neurons (12, 38). The Drosophila 
melanogaster NDR kinase family members are WARTS/LATS and TRICORNERED. 
Mutations of WARTS/LATS are tumour suppressors that lead to tissue overgrowth in 
affected tissues or clones as well as developmental lethality in embryonic, larval, 
pupal or pharate-adult stages in different allelic mutations. (19, 37). TRICORNERED 
mutations are also embryonically lethal. Clonal mutations in the fly’s wing hairs, 
bristles or antennae result in a splitting and branching phenotype of the cellular 
outgrowths. Just like SAX-1 mutations in the worm, TRICORNERED mutations have 
also been shown to cause a branching and tiling phenotype in sensory neurons. 
In humans and mice there are four NDR kinases: LATS1 (also termed WARTS) and 
LATS2 as well as NDR1 and NDR2 (33). LATS1 knockout mice develop soft tissue 
carcinomas and ovarian tumours and are highly susceptible to carcinogenic treatment 
(28). Additionally, expression of a LATS1 mutant has been shown to cause prolonged 
delay in anaphase entry, and tetraploidy (16). Furthermore, LATS1 negatively 
regulates cell cycle progression (36). LATS2 knockout mice are embryonically lethal 
due to overgrowth of the mesodermal lineage. Knockout MEFs (mouse embryonic 
fibroblasts) show increased proliferation and lack of contact inhibition, as well as 
centrosome amplification, aberrant cytokinesis and genomic instability (24). 
Furthermore, LATS1 and LATS2 are thought to regulate IAP proteins, known 
inhibitors of caspase activation (10, 22), and promote apoptosis (21, 36).  
However, little is known about the function of mammalian NDR1 and NDR2 kinases.  
Ndr1 mRNA is mainly expressed in the spleen, thymus and lungs, and at lower levels 
in the brain, heart, liver, testes and muscle, whereas Ndr2 mRNA is ubiquitously 
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expressed, and especially high in the gastrointestinal tract (29). Ndr1 mRNA is 
upregulated in progressive ductal carcinoma in situ (1), and Ndr2 is upregulated in the 
highly metastatic non-small cell lung cancer cell line NCI-H460 (26). In addition, 
Ndr2 mRNA is upregulated in the amygdalla of fear-conditioned mice and has been 
shown to affect cell spreading and neurite outgrowth of PC12 cells (30). In contrast, 
NDR1 and NDR2 kinases are well characterised in biochemical terms. NDR kinases 
are part of a conserved signalling module regulated by the release of autoinhibition by 
binding to MOB1A protein, hydrophobic motif phosphorylation mediated by MST3, 
and dephosphorylation by protein phosphatase PP2A (4, 8, 15, 25) (Stegert et al., 
chapter 8.). Here we address the biological function of NDR protein kinase by 
generating NDR1 knockout mice by targeted disruption. Heterozygous matings yield 
offspring according to the Mendelian inheritance pattern. The NDR1 knockout mice 
are viable and fertile, and grow normally. Pathological analysis of 14-week-old NDR1 
knockout mice has revealed no major abnormalities apart from a 14% decrease in 
testis weight compared to wild type mice, but there is no clear correlating microscopic 
finding. Microscopically, no major histomorphological differences were noted in 
NDR1 mice when compared to the wild type. However, 20- to 30-month-old NDR1-
knockout mice showed a frequent occurrence of tumours and tumour-like lesions, 
especially in the liver and the lymphatic system. 
 
Materials and methods 
Targeted disruption of the Ndr1 gene by homologous recombination  
An ~9 kb BamHI-NotI fragment containing exons 4, 5 and 6 was amplified from BAC 
clone 25140 (244/G01) (Incyte Genomics) using Expand Long Template Taq 
polymerase (Roche), and subcloned in pMCS5. A 5 kb IRES/lacZ/Neo cassette was 
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inserted in the XhoI site of exon 4. The targeting vector was linearised using the SalI 
site and electroporated into 129/Ola ES cells. An external probe was used for ES cell 
Southern screening following KpnI digestion. An internal probe and a lacZ-Neo probe 
were used to characterize ES clones positive for homologous recombination (data not 
shown). Correctly targeted ES cells were used to generate chimeras. Male chimeras 
were mated with wild type C57BL/6 females to obtain Ndr1 +/– mice. Ndr1 +/– mice 
were backcrossed for at least four generations with pure C57BL/6 mice. The progeny 
of Ndr1 +/– intercrosses were genotyped by multiplex PCR with the following three 
primers: (1) Ex4checkb, 5’-GTCTTCTCATCGCTGTCACAGCT-3’; (2) Neo-2, 5’- 
GCTGCCTCGTCCTGCAGTTCATTC-3’; and (3) 6540bk, 5’-GCTCCCGCTCAGT-
TACCTGCTCC-3’. 
Microarray analysis 
Microarray analysis was performed using murine U74 GeneChipsTM (Affymetrix). 
Total RNA (10 µg) was reverse-transcribed using the SuperScript Choice system for 
cDNA synthesis (Life Technologies) and biotin-labelled cRNA generated using the 
Enzo BioArray High Yield RNA transcript labelling kit (Enzo Diagnostics) following 
the manufacturer’s protocol. cRNA fragmentation and hybridisation were performed 
as recommended by Affymetrix. Expression data were calculated using the RMA 
algorithm from BioConductor (17). A gene was considered to be significantly altered 
in its expression if it had an Affymetrix change P-value of less than 0.003 for either 
increase or decrease in both replicate comparisons, and it had a minimum expression 
value of 80 in at least one condition. A fold-change threshold of 1.5 was then applied 
and the resulting genes were subjected to a one-way ANOVA with a P-value cut-off 
of 0.05. A Benjamini and Hochberg multiple testing correction and a Tukey post-hoc 
test were applied. 
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Histopathology and haematology 
Animals were euthanized after exposure to carbon dioxide followed by 
exsanguination. For calculation of organ weights relative to body weight, the terminal 
body weight measured before exsanguination at necropsy were used. In addition, 
organ weights were calculated relative to the brain weight. Brian, heart, kidneys, liver, 
ovaries, spleen, testes and thymus were weighed. The following tissues were 
processed for further examination: adrenals, bone marrow, brain, caecum, colon, 
duodenum, gall bladder, heart, ileum, jejunum, kidneys, knee joint, liver, lung, 
auxiliary and mesenteric lymph nodes, ovaries, pancreas, peripheral nerve, pituitary, 
rectum, spleen, sternum, skeletal muscle, skin, spinal cord, sternum, stomach, testes, 
thymus, thyroid with parathyroid and trachea.  
All tissues were fixed in neutral phosphate-buffered formalin. Bone was 
demineralised with 10% formic acid. The tissues were embedded in Paraplast® 
(McCormick Scientific). Sectioning was at (nominally) 4 µm and all tissue samples 
stained with haematoxylin and eosin. All histologically processed tissues were 
subjected to microscopic examination. Data for all investigations were, whenever 
possible, recorded online, using software packages specifically designed for the 
purposes of the test facility/sites (PathData® v. 5.1). Where online recording was not 
possible (organ weights and macroscopic examinations), handwritten raw data sheets 
were used. The data were subsequently entered manually into the computer and the 
raw data sheets were archived. For organ weight data, an automated program was 
used to decide whether parametric or non-parametric group comparisons should be 
made. This program used Kolmogorov’s test to examine the normality of the data, and 
Bartlett’s test to examine the homogeneity of variances. Accordingly, either Dunnett’s 
test or Student’s t-test for parametric group comparisons, or Dunn’s test or 
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Wilcoxon’s test (U-test) for non-parametric group comparisons were used. No 
statistical analysis was performed for microscopic examinations. 
For haematology, blood samples and bone marrow smears of wild type mice and 
NDR1 mice were taken by terminal bleeding. EDTA (ethylene-diamin-tetra-acetate) 
blood was used for the haematology determinations. No anticoagulant was used for 
the clinical biochemistry parameters. Complete blood counts (erythrocytes (RBC), 
haemoglobin (HGB), haematokrit (HCT), mean corpuscular volume (MCV), mean 
corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration 
(MCHC), red cell distribution width (RDW), total and relative white blood cell count 
(WBC), neutrophils, lymphocytes, monocytes, eosinophils, basophils, LUCs, 
reticulocytes (including total and relative total, high, medium and low reticulocyte 
counts) and total platelet count) using the ADVIA 120® analyzer (Diamond 
Diagnostics) were performed on animals for which an adequate sample was available. 
Blood smears were prepared and stained with modified Wright stain. Bone marrow 
smears were prepared using a push smear technique and stained with modified Wright 
stain. Microscopic evaluation was performed on all blood and bone marrow smears.  
 
Results 
Targeting strategy and confirmation of genotype 
To investigate the biological function of NDR1, NDR1-deficient mice were generated 
by targeted disruption of exon 4 as shown in Fig. 1A. The targeted disruption of the 
NDR1 gene locus was confirmed by Southern blotting and PCR using tail-tissue 
samples from NDR1 wild type (NDR1+/+), heterozygous (NDR1+/-) and mutant 
(NDR1-/-) mice (Fig. 1B and C). Microarray analysis showed an ablation of the NDR1 
mRNA in spleen samples of NDR1 mutant mice (see table 2). To confirm the absence 
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of NDR1 at the protein level, western blot analysis was performed on mouse 
embryonic fibroblasts (MEFs) using an anti-N-terminal NDR antibody, which 
recognizes both NDR1 and NDR2. In contrast to NDR1+/+ MEFs, NDR1 was not 
detectable in samples derived from mutant mice (Fig. 1D), but NDR2 appeared to be 
expressed at higher levels in NDR1-/- mice, indicating a compensatory upregulation of 
NDR2.  
NDR1-deficient mice 
In order to address the biological function of NDR1, targeted ES cell clones were 
used to generate NDR1-/- mouse lines. Intercrosses of NDR1-targeted heterozygotes 
gave rise to NDR1-/- homozygotes at the expected Mendelian frequency (see table 1). 
We have not detected any effect of NDR1 deficiency on mouse fertility, health or 
survival up to 1 year of age. Additionally 14-week-old mice (9-10) of each sex and 
genotype were subjected to a detailed analysis, including organ weight measurements 
of brain, heart, kidneys, liver, ovaries, spleen, testes and thymus (see table 2) and 
histological examination of adrenals, bone marrow, brain, caecum, colon, duodenum, 
gallbladder, heart, ileum, jejunum, kidneys, knee joint, liver, lung, auxiliary and 
mesenteric lymph nodes, ovaries, pancreas, peripheral nerve, pituitary, rectum, spleen, 
sternum, skeletal muscle, skin, spinal cord, sternum, stomach, testes, thymus and 
thyroid with parathyroid and trachea (data not shown). The body weight of NDR1-/- 
animals was slightly (but statistically not significantly) decreased (by 6%) in both 
sexes. For the testes, a small weight decrease of 14% was recorded in knockout mice. 
However, there were no clear correlating microscopic findings. No other organs and 
tissues of NDR1-/- mice showed any major weight or histopathological differences 
when compared to wild type mice.  
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 Fig. 1. Ablation of mouse NDR1 by a gene knockout approach. A, Targeting disruption of 
the mouse Ndr1 gene locus by insertion of an IRES/lacZ/neo cassette into exon 4 of the 
kinase. B, Southern blot analysis of tail DNA samples obtained from a heterozygous mating. 
C, Multiplex PCR of mouse DNA tail samples. D, Western blot analysis of knockout and 
wild type MEFs using the α-NT-NDR and α-actin antibodies. 
Genotype +/+ -/+ -/- 
Number of animals 63 119 60 
Obtained ratio 26.03% 49.17% 24.79% 
Expected ratio 25% 50% 25% 
Table 1. Ratio of NDR1 wild type, heterozygous and knockout animals in comparison to the 
expected Mendelian ratios.  
There were also no significant differences between wild type and NDR1 mice with 
regards to haematological evaluations. 
The lack of NDR1 requirement might reflect a compensatory upregulation of NDR2, 
as observed in MEFs (Fig. 1D) or the upregulation of other compensatory pathways.  
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Microarray analyis of NDR1-deficient spleen 
In order to evaluate the downstream effects of NDR signalling, we compared 
duplicate mRNA samples of NDR1-mutant spleen with spleen from its wild type 
littermate controls, because recent analysis of the expression levels of Ndr1 and Ndr2 
mRNA have revealed that Ndr1 is the dominant isoform in the thymus, lung and, 
especially, spleen, whereas Ndr2 mRNA is ubiquitously expressed, but with very low 
expression in spleen (see Fig. 2) (29). 
RNA was extracted from whole mouse brains, and microarray analysis was performed 
on three individual brains per genotype and timepoint using murine MG_U74Av2 
Affymetrix GeneChipsTM. 
 
Fig. 2. Relative mRNA expression levels of mNdr1 and mNdr2 determined by quantitative 
real-time PCR in brain and spleen as described previously (29). The expression level were 
normalised to the expression of mNdr1 in brain. 
Changes below 2.0-fold increase were considered insignificant, and differentially 
regulated genes were subjected to a Student’s t-test analysis (Tables 2 and 3). Among 
the 9761 expressed genes, 74 genes were found to be differentially expressed in 
NDR1-/- spleens versus NDR1+/+ spleens. Of these, 38 genes were upregulated and 36 
genes were downregulated. Strikingly, several of the altered genes are associated with 
similar cellular processes. There are genes involved in heat shock response and 
folding (e.g. Hspa1a, Hsp105, Bag3), apoptosis and cytotoxicity (Fcgr3, Igh4, Plg, 
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Bag3, Mst2, Col18a1), protein glycosylation (Siat3, Hs3st3a), angiogenesis and 
vasoconstriction (Plg, Col18a1, Edn1), regulation of the cytoskeleton (Krt1-1, Dvl2, 
Coro2B, Tnnt1, Eln), spermatogenesis and sperm motility (Mak1, Tssk1), proteolysis 
Description Genebank fold Function 
heat shock protein 1A, Hspa1a M12571 8.6 heat shock, folding 
cytochrome c oxidase, subunit Vic,Cox6c AV071102 7.7 unknown 
ubiquitin specific protease 14, Usp14 AV271750 7.4 synaptic transmission 
gastric intrinsic factor, Gif L24191 6.1 ion transport 
alanine and arginine rich domain containing protein, Aard AI390412 4.9 unknown 
sialyltransferase 8  A, Siat8a X84235 4.9 protein glycosylation 
laminin, alpha 1 M36775 4.4 cell adhesion, migr. 
cAMP responsive element binding protein 1, Creb1 X67719 4.1 transcription 
male germ cell-associated kinase, Mak X66983 4.1 sperm motility 
histone 1, H1b Z46227 3.9 transcription 
Prolin rich protein HaeIII family 1, prh1 M23236 3.6 unknown 
Fc receptor, IgG, low affinity III, Fcgr3 X60929 3.1 cytotoxicity, phagocytosis 
heat shock protein, Hsp105 L40406 3.0 heat shock, folding 
aristaless 4, Alx4 AF001465 3.0 transcription 
3-phosphoglycerate dehydrogenase, Phgdh L21027 3.0 amino acid biosynthesis 
immunoglobulin heavy chain 4, Igh4 V00793 2.8 cytotoxicity, phagocytosis
protein tyrosine phosphatase non rec. substrate , Ptpns1 AV317524 2.7 unknown 
5-hydroxytryptamine (serotonin) receptor 1B, Hrt1b M85151 2.7 behaviour 
pancreatic polypeptide, Ppy M18208 2.6 hormone signalling 
keratin complex 1, acidic, gene 1, Krt1-1 M27734 2.5 cyto., intermed. filaments 
metallothionein 3, Mt3 M93310 2.5 neurogenesis 
Rad9 homologue (S. pombe), Rad9 AF045663 2.4 cell cycle, DNA damage
plasminogen, Plg J04766 2.4 apoptosis, angiogenesis 
dishevelled 2, dsh homolog (Drosophila), Dvl2 AV312528 2.4 actin , motility 
Btb (POZ) domain containing 14, Btbd14 AV369001 2.4 unknown 
solute carrier family 25, member 3 Slc25a3 AW121063 2.3 unknown 
coronin, actin binding protein, 2B  Coro2B AI848032 2.3 actin binding 
thyrotropin releasing hormone, Trh X59387 2.3 hormone signalling 
phospholipase A2, group X, Pla2g10 AA607557 2.2 lipid catabolism 
N-myc (and STAT) interactor, Nmi AF019249 2.2 transcription 
zinc finger protein, 1 (Ikaros), Znfn1a1 AI325349 2.2 transcription 
cathepsin E, Ctse M17327 2.2 proteolysis 
Bcl2-associated athanogene 3, Bag3 AV373612 2.2 apoptosis, folding 
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A AV341572 2.2 protein glycosylation 
chitinase, acidic, Chia-pending AI594518 2.1 chitin metabolism 
ATP-binding cassette, sub-family C (CFTR/MRP), 8 AF037312 2.1 ATP-channel 
potassium voltage-gated channel, beta  1, Kcnab1 AV335854 2.0 ion channel 
phosphatidylinositol (4,5) bisphosphate 5-phosphatase, A AI850079 2.0 lipid modification 
Table 2. Upregulated genes in NDR1 knockout spleen samples. 
 119
(Chia-pending, Plg, Ctse, Pcsk1), the immune response (Fcgr3, Igh4, Tacstd2, Cx3cl1, 
CD276) and transcription (Creb1, H1b, Alx4, Nmi1, Znfn1a, Myt1, Hes3), indicating 
a potential role of NDR1 in these processes.  
Description Genebank fold Function 
HIV-1 tat interactive protein 2, homolog (human), Htatip2 AF061972 7.9 unknown 
RIKEN cDNA 2410015J15 gene AV240248 7.6 unknown 
GEF (RCC1 related), Gnefr-pending         AJ243952 6.9 nuclear import 
calcium/calmodulin-dependent protein kinase II, beta X63615 6.0 cell cycle 
stearoyl-Coenzyme A desaturase 1, Scd1 AW04789 5.1 lipid biosynthesis 
cytochrome P450, family 4, subfamily a, polypeptide 14 Y11638 4.6 electron transport 
tumour-associated calcium signal transducer 2, Tacstd2 AI563854 4.5 immune response 
chemokine (C-X3-C motif) ligand 1, Cx3cl1 U92565 4.5 immune response 
myelin transcription factor 1-like, Myt1l U86338 4.1 transcription 
insulin-like growth factor binding protein 6, Igfbp6 X81584 3.7 cell growth 
mini chromosome maintenance deficient 7, Mcmd7  AV377480 3.6 unknown 
casein kinase 1, delta, Csnk1d AI846289 3.4 DNA repair, signalling 
SPARC related  modular calcium binding 1, Smoc1 AI848508 3.3 calcium binding 
RIKEN cDNA E130103I17 gene U85993 3.3 unknown 
protein phosphatase 2, regulatory subunit B (B56), epsilon AI606577 3.2 unknown 
Tssk1 (spermiogenesis associated) U01840 3.1 spermatogenesis 
coiled-coil-helix-coiled-coil-helix domain containing 6 AI844709 3.1 unknown 
Ndr1 protein kinase AA691445 2.8 - 
procollagen, type XVIII, alpha 1, Col18a1 U03715 2.8 angiogenesis, apoptosis 
Purkinje cell protein 2 (L7), Pcp2 M21532 2.7 unknown 
pyruvate carboxylase, Pcx M97957 2.7 lipid biosynthesis 
hairy and enhancer of split 3 (Drosophila), Hes3 D32200 2.5 transcription, morphology
oxysterol binding protein-like 9, Osbpl9 AI846667 2.5 unknown 
Mst2 (Ste20, yeast homolog) U28726 2.5 apoptosis 
CD276 antigen AI593640 2.4 immune response 
RIKEN cDNA 3110004L20 gene AW123347 2.3 unknown 
homer homolog 3 (Drosophila), homer3,  FLJ10432 AI840678 2.3 unknown 
troponin T1, skeletal, slow, Tnnt1 AV213431 2.3 cytoskeleton, muscle dev.
dynein, axonemal, heavy chain 8, Dnahc8 AA144987 2.3 microtubule movement 
origin recognition complex, subunit 4-like, Orc4l AI553463 2.2 replication 
RIKEN cDNA C730036B01 gene AA690483 2.2 unknown 
RIKEN cDNA 1100001I22 gene AW121947 2.2 protein biosynthesis 
elastin, Eln U08210 2.1 actin cytoskeleton 
proprotein convertase subtilisin/kexin type 4, Pcsk4 L21221 2.1 proteolysis, fertility 
RIKEN cDNA 2610312E17 gene AI853476 2.0 unknown 
endothelin 1, Edn1 U07982 2.0 vasoconstriction 
Table 3. Downregulated genes in NDR1 knockout spleen samples. 
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Phenotypes of aged NDR1 knockout mice 
In aged NDR1 knockout mice we observed a frequent occurrence of peliosis hepatis 
and/or nodular regenerative hyperplasia (see Fig. 3 and table 4). A preliminary 
summary is shown in table 3. No macroscopic observations were made in four control 
wild type animals. However, the number of NDR1 wild type and knockout animals 
used for this study was rather small, and higher numbers would be required to 
attribute this to NDR deficiency.  
Fig. 3 shows a peliosis hepatis liver, a benign vascular disorder which is characterised 
by blood-filled cavities and cystic hepatic sinusoidal dilatation. Notably, the 
microarray analysis showed a downregulation of endothelin (Edn), which is involved 
in vasoconsriction, an upregulation of plasminogen (Plg), an activation of 
angiogenesis, and a downregulation of procollagen type 18a1, an inhibitor of 
angiogenesis. 
 
Fig. 3: Liver lesions in aged (20- to 30-month-old) NDR1 knockout mice. A, Peliosis 
hepatis liver characterised by blood-filled cavities in the liver parenchyma. B, 10x 
magnification of the peliosis hepatis liver with highly dilated cavities. C, 10x magnification 
of a nodular hyperplasia of the liver. 
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In the group of aged animals, there were also at least 2 incidences of malignant 
lymphomas (see table 4). None of the four wild type mice of mixed background 
(C57Bl/6.129SvJ background) show an apparent lesion, but wild type C57Bl/6 mice 
are reported to develop lymphomas during aging (3). Higher animal number are 
required to see whether there are significant changes between knockout and wild type 
animals. 
An additional observation was that the size of the seminal vesicles of aged male 
knockout animals was heavily enlarged compared to the wild type animals (3 male 
mice). However, the functional implication of this is as yet unclear and requires 
further investigation.  
 
Fig. 4: Lymphoma in the abdomen. A, macroscopic view. B, 10x magnification of the 
lymphoma. 
 
  
Fig. 5: Enlargement of the seminal vesicles in aged NDR1-knockout mice. Comparision of 
seminal vesicles from knockout and wild type animals. 
 
 122
  
Morphological abnormalities in 13 aged (8 male) knockout mice:  
Liver  2x peliosis hepatis 
1x nodular hyperplasia 
1 uncharacterised 
abnormalities 
Lymphatic system 2x lymphoma   
Seminal vesicles 7x enlarged vesicles  
Not yet characterised 
masses 
1x lung 
1x abdominal mass 
 
Table 4. Summary of initial observation in aged NDR1 knockout animals. 
 
Discussion 
 
NDR protein kinases show an extremely high conservation from yeast to mammals, 
indicating that they have an important function. However, here we report that the 
phenotypic consequences of an ablation of NDR1 in mice are rather mild or of late 
onset. 
Worms and flies only have one NDR kinase each, SAX-1 and TRICORNERED, both 
with a strong neuronal morphology phenotype. SAX-1 and TRICORNERED mutants 
show a branching and tiling phenotype of chemosensory neurons (11, 12). The 
TRICORNERED mutation results in a splitting and branching phenotype of bristles, 
wing hairs or antennae (13). The organismal knockout of TRICORNERED is lethal. 
In contrast, mice and humans have two isoforms, NDR1 and NDR2, indicating that 
the duplication occurred from a recent expansion of the kinome. Therefore, the mild 
and/or late onset phenotype of NDR1-knockout mice might be due to overlapping 
functions of NDR1 and NDR2. This idea is also supported by the increase in NDR2 
protein levels in NDR1-knockout MEFs compared to wild type, which indicates a 
compensatory role of NDR2 in the knockout MEFs. However, an upregulation of 
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Ndr2 mRNA could not be detected by microarray analysis because the MG_U74Av2 
Affymetrix chip used did not contain Ndr2. Furthermore, no differences have been 
found in terms of regulation of the kinases (14, 29) and both kinases were identified in 
the same complex using a proteomics approach (18). 
The microarray analysis of spleen mRNA expression in wild type and knockout 
animals revealed several interesting findings. First, several genes involved in heat 
shock response, immune response, cellular cytotoxicity and apoptosis were changed, 
indicating that NDR1 might be involved in the response to cellular stress. 
Interestingly, NDR kinases were shown to be regulated by MST3, a STE20 group 
kinase, which is implicated in the regulation of apoptosis. Of note, within these genes 
MST2, a mammalian STE20-like kinase, which is reported to phosphorylate the NDR 
family kinase LATS, is downregulated. This could reflect some crosstalk between the 
NDR and LATS signalling modules as indicated by data from flies and yeast (14, 20). 
Additionally, several genes involved in the regulation of the actin cytoskeleton, 
microtubule network and intermediate filaments were changed. NDR in yeast, worms 
and flies is also implicated in the regulation of cellular morphology, especially cell 
spreading and cellular extensions, indicating that mammalian NDR kinase might also 
play a role in these processes. However, it is unclear whether these changes are 
primary or secondary effects of NDR1 deficiency.  
In aged NDR1 knockout mice, more obvious phenotypes occur. Two out of 13 mice 
show hepatis peliosis, an aberrant proliferation of endothelial cells in the liver, which 
is also associated with an increased sinusoidal dilatation. Interestingly, endothelin, a 
vasoconstrictor (34), and procollagen type18 alpha1 (endostatin) (30), an 
angiogenesis inhibitor, are downregulated in hepatis peliosis whereas plasminogen, an 
angiogenic protease (2), is upregulated, providing a potential explanation for the 
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observed phenotype. However, further studies and increased animal numbers are 
required in order to make this finding more significant. Hepatis peliosis is a very rare 
disease in humans, but is more frequent in immunodeficient people. For example, it is 
more common in HIV patients. NDR kinase is also reported to be incorporated into 
HIV particles and proteolytically inactivated by the viral protease (9), suggesting a 
potential link between hepatis peliosis and NDR deficiency. 
Aged NDR1 knockout animals also showed incidences of spontaneous lymphoma. 
NDR kinase was shown to be part of a signalling module, together with MST3, a 
member of the mammalian STE20-like kinases, which are implicated in the regulation 
of apoptosis by inducing DNA fragmentation by apoptotic histone phosphorylation in 
the nucleus. Furthermore, NDR has been shown to be part of a feedback regulation, 
which induces cleavage and nuclear translocation of MST3 (Stegert et al., chapter 8.). 
Further research will be needed to reveal whether NDR ablation causes lymphomas 
by reducing programmed cell death. In humans there have been rare cases reported 
where hepatis peliosis is found in association with lymphomas (8). Interestingly, 
disruption of the murine Ndr2 gene by retroviral insertional mutagenesis caused B-
cell lymphomas (32). However, the significance of this observation is unclear, 
because also wild type animals of the C57Bl/6 strain are known to have a significant 
incidence of lymphomas (3). Therefore, studies with increased mouse numbers will be 
required to enable meaningful conclusions about the effect of NDR deficiency.  
Furthermore, the seminal vesicles are highly enlarged in knockout animals compared 
to wild type. However, again further research is required in order to evaluate whether 
this finding correlates with defects in spermatogenesis, sperm motility or other defects. 
Notably, male germ cell associated kinase (Mak) was upregulated, and testis-specific 
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serine/threonine kinase (Tssk) was downregulated in the microarray experiment (see 
tables 2 and 3).  
So far, the number of aged animals available, in combination with the late onset of the 
phenotype, limits the significance of this part of the study. However, an expansion of 
the study is underway. Further, it will be interesting to see whether the phenotype 
could be consolidated by crossing the mice with, for example, p53-+/- mice, which are 
more prone to the development of hepatis peliosis or lymphoma, or by treatment with 
carcinogens. 
Furthermore, the ablation of NDR2 and the generation of NDR1-/-/NDR2-/- mice will 
be critical for evaluating and understanding the role and function of NDR kinases in 
mammals. Indeed, studies in our laboratory using NDR1-/- MEFs, in which NDR2 is 
ablated by using stably integrated short-hairpin constructs, have indicated a role of 
NDR in regulating cytokinesis and genomic integrity (Tamaskovic et al., in prep.). 
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Supplementary data  
Generation of a conditional targeting vector for mNdr1 
In order to evaluate the function of NDR1 and in order to circumvent potential 
lethality of a disruption of the Ndr1 gene a conditional targeting vector was generated. 
A BamH1 –NotI fragment of the indicated region of the Ndr1 gene locus cloned into 
pMCS5 was used as the vector backbone. An AatII site upstream of exon 4 was used 
to insert a PstI flanked loxP sequence and a ‘floxed’ Neo cassette was insert into the 
PmeI site downstream of exon 4 (Fig. S1A). Exon 4 contains the catalytic lysine of 
the kinase. Cre recombinase induced excision of exon 4 is expected result in a 
catalytically inactive protein lacking 28 amino acids within the kinase domain, which 
might still be able to form complexes with other proteins. Therefore, this could result 
in a dominant negative protein. The targeting vector was linearised using the SalI site 
and electroporated into 129/Ola ES cells. An external probe was used for ES cell 
Southern screening following PstI digestion. The targeting construct was proven to 
integrate into the genomic locus by homologues recombination (Fig. S1B) and single 
integration was confirmed by Southern screening using an internal probe (Xba-Xba 
fragment) following a BamHI digestion (data not shown). The correctly targeted ES 
cell was used to generate chimeric animals. However, no germline transmission was 
observed using this ES cell clone. Therefore, new ES cell clones have to be screened 
in order to implement this strategy.  
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Fig. S1. Conditional targeting of the mouse NDR1 locus. A, Targeting of the mouse Ndr1 
gene locus by flanking exon 4 with loxP (P) and a ‘floxed’ neomycin cassette (Neo) (white 
squares indicate the region of the targeting construct. Expression of Cre recombinase removes 
exon 4, which contains the catalytic lysine of the kinase. B, Southern blot analysis of ES cell 
DNA clones electroporated with the targeting construct. 
 
Generation of inducible short hairpin constructs targeting mNdr2 
To investigate the effect of NDR deficiency we also generated short-hairpin 
constructs which target the mouse Ndr2 mRNA. The main advantage of this approach 
compared to generating knockout cell and animals is the reduced time required for 
generating the cells. However, the analysis is more complex, and as for most 
transgenic approaches several clones have to be used in order to ensure that the 
observed effect is due to the specific knockdown and not the integration of the 
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construct into a specific locus. Therefore, we used the pTER vector in order to 
generate short hairpin constructs (Wetering et al., 2003). This vector contains the H1 
promotor of RNA polymerase III and a TET operon which allow the doxycycline-
inducible regulation of the knockdown in TET repressor expressing cells (Wetering et 
al., 2003). The following primer pairs were used in order to subclone the targeting 
sequence into the BglII and HindIII cut vector backbone: pTER-shmNdr2-1 5’-GAT-
CCCGTTACGTCGATCGCAGCATTTCAAGAGAATGCTGCGATCGACGTAAC-
TTTTTGGAAA-3’ and 5’-AGCTTTTCCAAAAAGTTACGTCGATCGCAGCATT-
CTCTTGAAATGCTGCGATCGACGTAACGG-3’ and pTER-shmNDR2-2: 5’-GA-
TCCCGAGCAGGTGGCTCATATCCTTCAAGAGAGGATATGAAGCCACCTGC-
TCTTTTTGGAA-3’ and 5’-AGCTTTTCCAAAAAGAGCAGGTGGCTCATATCC-
TCTCTTGAAGGAAATATGAGCCACCTGCTCGG-3’. The vector is visualized in 
Fig. S2A. 
Using this constructs in NDR1-/- MEFs expressing the TET repressor resulted in an 
inducible cell line which is NDR1 and NDR2 deficient. However, also without 
doxycyclin induction NDR2 was downregulated to a large degree, indicating that the 
system is leaking. In contrast, NDR2 was not downregulated after stable intergration 
of an unspecific short-hairpin construct (Tamaskovic et al., in prep.).  
These NDR1-/- NDR2-knockdown MEFs display growth defects, multinucleation, 
polyploidy, impaired mitotic exit, and abortive cytokinesis suggesting that NDR 
kinases have an important function in maintaining genomic integrity and might be 
part of a mammalian mitosis exit network (Tamaskovic et al., in prep.) 
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Fig. S2. Knockdown of mouse Ndr2. A, Schematic representation of the pTER-shmNDR2 
constructs B, Downregulation of NDR2 using stably integrated pTER-shmNdr2 constructs in 
TET-expressing NDR1 knockout MEFs in presence and absence of doxycylin. MEF cell 
lysates were subjected to Western analysis using α-NT-NDR and α-actin antibodies. 
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III. GENERAL DISCUSSION 
 
10. REGULATION AND EXPRESSION OF MAMMALIAN NDR1 
AND NDR2 KINASE 
 
NDR protein kinases are tightly regulated by a number of mechanisms. Full NDR 
kinase activity requires autophosphorylation at the activation segment, hydrophobic 
motif phosphorylation by a Ste20-like kinase, and release of autoinhibition by MOB 
proteins. Activation of NDR is also regulated in a temporal and spatial manner. NDR 
hydrophobic motif phosphorylation is increased in G2/M, suggesting a role in cell 
cycle progression (Tamaskovic et al., unpub. data). Furthermore, hydrophobic motif 
phosphorylation is stimulated upon localisation of NDR to cellular membranes 
(Hergovich et al., 2005; this study). The phosphorylation at the membrane is further 
dependent on the levels of the Ste20-like kinase MST3 in HEK293F cells. Despite the 
largely overlapping localisation of MST3 and NDR2 to the cytoplasm, activation of 
NDR2 has additional requirements. Fractionation of cells into membranous and 
cytoplasmic structures indicates that a portion of the cellular MST3 is associated with 
cellular membranes, indicating that membrane-associated MST3 might be active. 
Interestingly, recruitment of Ste5-associated kinase to membrane-localised Ste20 
kinase is important for the activation of the yeast pheromone response pathway 
(Pryciak and Huntress, 1998), and membrane recruitment is shown to activate MST1 
(Praskova, et al., 2004). However, additional studies are required to unravel the 
regulation of Ste20-like kinases. 
Recent studies have further demonstrated that NDR phosphorylation and activation is 
dependent on the cellular level of Ca2+ (Tamaskovic et al., 2003a). There might be 
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several reasons. First, NDR kinase binds to S100B proteins, EF hand proteins, which 
are able to bind to substrate proteins in their Ca2+-bound state (Millward et al., 1998). 
Second, upstream regulatory elements require Ca2+, because BAPTA treatment of 
cells abolishes NDR hydrophobic motif phosphorylation. (Tamaskovic et al., 2003). 
However, it is unclear whether this is a direct effect on the localisation of NDR, or 
whether Ca2+ affects MST3 activity. Also, other ions might affect NDR activity. MOB 
proteins have been shown to bind Zn2+ ions. MST3 also has an atypical ion preference, 
and autophosphorylates with Mg2+, Mn2+, Co2+ and Zn2+ (Schinkmann et al., 1997; Lu 
et al., 2005). Therefore, the local ionic composition within the cell might have a 
crucial effect on NDR activity. Local and temporal changes in ion concentrations are 
a way to restrict kinase activities to their place of action. Localisation of the kinase is 
likely to regulate NDR function as well. Interestingly, overexpression of wild type 
NDR, but not kinase-dead NDR, has the same effect on MST3 cleavage as the 
constitutively active NDR-PIF (this study), and overexpression of NDR wild type and 
NDR-PIF result both in polyploidy (Hergovich et al., unpub. data; Tamaskovic et al., 
unpub. data). This indicates that activation itself is not sufficient to transduce the 
signal, but that localisation regulates activation and signal-transduction to specific 
substrates. NDR activity is also regulated through the binding of coactivator 
molecules such as MOB1A (this study) or S100B to the N-terminal regulatory SMA 
domain of the kinase. The binding of MOB in vitro stimulates phosphorylation at the 
activation segment as well as at the Thr75 within the SMA domain (Bichsel et al., 
2004). However, the in vivo significance of Thr75 phosphorylation still needs to be 
determined. MOB binding stimulates autophosphorylation by releasing the kinase 
from autoinhibition mediated by the AIS within the catalytic domain insert (Bichsel et 
al., 2004; this study). The AIS sequence in the kinase domain insert resembles the 
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substrate peptide sequence of NDR kinases and might, therefore, act by blocking the 
substrate binding pocket. The crystal structures of NDR and the NDR-MOB complex 
will probably provide further insights into the function of the AIS. 
The binding to scaffold proteins, such as the FURRY protein AF4p12, might also be 
important for the formation of signalling modules. Protein phosphatase 2A is a 
negative regulator of NDR activity, indicating that dephosphorylation is another mode 
of regulation of NDR activity. It will be interesting to find out what the signals are 
which prevent or stimulate dephosphorylation of the kinase.    
Altogether, the multi-factorial regulation of NDR kinases activity and function 
involves phosphorylation and dephosphorylation events mediated by MST3 and PP2A 
respectively: binding of coactivator proteins such as MOB1A or S100B, which 
stimulate autophosphorylation and release the kinase from autoinhibition; and 
localisation of the kinase. 
The intensity of NDR kinase signalling is not only regulated by altering NDR activity 
and localisation but also by the expression levels of the kinase. Overexpression of the 
kinase in COS-7 cells promotes cleavage of MST3, indicating that the levels of NDR 
are critical for its function and biological effects. Ndr1 and Ndr2 kinases show a 
ubiquitous expression pattern. Ndr1 mRNA is mainly expressed in spleen, thymus, 
muscle and lung (Devroe et al., 2004; this study). In most tissues, NDR2 shows 
higher expression levels and is especially high in proliferative tissue such as stomach 
and intestine. The high cellular turnover in these tissues, and the induction of MST3 
cleavage by NDR2, which is most probably mediated by caspases, point to a potential 
role of NDR in the induction of apoptosis. 
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Interestingly, overexpression of LATS2 leads to activation of caspases and induces 
apoptosis (Ke et al., 2004). Therefore, NDR and LATS kinases might have similar 
and overlapping functions. 
So far, no differences are known in the regulation of NDR1 and NDR2 kinase activity, 
indicating that they have the same functions. In NDR1-knockout mouse embryonic 
fibroblasts, NDR2 levels are upregulated. This indicates that NDR2 at least partially 
compensates for the loss of NDR1. This might explain the mild and/or late-onset 
phenotype of NDR1-knockout animals. Furthermore, NDR1 and NDR2 were 
identified in the same protein complexes coimmunoprecipitating with 14-3-3 proteins 
(Jin et al., 2004). 
 
11. CONSERVATION OF THE NDR SIGNALLING NETWORK 
 
The NDR protein kinase family is one of the most conserved kinase families 
throughout evolution, indicating an important function. NDR1 and NDR2 kinase are 
86% identical and have a similarity of 91%. Therefore, it is not surprising that, so far, 
no differences have been found regarding NDR1 and NDR2 function and regulation. 
Also, their co-occurrence in the protein complexes points to redundant functions of 
mammalian NDR kinases (Jin et al., 2004). 
In contrast, Caenorhabditis elegans and Drosophila melanogaster only have one 
NDR kinase, SAX-1 and TRICORNERED, respectively, with identities of 69% and 
71% to human NDR1 kinases. Both worm and fly NDR mutants show an apparent 
morphological phenotype in mechanosensory and chemosensory neurons: increased 
dendritic branching and tiling defects (Emoto et al., 2004; Gallegos et al., 2004). 
Clonal knockouts of TRICORNERED also result in a splitting phenotype of cellular 
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extensions such as wing hairs, bristles or arista. The organismal knockout is lethal. 
This points to a potential role of NDR in the regulation of cell morphology, especially 
neuronal morphology. Indeed, NDR2 is implicated in the regulation of neurite 
outgrowth and cell spreading (Stork et al., 2004). 
Furthermore, the budding and fission yeast NDR kinases CBK1 and ORB6 are also 
known to affect cell cycle progression (Verde et al., 1998; Colman-Lerner et al., 2001; 
Laabs et al., 2004). The regulation of NDR hydrophobic motif phosphorylation during 
the cell cycle (Tamaskovic et al., unpublished) indicates that mammalian NDR 
kinases are also involved in cell cycle progression. Therefore, it is likely that NDR 
kinases from yeast to humans have a common role in the regulation and coordination 
of cell morphology and cell cycle progression (Tamaskovic et al., 2003a). 
Not only NDR kinases, but also the regulatory elements of NDR kinase activation 
(see also table 1b of the introduction section), are highly conserved, indicating that the 
NDR kinase-signalling pathway is a conserved signalling module. In recent years, 
several proteins have been shown to genetically interact with NDR kinases in yeast, 
worms and flies, encompassing MOB proteins, FURRY proteins and STE20-like 
kinases (Zallen et al., 2001; Cong et al., 2002; Nelson et al., 2003; Gallegos et al., 
2004; He et al., 2005; see also table 1b of the introduction section). Similarly, the 
LATS kinase pathway consists of MOB proteins, SALVADOR and STE20-like 
kinases (see Table 1a; Bardin et al., 2001; Tapon et al., 2002; Harvey et al., 2003; Jia 
et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003; Lai et al., 
2005). The similarity and conservation of NDR family kinase networks is likely to 
allow vertical and horizontal transfers of information regarding the regulation and 
activation of NDR kinases. This is confirmed by this and other recent studies, which 
showed that also human MST3, MOB1A/B and MOB2 are important for the 
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activation of human NDR (this study; Bichsel et al., 2004; Devroe et al., 2004; 
Hergovich et al., 2005). Correspondingly, LATS kinases are activated by MOB1A, 
MST1 and MST2 (Lai et al., 2005; Chan et al., 2005). Genetic evidence indicates that 
MOB3A, B and C might also be able to interact with NDR and/or LATS kinases (He 
et al., 2005b). Based on the conservation of STE20-like kinases, it is also possible that 
MST4 and YSK1 might be hydrophobic motif kinases of NDR, because they share 
identical residues in their substrate binding pocket with MST3. However, gene 
knockout/knockdown, and overexpression studies, are required to address the 
functions of these proteins in the mammal. 
FURRY proteins also exist in budding and fission yeast (PAG1/TAO3 and 
CPS12/MOR2), worms (SAX-2) and flies (FURRY), and they are thought to function 
a scaffolding protein, which is important for the activation and/or function of NDR 
kinases (Cong et al., 2001; Du et al., 2002; Hirata et al., 2002; Emoto et al., 2004; 
Gallegos et al., 2004). A human FURRY relative, AF4p12, was found to exhibit 
transcriptional activities (Hayette et al., 2005). However, the interaction of AF4p12 
and NDR kinases might be expected, but has not yet been described in mammals.  
Apart from FURRY, MOB and STE20-like kinases, the yeast NDR kinase pathways 
also encompass other regulatory proteins, such as MO25 and SKB1 (Nelson et al., 
2003; Wiley et al., 2003). MO25 proteins show a similar degree of conservation from 
yeast to mammals as NDR kinases. Budding as well as fission yeast MO25 (HYM1 
and MO25) regulate NDR kinases by interacting with the corresponding STE20-like 
upstream kinases KIC1 and NAK (Dorland et al., 2000; Bidlingmaier et al., 2001; 
Nelson et al., 2003; Bogomolnaya et al., 2004; Kanai et al., 2005). Drosophila 
melanogaster MO25 and human MO25α/β have been reported to form a signalling 
complex with LKB1 and the STE20 pseudokinase STRADα/β (Baas et al., 2004; 
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Boudeau et al., 2004). However, data using fly mutants of MO25 and 
TRICORNERED indicate that MO25 is not part of the NDR signalling pathway, at 
least as far as it concerns the regulation of the integrity of cellular outgrowths such as 
bristles and wing hairs (He et al., 2005). The phenotypic differences of MO25 and 
TRICORNERED mutants might also be due to multiple functions of MO25 and/or the 
regulated upstream kinase in several pathways. Nonetheless, it is possible that not all 
of the conserved components are functioning in the NDR pathway. 
The SKB1 relative in humans is the protein arginine methyltransferase PRMT5. 
Interestingly, PRMT5 and NDR1 co-immunopreciptitate with FCP1 phosphatase and 
14-3-3 proteins (Jin et al., 2004; Amente et al., 2005) indicating that they might 
interact in mammals, as well. 
Similarly, the conservation of the LATS signalling pathway proposes a LATS kinase 
signalling module consisting of MOB proteins, MST1 and/or MST2, hSALVADOR 
(hWW45) and RAB family GTPases. Indeed, SALVADOR and MOB1A have been 
shown to interact with LATS kinases (Tapon et al., 2002; Lai et al., 2005). 
Additionally, in vitro evidence and our results indicate that MST1 and MST2 might 
function as hydrophobic motif kinases of LATS1 and LATS2 (Chan et al., 2005). 
 
12. THE FUNCTIONS OF NDR PROTEIN KINASES 
 
NDR protein kinases in yeast are implicated in the coordination of cell cycle 
progression and cell morphology. For example, DBF2 is a member of the mitosis 
network and is important for the metaphase-anaphase transition (Tamaskovic et al., 
2003a). Also, CBK1 is activated during the cell cycle and is important for septum 
degradation (Colman-Lerner et al., 2001). However, despite no mammalian mitosis 
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exit network having been described so far, NDR protein kinase phosphorylation is 
also regulated during the cell cycle (Tamaskovic et al., unpublished), indicating a 
potential role of NDR kinase in a mammalian mitosis exit network and/or cytokinesis. 
ORB6, the fission yeast NDR kinase, also shows a cell cycle-regulated activity. 
Additionally, ORB6 is important for polarised growth, and has profound effects on 
actin and the microtubule cytoskeleton (Verde et al., 1998). This effect on the 
cytoskeleton is also apparent in the Caenorhabditis elegans SAX-1 and Drosophila 
melanogaster TRC mutants. SAX1 mutants show an expanded cell body as well as 
additional neurite outgrowth and branching of dendrites (Zallen et al., 2000; Gallegos 
et al., 2004). Similarly, TRC mutant are hypersensitive to actin cytoskeleton 
destabilising agents such as cytochalasin D, and show a splitting of actin bundles in 
clonal knockouts affecting cellular extensions such as bristles, wing hairs and arista 
(Geng et al., 2000). Furthermore, a branching and tiling phenotype of 
mechanosensory neurons has been described, which is attributed to an interaction of 
NDR with RAC GTPase, a known modulator of the actin cytoskeleton (Emoto et al., 
2004). Interestingly, RAC GTPase is inhibited by caspase activation, which provides 
a potential link between protease activation by NDR (see results section) and 
inhibition RAC activity (Zhang et al., 2003; Geisbrecht and Montell, 2004). Also, 
human NDR2 protein kinase is implicated in the regulation of neurite outgrowth and 
cell spreading, and interacts with actin (Stork et al., 2004). This indicates a general 
involvement of NDR protein kinase in the regulation of the actin cytoskeleton and cell 
morphology. It is worth noting that the Ste20-like kinases MST3, MST4 and YSK1 
are implicated in cell migration (Lai and Lai, 2004; Preisinger et al., 2004). 
In addition to their role in cell cycle progression and cell morphology, NDR kinases 
in yeast play a role in the regulation of transcription. CBK1 has been shown to 
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regulate daughter cell-specific transcription to determine asymmetric cell fates via the 
zinc finger transcription factor ACE2 (Colman-Lerner et al., 2001). ACE2 regulates 
cyclin3 (CLN3), glucanase (SCW11) and chitinase (CTS1) expression (O’Conallain 
et al., 1998; Colman-Lerner et al., 2001; Laabs et al., 2004), indicating a role in cell 
cycle progression and sugar metabolism. Human NDR1 kinase has been identified in 
a coimmunoprecipitates of FCP1 phosphatase, which contained also RNA polymerase 
II and the protein arginine methyltransferase PRMT5 (Amente et al., 2005). This 
indicates that NDR kinases might also have a role in the transcriptional regulation of 
genes. Recently, the NDR relative WARTS/LATS was shown to control the cell fate 
of Drosophila melanogaster R8 photoreceptors by repressing the expression of the 
antagonist MELTED, a VEPH (novel gene encoding a PH domain containing protein) 
homologue (Mikeladze-Dvali et al., 2005). 
Altogether, this indicates multiple functions of NDR kinases, ranging from the control 
of cell cycle progression to cell morphology and transcription. 
 
13. POTENTIAL IMPLICATIONS OF NDR SIGNALLING IN 
CELLULAR PROCESSES AND DISEASES  
  
The function of NDR protein kinases, as well as the components of the NDR 
signalling pathway, point to a role of NDR protein kinases in cell cycle progression 
and cancer. Preliminary results from aged NDR1-deficient mice (see results section 
12), which show hyperplasia and/ peliosis in the liver as well as lymphomas, indicate 
that NDR1 protein kinases affect proliferation (this study). However, overexpression 
of NDR is also reported to lead to a poor prognosis in cancer (Adeyinka et al., 2004). 
Furthermore, results from NDR-deficient MEFs show that NDR is important for 
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genomic integrity (Tamaskovic, unpublished). Therefore, it is not surprising that 
overexpression, as well as NDR deficiency, might have an impact on cancer 
development. Overexpression of NDR protein kinase results in the cleavage of MST3, 
presumably by caspase activation, which points to a possible role of NDR in the 
induction of apoptosis. Caspase activation is also important for cell migration and cell 
morphology changes, because caspases are known to cleave Rac GTPases and 
effector molecules such as LyGDI (Zhang et al., 2003; Zhou et al., 2004). Therefore, 
on the one hand increased NDR activity might cause cell death by induction of 
apoptosis, on the other hand an increased activity might also result in an enhanced 
migratory potential of cells and altered cell morphology. Indeed, Ndr1 mRNA is 
overexpressed in aggressive forms of ductal carcinoma in situ (DICS) of the breast, 
and Ndr2 mRNA levels are high in the highly metastatic non-small cell lung cancer 
cell line NCI-H460 (Ross et al., 2000; Adeyinka et al., 2004). This indicates that 
NDR kinase activity might be involved in cancer development and progression in 
different ways. 
The STE20-like kinases MST4 and YSK1 are further implicated in intracellular 
transport mechanisms (Preisinger et al., 2004). Interestingly, the yeast CBK1 was also 
shown to interact with proteins involved in the intracellular transport, such as SEC28 
(Ho et al., 2002). Furthermore, CBK1 binding protein SSD1 is a RNAse II like RNA-
binding protein which is implicated in endocytosis, vesicle transport, cell wall 
integrity and splicing (Kurischko et al., 2005). However, so far there is no evidence 
for an involvement of NDR protein kinases in these processes. 
Another field of action for NDR kinase is neuronal processes. Human Ndr2 mRNA is 
upregulated in the amygdala of fear-conditioned mice, and overexpression of NDR2 
in PC12 cells affects neurite outgrowth and cell spreading (Stork et al., 2004). In 
 146
worms and flies, NDR mutations result in a tiling and branching of dendrites (Emoto 
et al., 2004; Gallegos et al., 2004). Therefore, mutations of NDR in humans might 
have implications in a variety of neurological diseases. It is also worth noting that 
NDR1 protein as well as the protein arginine methyltransferase PRMT5 are co-
immunoprecipitated by FCP1, 14-3-3alpha-beta and 14-3-3delta-zeta (Jin et al., 2004; 
Amente et al., 2005). PRMT5 is part of the transcriptional repressor complexes, the 
spliceosome and the SMN (survival of motor neuron) protein complex. NDR protein 
kinase has also been identified in transcriptional complexes (Amente et al., 2004). 
Furthermore, NDR protein kinase was identified in 14-3-3alpha-beta 
coimmunoprecipitates together with arginine/serine-rich splicing factors (SFRS5 and 
10) (Jin et al., 2004). These splicing factors also contain basic sequences which 
resemble the NDR substrate consensus sequence. SMN1 and SMN2 proteins are 
mutated in spinal muscular atrophy (SMA), a disease which is characterised by the 
loss of motor neurons due to increased apoptosis (Kesari et al., 2005). However, the 
cause of apoptosis is so far unknown. It will be interesting to find out whether NDR 
protein kinases are also involved in these processes. 
 
14. CONCLUSIONS AND FUTURE PROSPECTS 
 
NDR protein kinases are part of a highly conserved signalling module, indicating an 
important function in vivo. Components of the NDR signalling module indicate an 
involvement of NDR in a wide variety of cellular processes, ranging from 
transcription, cellular transport, apoptosis, cell cycle progression and cell morphology 
control to migration. However, little is known about the function of NDR kinases in 
the cellular or organismal context. NDR1-/- mice and upregulation of NDR in human 
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cancers point to an involvement of NDR protein kinase in cancer development and 
progression (Adeyinka et al., 2004; this study). However, the phenotypic penetrance 
is rather low and/or characterised by a late onset. This is most probably due to a 
redundancy of NDR protein kinases in mammals, displayed by the upregulation of 
NDR2 in NDR1-/- MEFs (see results chapter 9.). Therefore, the generation of NDR2-
deficient animals, as well as NDR1-/- NDR2-/- cells or animals, will be important for 
unravelling the functions of NDR kinases. A conditional approach might turn out to 
be the most useful strategy, because it might expand the possibilities in case of 
lethality of double-deficient cells and/or animals. The identification of inhibitors of 
NDR protein kinases would also be an extremely useful tool to characterise NDR 
kinases. 
However, the accessibility of inhibitors to the ATP and substrate binding pockets 
might be blocked by the autoinhibitory insertion (AIS) of NDR kinases. In order to 
fully understand the mechanism of autoinhibition and NDR activation, the structures 
of NDR and of the NDR/MOB complex need to be determined. This might also give 
hints for the development of inhibitors. 
An open question in NDR signalling is still the identity of in vivo substrates. Despite 
several efforts, no direct substrates are known to date. Several techniques have been 
described for substrate identification, ranging from bioinformatic approaches using 
peptide subtrate sequences, to crosslinking approaches or the use of phospho-
antibodies towards peptide substrates. Other approaches include mass spectrometry 
analysis of protein extracts after 2D-gel electrophoresis (Johnson and Hunter, 2005). 
Also, the use of an ATP analogue-sensitive kinase, also described as the Shokat-
method, might be useful for identifying substrates (Bishop et al., 1998). Furthermore, 
the high conservation of the NDR signalling module might also enable the use of 
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information which has been obtained by using these methods in lower organisms. 
Substrates, especially the most conserved ones, might simply be identified by testing 
orthologue proteins to substrates identified in lower organisms. 
The present study provides detailed insights into the activation mechanism of NDR 
kinase by binding MOB1A proteins, and hydrophobic motif phosphorylation by 
MST3 in vitro and in vivo. It will be interesting to know what effects other MOB 
proteins and Ste20-like kinases have on NDR activity and localisation. A key task is 
still the identification of signals which regulate NDR, MOB or MST3 activity and/or 
localisation. The high conservation of the NDR kinase pathway might indicate that, 
similar to the yeast ORB6 kinase, NDR kinases show a cell cycle-dependent 
regulation of activity (Kanai et al., 2005). This is supported by the cell cycle-
dependent phosphorylation of NDR on the hydrophobic motif (Tamaskovic, et al., 
unpublished). Again, more insights might be obtained from work done in other 
organism, or the LATS pathway. For example, MST2 is negatively regulated by RAF-
1 (Kolch et al., 2004). Interestingly, NDR1 and NDR2 have been identified in 14-3-
3alpha-beta and 14-3-3 complexes containing B-RAF (Jin et al., 2005). Therefore, an 
interesting experiment would be to test whether B-RAF inhibits MST3, MST4 or 
YSK1 (for illustration, see table1 of the introduction section). A key question is what 
regulates MST3 activation and localisation at physiological conditions. The 
Schizosaccharomyces pombe NAK1 kinase regulates and cooperates with HOB1 and 
WSP1 to promote F-actin formation and polarized growth (Huang et al., 2005a).  
Therefore, the HOB homologue amphiphysin and the WSP homologue Wiskott 
Aldrich syndrome protein (WASP) are interesting candidates for interactors of MST3. 
Amphiphysin is reported to play a role in vesicle formation and the sensing of 
membrane curvature (Peter et al., 2005) and might be involved in membrane 
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recruitment of MST3 in vivo. WASP is similar to NDR kinases implicated in neurite 
formation and dendritic branching (Pollard and Borisy, 2003). 
The human FURRY protein AF4p12 has been identified as a fusion protein with MLL, 
but no studies have addressed, so far, whether AF4p12 also interacts with NDR kinase 
in a similar way to their yeast, worm and fly orthologues, and what the molecular 
basis of this interaction is. 
In general, the vertical (using different organisms) and horizontal transfer (using 
similarities within the same organism) of information has proven to be a highly 
valuable strategy for NDR protein kinases in order to identify interactors and 
modulators of the pathway, and is likely to lead to the identification of new 
components of the NDR signalling module. Therefore, the combination of 
conventional biochemical methods such as mass spectrometry, co-
immunoprecipitation, immunolocalisation, microarray analysis or protein arrays, 
together with bioinformatics and genetics in multiple organisms, is probably the key 
to unveiling the functions of NDR protein kinases in future. 
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NDR1 (nuclear Dbf2-related) is a serine/threonine
protein kinase belonging to subfamily of kinases im-
plicated in the regulation of cell division and morphol-
ogy. Previously, we demonstrated that the activity of
NDR1 is controlled by phosphorylation of two regula-
tory residues, Ser-281 and Thr-444. Moreover, we
found that NDR1 becomes activated through a direct
interaction with EF-hand Ca2-binding proteins of the
S100 family. In this work, we characterize this regula-
tory mechanism in detail. We found that NDR1 auto-
phosphorylates in vitro predominantly on Ser-281 and
to a lesser extent on Thr-74 and Thr-444. All of these
residues proved to be crucial also for NDR1 activity in
vivo; however, in contrast to Ser-281 and Thr-444,
Thr-74 seems to be involved only in binding to S100B
rather than directly regulating NDR1 activity per se.
When we added Ca2/S100B, we observed an increased
autophosphorylation on Ser-281 and Thr-444, resulting
in stimulation of NDR1 activity in vitro. Using phos-
phospecific antibodies, we found that Ser-281 also be-
comes autophosphorylated in vivo, whereas Thr-444 is
targeted predominantly by an as yet unidentified up-
stream kinase. Significantly, the Ca2-chelating agent
BAPTA-AM suppressed the activity and phosphoryla-
tion of NDR1 on both Ser-281 and Thr-444, and specif-
ically, these effects were reversed when we added the
sarcoplasmic-endoplasmic reticulum Ca2 ATPase
pump inhibitor thapsigargin.
NDR1 (nuclear Dbf2-related) is a conserved and widely ex-
pressed nuclear serine/threonine kinase that belongs to a re-
cently identified subfamily of kinases that play a crucial role in
cell division and cell morphogenesis. We originally cloned this
kinase from a human fetal brain cDNA library using Caenorh-
abditis elegans expressed sequence tag clone cm11b8 (1). Later,
it was mapped to chromosome 6p21 next to the major histo-
compatibility complex class I gene cluster (2). Recently, we
isolated a second NDR isoform, termed NDR2, which is local-
ized on chromosome 12p11 next to the K-ras gene.1 The two
isoforms display an identity of more than 87% at the protein
and 77% at the DNA level. In addition to mammalian NDR1
and NDR2, the NDR family of protein kinases comprises or-
thologous proteins Tricornered (trc gene) from Drosophila
melanogaster; Sax-1 from C. elegans; and several closely re-
lated kinases such as Warts/Lats kinases from mammals, D.
melanogaster, and C. elegans; Cbk1, Dbf2, and Dbf20 from
Saccharomyces cerevisiae; Orb6 from Schizosaccharomyces
pombe; Ukc1 from Ustilago maydis; and Cot-1 from Neurospora
crassa (for review, see Ref. 3). These kinases share 40–60%
amino acid identity within their catalytic domains as well as
conserved regions in their regulatory domains. The structural
similarity within this family suggests that these kinases might
perform related functions even in evolutionary distant
organisms.
In fact, recent reports confirmed the involvement of this
group of kinases in various aspects of regulation of cell division
and cell morphogenesis. For instance, mutations in trc result in
splitting of surface projections such as epidermal hairs, shafts
of sensory bristles, larval denticles, and the lateral branches of
arista (4). The sax-1 mutants display expanded cell bodies and
ectopic neurites in several classes of neurons (5). Mutation in
cot-1 results in excessive numbers of branched hyphal tips at
restrictive temperature, but these tips fail to elongate (6). The
cbk1 mutants show profound defects in cell morphogenesis,
including changes from ellipsoidal to round morphology, ran-
dom budding patterns, and abnormal mating projections (7).
Likewise, disruption of ukc1 leads to a change of cell shape
from elongated to rounded form, to formation of hyphal exten-
sions, and prevents cells from forming filamentous colonies (8).
The orb6 mutants lose growth polarity and display altered,
spherical morphology with disorganized microtubuli and actin
filaments; and moreover, they enter mitosis prematurely (9).
On the other hand, cells carrying temperature-sensitive alleles
of dbf2 arrest at the end of anaphase with uniform, large
budded “dumbbell” morphology (10). Taken together, the func-
tional and structural relatedness within this group of kinases
suggests that they may be regulated by similar mechanisms,
including, e.g. stimulatory phosphorylation and association
with activating proteins, and they may also partially share the
same substrates.
The NDR group kinases contain all 12 subdomains of the
kinase catalytic domain described by Hanks et al. (11). Regard-
ing their kinase domain sequence, they are most closely related
to the members of AGC2 family of protein kinases comprising
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PKA,3 PKB, PKCs, PRK, p70S6K, p90RSK, and PDK1. A unique
feature of NDR group kinases is an insert of about 30 amino
acids between subdomains VII and VIII, which, in the case of
NDR1, accommodates a nonconsensus nuclear localization sig-
nal (1). All members of this group also contain a poorly char-
acterized N-terminal regulatory domain of different lengths. In
NDR1, this domain consists of 87 amino acids, and it encom-
passes a region that is predicted to form an amphiphilic -helix
responsible for binding to S100B (12).
In our previous work, we described the basic mechanisms of
activation of NDR1 protein kinase (13). We found that NDR1 is
potently activated by treatment of cells with the protein phos-
phatase 2A inhibitor okadaic acid (OA), indicating involvement
of phosphorylation of serine and/or threonine residues in the
regulation of NDR1 activity. Indeed, we demonstrated that
activation of NDR1 involves phosphorylation of two regulatory
residues, Ser-281 of the activation segment and Thr-444 from
the hydrophobic motif located in the C-terminal region (13).
Moreover, we described a mechanism of in vitro activation of
NDR1 through a direct interaction with EF-hand Ca2-binding
protein S100B, which augments NDR1 autophosphorylation
(12). Notably, NDR1 also interacts with S100B in vivo, its
activity is rapidly stimulated by treatment with the Ca2 iono-
phore A23187, and this activation is dependent upon the N-
terminally located S100B binding domain. Intriguingly, we
observed that overexpression of S100B in several melanoma
cell lines leads to hyperactivation of NDR1 and that NDR1
activity can be inhibited in those cells by W7, a cell-permeable
inhibitor of CaM and S100 proteins. Altogether, these results
point to the involvement of Ca2 signaling in regulation of
NDR1.
In this study, we have examined the mechanism of Ca2/
S100B-induced autophosphorylation and activation of NDR1
by means of electrospray ionization mass spectrometry (ESI-
MS) and phosphospecific antibodies raised against the regula-
tory phosphorylation sites Ser-281 and Thr-444. We also inves-
tigated the mechanism of NDR1 phosphorylation in vivo as
well as the dependence of NDR1 phosphorylation events on
intracellular Ca2. Our findings delineate a Ca2-dependent
mechanism for activation of NDR1, involving S100B-mediated
stimulation of autophosphorylation on Ser-281 and phospho-
rylation of Thr-444 by an unknown Ca2-dependent upstream
kinase.
EXPERIMENTAL PROCEDURES
Cell Culture—COS-1 cells were maintained in Dulbecco’s modified
Eagle’s medium containing 10% fetal calf serum, 100 units/ml penicil-
lin, and 100 g/ml streptomycin. Cells were transfected at the subcon-
fluent stage with FuGENE 6 transfection reagent (Roche Molecular
Biochemicals) according to the manufacturer’s instructions. In some
experiments, the cells were treated for 60 min with 1 M OA in 0.1%
N,N-dimethylformamide (Alexis Corp.), 50 M BAPTA-AM in 0.1% di-
methyl sulfoxide (Sigma), or 20 M thapsigargin in 0.1% dimethyl
sulfoxide (Alomone) 24 h after transfection.
Plasmids—Mammalian expression vector pCMV5 with HA-tagged
NDR1 was constructed by PCR using primers 5-CCC AAG CTT GCC
ACC ATG GCT TAC CCA TAC GAT GTT CCA GAT TAC GCT TCG
ATG CAA TGA CGG CAG-3 and 5-CGG GAT CCC TAT TTT GCT
GCT TTC ATG-3. The PCR product has been subcloned into the Hin-
dIII and BamHI sites of pCMV5. pGEX-2T_NDR1 plasmid has been
described previously (1). The pCMV5_HA-NDR1 and pGEX-2T_NDR1
plasmids for kinase-dead (K118A) and phosphorylation site alanine
mutants (T74A, S281A, and T444A) were generated from wild-type
vectors using the QuikChange site mutagenesis protocol (Stratagene)
with the following primers: 5-GGA CAT GTG TAT GCA ATG GCT ATA
CTC CGT AAA GCA GAT ATG CTT GAA AAA GAG CAG G-3 and
5-GCA TAT CTG CTT TAC GGA GTA TAG CCA TTG CAT ACA CAT
GTC CCG TAT CTT TCT TCT GAA CAA GC-3 (K118A), 5-GCT CGG
AAG GAA GCA GAG TTT CTT CGT TTG AAG AGA ACA AGA CTT
GG-3 and 5-CGA AGA AAC TCT GCT TCC TTC CGA GCA TGT GCT
GAT CTC CG-3 (T74A), 5-CGT CAG CTA GCC TTC GCT ACA GTA
GGC ACT CCT GAC TAC ATT GC-3 and 5-GGA GTG CCT ACT GTA
GCG AAG GCT AGC TGA CGT CTA TTT CTT TTC C-3 (S281A), and
5-GGT CTT CAT CAA TTA CGC TTA CAA GCG CTT TGA GGG CCT
GAC TGC-3 and 5-CCT CAA AGC GCT TGT AAG CGT AAT TGA
TGA AGA CCC AGT CTT TGT TC-3 (T444A). pECE_S100B plasmid
has been described previously (12). Sequence of all plasmids was con-
firmed by DNA sequencing.
Antibodies—Anti-Ser-281P and anti-Thr-444P rabbit polyclonal an-
tisera were raised against the synthetic peptides NRRQLAFS(PO4)T-
VGTPD for the Ser-281 phosphorylation site and KDWVFINYT-
(PO4)YKRFEG for the Thr-444 phosphorylation site (Neosystem,
Strasbourg, France). The peptides had been conjugated to keyhole lim-
pet hemocyanin. Rabbit injections and bleed collection were done by
Strategic Biosolutions. The anti-Ser-281P antiserum was used without
further purification, but the anti-Thr-444P antibody was purified on
protein A-Sepharose (Amersham Biosciences) followed by antigenic
peptide coupled to cyanogen bromide-activated Sepharose (Amersham
Biosciences). Antibodies were eluted with 0.1 M glycine, pH 2.5. The
12CA5 HA monoclonal antibody hybridoma supernatant was used for
immunodetection and immunoprecipitation of HA-NDR1 variants. A
rabbit anti-NDR1_C-term polyclonal antiserum directed against a syn-
thetic peptide TARGAIPSYMKAAK (corresponding to NDR1 amino
acids 452–465) has been described previously (1). A rabbit polyclonal
antiserum that recognizes S100B was raised against recombinant hu-
man S100B and was used without further purification (14).
Bacterial Expression of Human GST-fused NDR1—BL21-DE3 Esch-
erichia coli strain (Novagen) was transformed with the pGEX-
2T_NDR1 wild-type or mutant plasmids and the pRep4 plasmid bearing
LacIq repressor (Qiagen). Mid-logarithmic phase cells were induced
with 0.5 mM isopropyl -D-thiogalactopyranoside for 4 h at 30 °C. Bac-
teria were lysed by a French press in presence of 1 mg/ml lysozyme, and
the fusion proteins were purified on glutathione-agarose (Amersham
Biosciences) as described. Recombinant proteins were assayed for ki-
nase activity as described below, and autophosphorylation was deter-
mined after SDS-PAGE separation either by Cerenkov counting or by
exposure to a PhosphorImager screen followed by analysis with Image-
Quant software (Molecular Dynamics).
GST-NDR1 Kinase Assay—1 g of purified recombinant GST-NDR1
wild-type and mutants (without further treatment or autophosphoryl-
ated for 2 h in the presence or absence of 1 mM CaCl2 and 10 M bovine
S100B (Sigma)) were assayed in a 20-l reaction containing 20 mM
Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 100 M [-
32P]ATP
(2,000 cpm/pmol; Amersham Biosciences), and 1 mM NDR1 substrate
peptide (KKRNRRLSVA). After a 30-min incubation at 30 °C, reactions
were stopped with 50 mM EDTA, and 10-l reaction solutions were
spotted onto 2-cm2 squares of P-81 phosphocellulose paper (Whatman).
These were subsequently washed 4  5 min and 3  20 min in 1%
phosphoric acid and once in acetone before counting in a liquid scintil-
lation counter. One unit of NDR1 activity was defined as the amount
that catalyzed the phosphorylation of 1 nmol of peptide substrate in 1
min.
HA-NDR1 Kinase Assay—Transfected and treated COS-1 cells were
washed once with ice-cold phosphate-buffered saline and harvested by
scraping into 1 ml of ice-cold phosphate-buffered saline containing 1 mM
Na3VO4 and 20 mM -glycerophosphate before lysis in 500 l of immu-
noprecipitation (IP) buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 1%
Nonidet P-40, 10% glycerol, 1 mM Na3VO4, 20 mM -glycerophosphate,
1 M microcystin-LR, 50 mM NaF, 0.5 mM phenylmethylsulfonyl fluo-
ride, 4 M leupeptin, 1 mM benzamidine, and 1 tablet of Complete
protease inhibitors/10 ml of IP buffer (Roche)). Lysates were centri-
fuged at 20,000  g for 20 min, and triplicate aliquots (200 g) of
supernatant were precleared with protein A-Sepharose for 60 min and
mixed subsequently for 3 h at 4 °C with 12CA5 antibody prebound to
protein A-Sepharose (1 g of antibody bound to 2 l of beads). The
beads were then washed twice with IP buffer, once for 10 min with IP
buffer containing 1 M NaCl, once again for 10 min with IP buffer, and
finally twice with 20 mM Tris-HCl pH 7.5, containing 4 M leupeptin
and 1 mM benzamidine. Thereafter, beads were resuspended in 30 l of
3 The abbreviations used are: PKA, PKB, PKC, protein kinase A, B,
and C, respectively; BAPTA-AM, 1,2-bis(o-aminophenoxy)ethane-
N,N,N,N-tetraacetic acid tetra(acetoxymethyl)ester; CaM, calmodu-
lin; ESI-MS, electrospray ionization-mass spectrometry; GST, glutathi-
one S-transferase; HA, hemagglutinin; HPLC, high performance liquid
chromatography; IP, immunoprecipitation; LC-MS, liquid chromatog-
raphy-mass spectrometry; MS/MS, tandem mass spectrometry; OA,
okadaic acid; PDK, phosphoinositide-dependent kinase.
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buffer containing 20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM dithio-
threitol, 100 M [-32P]ATP (1,000 cpm/pmol), 1 M cAMP-dependent
protein kinase inhibitor peptide (Bachem), 4 M leupeptin, 1 mM ben-
zamidine, 1 M microcystin-LR, and 1 mM NDR1 substrate peptide
(KKRNRRLSVA). After a 60-min incubation at 30 °C, 15 l of super-
natant was removed, and phosphate incorporation into the substrate
peptide was determined as described for GST-NDR1.
Western Blotting—To detect GST-NDR1 or HA-NDR1, samples were
resolved by 10% SDS-PAGE and transferred to polyvinylidene difluo-
ride membranes (Immobilon-P; Millipore). Membranes were blocked in
TBST (50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 0.05% Tween 20)
containing 5% skimmed milk powder and were then probed for 2 h with
4 g/ml anti-NDR1_C-term or 1:100 12CA5 monoclonal antibody super-
natant. Bound antibodies were detected with corresponding horserad-
ish peroxidase-linked secondary antibodies and ECL (Amersham Bio-
sciences). For detection of phosphorylated NDR1, either 1 g of GST-
NDR1 or HA-NDR1 immunoprecipitated from 100 g of COS-1
detergent extracts as described earlier in this paper were separated on
10% SDS-PAGE and transferred to polyvinylidene difluoride mem-
branes. Membranes were blocked in TBST containing 5% skimmed milk
powder and incubated for 2 h at room temperature or overnight at 4 °C
with 1:1,000 anti-Ser-281P antiserum in the presence of 50 g/ml
competing dephosphopeptide or 1:500 anti-Thr-444P purified antibody.
Both antibodies were detected with horseradish peroxidase-conjugated
donkey anti-rabbit Ig antibody (Amersham Biosciences) and ECL. To
detect immunoprecipitated S100B, samples were separated on 18%
SDS-PAGE and transferred to polyvinylidene difluoride membrane.
The membrane was blocked for 2 h with 5% bovine serum albumin and
1% fetal calf serum in TBST and was then probed with anti-S100B
antiserum diluted 1:1,000 in the same buffer. Bound antibody was then
detected with corresponding horseradish peroxidase-linked secondary
antibody in TBST and ECL.
Coimmunoprecipitation of NDR1 and S100B—Cytoplasmic COS-1
cell extracts were prepared by lysing the cells for 10 min in a hypotonic
buffer containing 10 mM HEPES pH 7.9, 0.5 mM CaCl2, 1.5 mM MgCl2,
10 mM KCl, 1 mM Na3VO4, 20 mM -glycerophosphate, 1 M microcys-
tin-LR, 50 mM NaF, 0.5 mM phenylmethylsulfonyl fluoride, 4 M leu-
peptin, 1 mM benzamidine, and 1 tablet of Complete protease inhibi-
tors/10 ml of buffer. Afterward, the cells were homogenized in Dounce
homogenizer. After centrifugation at 3,300 g for 15 min, supernatants
with cytoplasmic extracts were saved, and isolated nuclei found in the
pellets were processed further by lysis for 30 min in a high salt buffer
containing 20 mM HEPES pH 7.9, 25% glycerol, 0.5 mM CaCl2, 1.5 mM
MgCl2, 0.5 M KCl, 1 mM Na3VO4, 20 mM -glycerophosphate, 1 M
microcystin-LR, 50 mM NaF, 0.5 mM phenylmethylsulfonyl fluoride, 4
M leupeptin, 1 mM benzamidine, and 1 tablet of Complete protease
inhibitors/10 ml of buffer. After centrifugation at 20,000  g for 30 min,
the cytoplasmic and nuclear extracts were pooled at a ratio of 4:1. 1 mg
of protein extracts was precleared for 60 min with protein A-Sepharose
and incubated for 3 h at 4 °C with 5 l of anti-S100B antiserum
immobilized on 10 l of protein A-Sepharose. Afterward, the beads were
washed four times in buffer containing 20 mM HEPES pH 7.9, 25 mM
KCl, 5% glycerol, 1 mM MgCl2, 0.1 mM CaCl2, 0.5 mM phenylmethylsul-
fonyl fluoride, 4 M leupeptin, 1 mM benzamidine, 1 mM Na3VO4, 20 mM
-glycerophosphate, 1 M microcystin-LR, and 50 mM NaF. Immuno-
precipitates were boiled in sample buffer and immunoblotted for S100B
or HA-NDR1 as described above.
Mass Spectrometry—10 g of untreated or autophosphorylated GST-
NDR1 (2 h at 30 °C, either in presence or absence of 1 mM CaCl2 and 10
M bovine S100B homodimer) was separated by 10% SDS-PAGE,
stained with Coomassie Blue R-350 (Sigma), and excised from the gel
for further processing. Gel slices were sequentially washed 3 8 min in
acetonitrile and 2  12 min in 25 mM NH4HCO3. Afterward, the gel
slices were reduced for 1 h at 57 °C in 10 mM dithiothreitol followed by
alkylation for 45 min at room temperature in 55 mM iodoacetamide.
Upon repeated washing in acetonitrile/NH4HCO3, gel-bound GST-
NDR1 was digested with modified trypsin (sequencing grade; Promega)
overnight at 37 °C. The cleaved peptides were then extracted by two
15-min sonication steps in H2O:acetonitrile:formic acid (20:70:10) and
H2O:methanol:formic acid (93:2:5). All experiments were performed on
an API 300 triple-quadrupole mass spectrometer (PE-Sciex, Toronto,
Canada) equipped with a NanoESI source (Protana, Odense, Denmark).
For precursor ion scans of m/z 79, samples were injected by off-line
nanoelectrospray according to Wilm and Mann (15). The instrument
was operated in negative ion mode; a small percentage of ammonia was
added in the spraying needle during sample preparation for better
sensitivity in the detection of m/z 79. For LC-MS sequence analysis,
phosphopeptides were further separated by high performance liquid
chromatography (HPLC) interfaced with the API 300 mass spectrome-
ter. The Rheos 4000 chromatograph was equipped with a 1  250-mm
Vydac C8 column (Hesperia, Canada). The HPLC column was equili-
brated in 95% solvent A (2% CH3CN, 0.05% trifluoroacetic acid in H2O),
5% solvent B (80% CH3CN, 0.045% trifluoroacetic acid in H2O), and a
linear gradient was developed from 5 to 50% of solvent B in 60 min at
a flow rate of 180 l/min After the column, the flow was split with a
small percentage (about 5%) being directed to the mass spectrometer.
The phosphopeptides were detected in the collected HPLC fractions by
Cerenkov counting. For further sequence investigation, phosphopep-
tides containing fractions were dried, redissolved in a few l of H2O:
CH3CN:formic acid (49.5:49.5:1), individually injected into the mass
spectrometer using the nanoelectrospray source and analyzed by low
energy tandem MS (MS/MS) experiments in positive ion mode.
FIG. 1. Mapping of NDR1 in vitro autophosphorylation sites.
A–C, 10 g of GST-NDR1 was left untreated (A) or was autophospho-
rylated for 2 h in the absence (B) or presence of 1 mM CaCl2 and 10 M
bovine S100B (C). After separation by SDS-PAGE, GST-NDR1 was
excised and processed by tryptic cleavage for MS analysis of phos-
phopeptides by precursor ion scanning of m/z 79. Phosphopeptides
whose m/z could be assigned to NDR1-derived phosphopeptides are
labeled P1–P4. Some of the peptides were detected in several charged
states designated [M-2H]2, [M-3H]3, etc. Peptide P2 results presum-
ably from trace chymotryptic contamination of the trypsin preparation
because it overlaps with P1 and terminates with an aromatic residue.
Asterisks denotes an abundant, double-charged nonphosphorylated
NDR1 peptide (amino acids 378–391) with m/z 860. D, the phosphopep-
tides from A–C which derive from three regions of the NDR1 polypep-
tide are summarized with the phosphoacceptor residues marked in each
peptide in bold.
Mechanism of NDR1 regulation by Ca26712
RESULTS
Mapping of in Vitro Autophosphorylation Residues of
NDR1—We observed that NDR kinase becomes potently auto-
phosphorylated on serine and threonine residues in vitro, and
that the autophosphorylation as well as NDR1 kinase activity
markedly increase upon incubation of NDR1 with the EF-hand
Ca2-binding proteins of the S100 family, in particular S100B
(1, 12). These results prompted us to analyze the NDR1 auto-
phosphorylation sites by means of nanospray ECI-MS/MS anal-
ysis. 10 g of purified GST-NDR1 was left untreated (Fig. 1A)
or autophosphorylated either in the absence (Fig. 1B) or pres-
ence (Fig. 1C) of purified bovine S100B. After tryptic cleavage
of the differently treated GST-NDR1 samples, resultant mix-
tures of peptides were introduced into a triple-quadrupole mass
spectrometer and analyzed for phosphorylated peptides by pre-
cursor ion scanning for m/z 79 in negative ion mode. This
procedure detects each peptide in the mixture which, upon
fragmentation in the collision cell, liberates a species of m/z
79, representing a negative fragment ion PO3
 characteristic
of phosphorylated peptides (16, 17).
When nontreated GST-NDR1 was analyzed by precursor ion
scan of m/z79, only weak phosphopeptide signals correspond-
ing to peptides P2 and P4 could been detected (Fig. 1, A and D).
With the GST-NDR1 samples autophosphorylated either in the
absence or presence of Ca2/S100B, however, the abundance of
phosphorylated peptides increased markedly (Fig. 1, B and C).
The observed m/z value of most of these signals could be as-
signed in both samples to four NDR1-derived phosphopeptides
P1–P4 which, upon liberation of the phosphate group (79.97
Da), give rise to expected tryptic (or in one case chymotryptic)
NDR1 dephosphopeptides (Fig. 1D). To confirm the identity of
these peptides, we performed a LC-MS analysis of GST-NDR1
autophosphorylated with [-32P]ATP (data not shown). After
collection of the phosphopeptide-enriched radioactive fractions,
we again analyzed the samples by ESI-MS using an m/z 79
precursor ion scanning method. Having found the same species
as in the analysis of the unlabeled GST-NDR1, we subse-
quently performed a low energy MS/MS analysis in positive ion
mode. We detected ion species corresponding to the phos-
phopeptides listed in Fig. 1D, including the phosphorylated
residues, thereby confirming identity of the NDR1 in vitro
autophosphorylation sites.
The four phosphopeptides derived from three regions of the
NDR1 polypeptide. The first three phosphopeptides correspond
to sites identified previously also in NDR1 activated in vivo by
OA. P1 and P2 correspond to phosphopeptides encompassing
Ser-281 of the activation segment and P3 represents a phos-
phopeptide containing the residue Thr-444 from hydrophobic
motif located in the C-terminal region of NDR1. Significantly,
the phosphopeptide P4 proved to be an as yet unidentified
FIG. 2. Ca2/S100B promotes the autophosphorylation of GST-NDR1 on both Ser-281 and Thr-444 through a Thr-74-dependent
mechanism. A, 1 g of purified GST-NDR1 (in solution 0.5 M) wild-type, kinase-dead (K118A), and alanine mutants of phosphorylation
residues Thr-74, Ser-281, and Thr-444 were autophosphorylated for 2 h in vitro without further additions or in the presence of 1 mM CaCl2 and
10 M bovine S100B as indicated. The upper panel represents a Coomassie Blue R-350-stained SDS-polyacrylamide gel, and the lower panel shows
autoradiograph of identical gel developed on PhosphorImager screen for [-32P]ATP incorporation. B, quantification of the experiment shown in A.
The amount of the incorporated [-32P]ATP was quantified by Cerenkov counting. Bars represent the mean  S.D. of triplicate determinations. C,
1 g of purified GST-NDR1 wild-type and alanine mutants as shown in A and B were left without further treatment or autophosphorylated for 2 h
in the presence or absence of 1 mM CaCl2 and 10 M bovine S100B as indicated. The specific activity of GST-NDR1 mutants was measured by a
peptide kinase assay as described under “Experimental Procedures.” Bars represent the mean  S.D. of triplicate determinations. D, GST-NDR1
mutants were treated as described in C and detected either with anti-NDR1_C-term antiserum or polyclonal antibodies recognizing NDR1
phosphorylated on Ser-281 or Thr-444 as indicated.
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phosphoresidue Thr-74 from the N-terminal part of NDR1
which has been defined previously as an S100 binding region
(residues 62–83; Ref. 12).
Reduction of Autophosphorylation Rate and Kinase Activity
in GST Phosphorylation Site Mutants—To confirm the in vitro
autophosphorylation of NDR1 on the residues Thr-74, Ser-281,
and Thr-444 and to estimate the influence of these residues on
the autophosphorylation-induced kinase activity of NDR1, we
constructed a series of GST-NDR1 alanine mutants at these
positions (as well as a GST-NDR1 kinase-dead alanine mutant
in the catalytic site residue Lys-118). As shown in Fig. 2, B and
C, wild-type GST-NDR1 became efficiently autophosphorylated
in vitro (up to 0.4 pmol of phosphorus/pmol of GST-NDR1). The
addition of S100B homodimers brought about an approximate
2-fold increase in the autophosphorylation rate accompanied by
about a 5-fold increase in kinase activity. Because the kinase-
dead mutant did not show any detectable autophosphorylation,
the NDR1 kinase activity must account for the observed effects.
As shown in Fig. 2, A and B, the S281A mutant displayed a
markedly reduced autophosphorylation rate (irrespective of the
addition of S100B), thereby confirming this residue as the
major in vitro autophosphorylation site of NDR1. As expected,
the kinase activity of S281A decreased similarly and was al-
most undetectable (Fig. 2C). Although not comparable with
S281A, the T444A point mutation also led to a significant
decrease of both autophosphorylation rate and kinase activity,
indicating that this residue is also susceptible to autophospho-
rylation in vitro. The smaller effects of T444A, compared with
the S281A mutation, may be readily explained by the unfavor-
able, hydrophobic peptide sequence upstream of this residue
with only two basic amino acids located at positions 8 and
10 (Table I). Finally, the T74A mutant displayed only a
negligible reduction in autophosphorylation rate and kinase
activity in absence of Ca2/S100B. Although the sequence N-
terminal to this site in fact matches the basic NDR1 consensus
sequence fairly well, according to the quantitative analyses by
LC-MS, the phosphorylation at this site always accounted for
less than 5% of the total phosphate incorporation (data not
shown). After the addition of Ca2/S100B, however, the impact
of this point mutation approached that of T444A, and the
stimulatory effect of Ca2/S100B on autophosphorylation rate
and kinase activity was diminished strongly compared with the
other GST-NDR1 variants. These facts indicate that Thr-74
represents only a minor autophosphorylation site, and the low
responsiveness to the addition of Ca2/S100B most likely re-
flects the inability of T74A mutant to interact with this protein.
Mechanism of NDR1 Activation by Ca2/S100B—To exam-
ine the effect of S100B on NDR1 phosphorylation status, we
raised rabbit polyclonal antibodies directed against phospho-
epitopes of the two known activation phosphorylation sites
Ser-281 and Thr-444. As shown in Fig. 2D, these antibodies
were specific for the phosphorylated NDR1 because corre-
sponding phosphorylation point mutants S281A, T444A, and
kinase-dead were not recognized. Using these reagents, we
found that Ca2/S100B enhances phosphorylation on both Ser-
281 and Thr-444 (similar to the general increase in autophos-
phorylation as presented in Fig. 2, A and B) without an appar-
ent preference for one of the residues (Fig. 2D, middle and
bottom panels). This synergy between the phosphorylation of
both activation segment and hydrophobic motif sites may pro-
vide a simple explanation for why NDR1 activity increases
more robustly than does the overall autophosphorylation after
the addition of Ca2/S100B. Nevertheless, it is striking that
although the S281A mutation entirely abolishes the autophos-
phorylation on Thr-444, the T444A mutant displayed an almost
normal autophosphorylation on Ser-281. Apart from the fact
that Thr-444 only was autophosphorylated to a minor extent,
these data indicate that the impact of the activation segment
phosphoresidue on the NDR1 kinase activity was higher than
the impact of the hydrophobic motif residue or that these res-
idues are phosphorylated in a sequential manner as is known
for most of other AGC family protein kinases (18). Both alter-
natives may apply for an intramolecular mechanism of the
NDR1 autophosphorylation as defined previously (1). Finally,
FIG. 3. NDR1 autophosphorylates on Ser-281 and becomes
phosphorylated by an upstream kinase on Thr-444 in vivo. A,
COS-1 cells expressing either wild-type HA-NDR1 or the indicated
mutants were treated for 1 h with 1 M OA (filled bars) or with solvent
alone (open bars). HA-tagged NDR kinase variants were then immuno-
precipitated (of 100 g of detergent extracts) with 12CA5 monoclonal
antibody and assayed for kinase activity by a peptide kinase assay as
described under “Experimental Procedures.” Bars represent the
mean  S.D. of triplicate immunoprecipitations. B, 1 g of protein
extracts from transfected COS-1 cells was immunoblotted with 12CA5
to verify similar expression levels of each HA-NDR1 construct (top
panel). For the analysis of phosphorylation status, 12CA5-immunopre-
cipitated HA-NDR1 variants (of 100 g of protein extract) were ana-
lyzed by immunoblotting with phosphospecific antibodies directed
against phosphorylated Ser-281 or phosphorylated Thr-444 (middle and
bottom panels, respectively).
TABLE I
Comparison of NDR1 substrate consensus sequence with the amino
acid sequences of the identified in vitro autophosphorylation sites
NDR1 consensus sequencea K/R-
K/R-
K/R-X-
K/R-
K/R-X-S
b
Thr-74 sequence L-R-R-S-A-H-A-R-K-E-T-E-F
Ser-181 sequence W-K-R-N-R-R-Q-L-A-F-S-T-V
Thr-444 sequence K-N-K-D-W-V-F-I-N-Y-T-Y-K
a The NDR1 consensus sequence has been identified by testing a
peptide library as described previously (12).
b X stands for any amino acid. Phosphate acceptor residues are in
bold. Single-letter codes used for amino acids.
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the T74A point mutation abolished the S100B-mediated in-
crease of phosphorylation on both Ser-281 and Thr-444 resi-
dues without affecting the intrinsic NDR1 autophosphoryla-
tion, again stressing the crucial role of this residue in the
interaction with S100B.
Ser-281 Is the Major Autophosphorylation Residue, whereas
Thr-444 Is Targeted by an Upstream Kinase in Vivo—To eval-
uate the relative influence of the individual phosphorylation
sites on kinase activity of NDR1 in vivo, we constructed a series
of mammalian expression vectors with HA-tagged NDR1 wild-
type, kinase-dead, and alanine mutants in the three identified
phosphorylation sites. As shown in Fig. 3A, point mutations in
the two established in vivo regulatory phosphorylation sites
Ser-281 and Thr-444 led to an expected decline of NDR1 kinase
activity in both untreated and 1 M OA-treated COS-1 cells
(again with some preference for the S281A mutant). In contrast
to the GST-NDR1 kinase assays, however, we also observed a
drastic reduction of HA-NDR1 kinase activity after mutating
Thr-74. This indicates that the Thr-74-dependent, S100B-me-
diated autophosphorylation may play a crucial role in vivo.
To examine this possibility, we analyzed extracts from trans-
fected COS-1 cells again with the anti-Ser-281P and anti-Thr-
444P antisera. As shown in Fig. 3B, the Ser-281 residue was
constitutively phosphorylated in vivo (and this phosphorylation
was enhanced further after treatment with 1 M OA), whereas
the Thr-444 site only became modified after OA treatment.
Intriguingly, we found that the phosphorylation of Ser-281
depends entirely on the activity of NDR1 because the kinase-
dead K118A mutant did not display any phosphorylation on
this position. This fact implies that Ser-281 is an autophospho-
rylation residue also in vivo. Significantly, autophosphoryla-
tion accounts for the major portion of NDR1 phosphorylation in
vivo because wild-type NDR1 incorporated markedly higher
amounts of radioactive orthophosphate than its kinase-dead
counterpart in metabolically labeled COS-1 cells upon treat-
ment with OA (data not shown). Furthermore, mutation of
Thr-444 did not impair the phosphorylation of Ser-281, which
again points to the low importance of this residue for NDR1
autophosphorylation (Fig. 3B, middle panel). For the phospho-
rylation of Thr-444, however, we found that this residue be-
came modified also after abolishing the kinase activity of NDR1
in kinase-dead mutant K118A (Fig. 3B, bottom panel). This fact
strongly suggests that, at least in OA-treated cells, this site
must be targeted by an as yet unidentified upstream kinase.
Finally, mutation of residue Thr-74 led to a marked reduction
of both Ser-281 and Thr-444 phosphorylation (both with and
without OA treatment), which explains the somewhat unex-
pected kinase activity data observed for this mutant. This
implies that Thr-74 is not only involved in the S100B-mediated
autophosphorylation of NDR1, but it probably participates also
in targeting the upstream kinase to NDR1.
Phosphorylation on both Ser-281 and Thr-444 Occurs in a
Ca2-dependent Manner—Because our current and previous
work indicated that Ca2/S100B is essential both for NDR1
activity in vivo and for an efficient NDR1 autophosphorylation
on Ser-281 and Thr-444 in vitro (Fig. 2D) and because the
S100B-NDR1 interaction is known to be fully Ca2-dependent
(12), we sought to examine the role of intracellular Ca2 in the
activation of NDR1. For this purpose, we treated transfected
COS-1 cells with the membrane-permeable agent BAPTA-AM,
which is freely taken up into cells, where it is hydrolyzed by
cytosolic esterases and trapped intracellularly as active, mem-
brane-impermeable Ca2 chelator BAPTA (19). As shown in
Fig. 4A, 50 M BAPTA-AM dramatically reduced the OA-stim-
ulated NDR1 activity almost to the basal activity level of the
untreated cells. Likewise, examination of the phosphorylation
status of NDR1 demonstrated that phosphorylation on both
Ser-281 and Thr-444 declined almost to the base line (Fig. 4B).
Notably, both NDR1 activity and the phosphorylation of Ser-
281 and Thr-444 were rescued by coincubation of BAPTA-AM
with 20 M thapsigargin, a sesquiterpene lactone capable of
increasing cytoplasmic Ca2 by inhibition of the sarcoplasmic-
endoplasmic reticulum Ca2 ATPase pumps, causing liberation
of intracellular Ca2 stores (20). These results confirm the
Ca2 specificity of the observed BAPTA-AM effects and com-
bined with the experiments showed in Fig. 3, allow us to con-
clude that NDR1 is regulated by a Ca2-dependent, most likely
S100B-mediated autophosphorylation on Ser-281 and by phos-
phorylation by an as yet unidentified Ca2-dependent up-
stream kinase on Thr-444.
Thr-74 Is Required for the Association of HA-NDR1 with
Ca2/S100B—We have demonstrated previously that NDR1
forms functional complexes with S100B in vivo and that this
interaction depends on an intact N-terminal domain of NDR1.
FIG. 4. Phosphorylation of both Ser-281 and Thr-444 is depend-
ent on intracellular Ca2. A, mock-transfected or HA-NDR1-express-
ing COS-1 cells were treated for 1 h as indicated with 1 M OA, 50 M
BAPTA-AM, and 20 M thapsigargin or with solvent (0.1% N,N-di-
methylformamide or 0.1% dimethyl sulfoxide) alone. 12CA5 immuno-
precipitates (of 100 g of protein extract) were then assayed by peptide
kinase assay for NDR1 kinase activity. Bars represent the mean  S.D.
of triplicate immunoprecipitations from HA-NDR1-expressing COS-1
cells after subtraction of mean values from identically treated mock-
transfected cells. B, Protein extracts (10 g) from mock- and HA-NDR1-
transfected COS-1 cells were immunoblotted with 12CA5 to verify equal
expression levels of HA-NDR1 construct (top panel, right five lanes). For
the analysis of phosphorylation status, 12CA5-immunoprecipitated
HA-NDR1 (of 100 g of protein extract) was analyzed by immunoblot-
ting with phosphospecific antibodies directed against P-S281 or P-T444
(middle and bottom panels, five right lanes).
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Now, we asked whether this association depends on phospho-
rylation status of NDR1 (12). Therefore, we transfected COS-1
cells with S100B and NDR1 wild-type or alanine-mutant ex-
pression plasmids and monitored the NDR1-S100B interaction
by coimmunoprecipitation of NDR1 with S100B. As shown in
Fig. 5, we found that the formation of NDR1S100B complexes
was independent of NDR1 kinase activity or the phosphoryla-
tion status of the regulatory residues Ser-281 and Thr-444, and
thus the NDR1-S100B interaction appears to be constitutive.
However, mutation of Thr-74 (the minor in vitro autophospho-
rylation site) markedly impaired interaction between these two
proteins, and therefore this residue seems to be essential for
NDR1 to undergo the interaction with Ca2/S100B. In the
context of the results gained with the recombinant GST-NDR1
(Fig. 2) and the fact that Thr-74 is a part of a putative, S100-
binding -helix formed by amino acids 65–81, it would not be
surprising if Thr-74 was one of the crucial residues forming the
contact interface between NDR1 and S100B. We are currently
addressing these questions by generating a phosphoepitope-
specific antibody against this residue, and the results will be
presented elsewhere.
DISCUSSION
We found that NDR1 autophosphorylates on three residues
in vitro. The first of them, Thr-74, is located in the N-terminal
S100B binding domain of NDR1. The second, major site Ser-
281, which is well conserved among all AGC group kinases,
constitutes an essential part of the activation segment in sub-
domain VIII of the kinase catalytic domain, immediately after
nuclear localization signal and kinase domain insert of NDR1.
The third site, Thr-444, also conserved in the AGC superfamily,
is located outside of the kinase catalytic domain in a region
enriched with hydrophobic amino acid residues (therefore “hy-
drophobic motif”). Mutational analysis showed, however, that
the residue Ser-281 alone was responsible for the major part of
phosphate incorporation into the autophosphorylated NDR1,
whereas Thr-74 and Thr-444 could merely account for a minor
percentage of the incorporated phosphate. Moreover, mutation
of Ser-281 led to most dramatic decrease of NDR1 autophos-
phorylation-induced kinase activity, thereby confirming this
residue as the major NDR1 autophosphorylation site.
The addition of Ca2/S100B led to a 2-fold increase of NDR1
autophosphorylation (on both Ser-281 and Thr-444) accompa-
nied by about a 5-fold increased kinase activity. As expected,
mutation of Ser-281 again led to an almost total decline of both
autophosphorylation and kinase activity. Nevertheless, we also
observed a marked, about 5-fold reduction of NDR1 kinase
activity for the T444A mutant. These facts suggest that both
residues are necessary for the full-active NDR1 and point to a
synergy between these two residues in activation of NDR1. The
outstanding importance of these residues is not surprising
because similar observations were made also for other AGC
group kinases (for review, see Refs. 21 and 22). Based upon
structural analysis, the PKA activation segment residue Thr-
197 was found in its phosphorylated form to align the catalytic
site of that enzyme, thereby generating an active kinase con-
formation (23). On the other hand, the recently resolved struc-
ture of PKB confirmed the crucial role of the hydrophobic
motif with its residue Ser-474 which, upon phosphorylation,
undergoes a series of interactions with B and C helices of the
catalytic domain, thereby promoting the disorder to order tran-
sition of this part of molecule with concomitant restructuring of
the activation segment and reconfiguration of the kinase bilo-
bal structure (24, 47).
Notably, we also observed a strongly compromised capabil-
ityoftheNDR1T74Amutanttobesignificantlyautophosphoryl-
ated and activated by Ca2/S100B. As mentioned above, this
residue is a part of the S100B binding domain of NDR1
(amino acids 62–86), and it is broadly conserved among pro-
tein kinases of the NDR group from different origin (Fig. 6A).
However, we cannot unambiguously distinguish between the
possibility that solely a presence of a threonine or serine
residue at this position is necessary for activation of NDR1 by
Ca2/S100B and the possibility that their phosphorylation is
required as well. Nevertheless, the N-terminal domain of
NDR1, which is highly conserved in its S100B binding region
within the whole NDR subgroup of AGC kinases, seems to
exert an autoinhibitory effect on the kinase catalytic domain
which can be relieved by binding S100B or other potential
interacting proteins. Analogous intramolecular domain-do-
main interactions are well known for a number of AGC and
other kinases, such as PKB (pleckstrin homology domain),
PKCs (C1 domain), PRK (HR1 domain), or calmodulin (CaM)-
dependent kinases (AID domain). Intriguingly, the mecha-
nism of NDR1 regulation by Ca2/S100B is reminiscent of the
regulatory features of CaM kinase II, another Ca2-con-
trolled kinase, which is known to undergo an intramolecular
(intersubunit) autophosphorylation on two threonine resi-
dues within its autoinhibitory and a nearby CaM binding
domain upon binding of CaM (25). We have demonstrated
previously that NDR1 also possesses the capacity to interact
with CaM, although to a lesser extent than S100B, but CaM
failed to activate NDR1 (12). Notably, the S100B relative
S100A1 and, in part, S100B itself, are known to activate
through a direct interaction the invertebrate giant sarcom-
eric kinase twitchin and its vertebrate counterpart titin;
however, the exact molecular mechanism of how this activa-
tion occurs has not been elucidated so far (26, 27).
As we reported earlier, the Ser-281 and Thr-444 residues
become phosphorylated also in vivo (13). However, it was not
known how these two regulatory sites are targeted in living
cells. Here, we report that the Ser-281 site is an autophospho-
rylation residue in vivo because the kinase-inactive K118A
mutant did not get phosphorylated on this position, i.e. the
kinase activity of NDR1 is indispensable for the phosphoryla-
FIG. 5. Thr-74 is required for association of HA-NDR1 with
Ca2/S100B in COS-1 cells. COS-1 cells were transfected with HA-
NDR1 wild-type, kinase-dead (K118A), and alanine mutants of phos-
phorylation residues Thr-74, Ser-281, or Thr-444, and S100B or corre-
sponding empty vectors as indicated. 48 h later, nondetergent nuclear
and cytoplasmic cell lysates were prepared, pooled, and analyzed for
expression of HA-NDR1 variants (top panel). 1 mg of protein extracts
was immunoprecipitated further with anti-S100B-Sepharose and ana-
lyzed for S100B expression (middle panel) and association of NDR1
with anti-S100B immunoprecipitates (bottom panel) as described under
“Experimental Procedures.”
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tion of Ser-281. Nevertheless, we cannot entirely exclude the
possibility that this mutation in the substrate binding site
leads, for instance, to conformational changes in the NDR1
molecule which do not permit phosphorylation action by a
putative upstream kinase. In fact, in most other AGC kinases
including PKB, p70S6K, serum and glucocorticoid-regulated ki-
nase (SGK), p90RSK, and PKC isoforms, the activation segment
residue (mostly threonine) has been reported to be a target of
PDK1 (for review, see Refs. 28 and 29). The pivotal role of
PDK1 in phosphorylation of AGC kinases is supported by high
conservation of activation segment residues within the AGC
family (Fig. 6A) and by the fact that a number of AGC kinases
are known to undergo a direct interaction with PDK1. How-
ever, more recent studies employing PDK1/ embryonic stem
cells confirmed that there are several exemptions to this gen-
eral concept. Some AGC kinases such as PKA, PKC, AMP-
activated protein kinase (AMPK), MSK1, and PRK2 become
efficiently phosphorylated at their activation segment residues
also in the absence of PDK1 (30, 31), and at least for the two
former kinases, it has been proven that this may occur through
autophosphorylation (32, 33). Our earlier observation on NDR1
also corroborated that this kinase is not modified by PDK1
either, inasmuch as cotransfection of PDK1 with NDR1 did not
significantly change the NDR1 activity in vivo, and immuno-
precipitated PDK1 failed to transfer phosphate to the GST-
NDR1 K118A mutant in vitro (13). Most likely, this can be
explained by the fact that the NDR1 sequence around Ser-281
displays apparent variations in P1 and 2 positions to the
highly conserved PDK1 consensus target site (Ser/Thr-Phe-
Cys-Gly-Thr-Xaa-Asp/Glu-Tyr-Xaa-Ala-Pro-Glu, where Ser/
Thr is the phosphoacceptor site, and Xaa stands for a hydro-
phobic residue; Fig. 6A). Taken together, our findings suggest
that NDR1, in contrast to most AGC group kinases, is not
targeted by PDK1 on its activation segment residue Ser-281
but instead, becomes efficiently autophosphorylated at this
residue both in vivo and in vitro.
Because the kinase-inactive K118A as well as the S281A
mutant became phosphorylated at Thr-444 virtually to the
same extent as wild-type NDR1 in vivo, we surmise that this
residue is targeted by an upstream kinase in OA-treated
COS-1 cells. However, we cannot rule out the possibility that
Thr-444 autophosphorylation also might contribute to the
overall phosphorylation rate at this residue because the vig-
orous treatment by OA is known to lead to a stoichiometric
phosphorylation of Thr-444 (13) and may, perhaps, favor an
upstream kinase at the expense of autophosphorylation
(thereby being sufficient to achieve full phosphorylation also
for the K118A and S281A mutants). Hence, it remains to be
elucidated whether NDR1 becomes exclusively targeted by
the putative upstream kinase also if stimulated by compara-
bly mild, as yet unknown physiological stimuli. Remarkably,
Thr-444 is flanked by hydrophobic amino acids, which in this
region are also conserved among all AGC group kinases (con-
sensus Phe-Xaa-Xaa-Phe-Ser/Thr-Phe/Tyr; except NDR1
has a tyrosine instead of phenylalanine at the P1 residue,
and PKA is truncated at this position). There is an ongoing
dispute in the field concerning the mechanism of hydrophobic
motif phosphorylation of several AGC protein kinases. We
have reported recently that the corresponding residue in
PKB (Ser-473) becomes phosphorylated independently of
PKB activity status (34); and furthermore, we have charac-
terized a constitutively active, staurosporine-insensitive Ser-
473 kinase activity enriched in buoyant, detergent-insoluble
plasma membrane rafts (35). Because this activity also de-
pends on phosphoinositide 3-kinase, it is sometimes referred
to as PDK2. Although few candidates such as integrin-linked
kinase or mitogen-activated protein kinase-activated protein
kinase-2 were originally reported to be capable of in vitro
phosphorylation of PKB at Ser-473 (36, 37), these proteins
turned out later to be physiologically irrelevant hydrophobic
motif kinases (38, 39). Thus, despite considerable efforts of
several laboratories, Ser-473 kinase resisted identification
and cloning so far. Moreover, because the sequence similarity
between PKB and NDR1 is low in this region (except the
three conserved hydrophobic residues) and because NDR1 is
FIG. 6. Structure of NDR1 and model of its regulation. A, NDR1 domain structure is shown including the N-terminal regulatory domain
containing S100 binding region and residue Thr-74; the catalytic domain spliced by a 30-amino acid insert (encompassing a nonconsensus NLS
sequence) and containing the activation segment residue Ser-281; and a C-terminal part comprising the hydrophobic motif with Thr-444. Below,
the conservation of S100B binding region is shown among several NDR-related kinases from different origin as well as conservation of parts of
activation segment and hydrophobic motif residues within the AGC family. The identical residues are boxed in black, and similar residues are in
gray. The phosphorylation sites are in bold. B, model of NDR1 regulation. NDR1 becomes autophosphorylated on the three indicated residues,
Thr-74, Ser-281, and Thr-444 in vitro. However, only Ser-281 is an autophosphorylation site in vivo. In contrast, Thr-444 is targeted mainly by an
as yet unidentified upstream kinase. Nevertheless, both phosphorylation events are Ca2-dependent and essential for NDR1 activity in vivo.
Although Thr-74 is also a minor autophosphorylation residue in vitro, it is currently not clear whether Thr-74 becomes (auto)phosphorylated also
in vivo. Nonetheless, this residue appears to be a crucial component of the S100B binding domain located in N terminus of NDR1 (for details, see
“Discussion”).
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not sensitive to inhibitors of phosphoinositide 3-kinase,4 it is
rather unlikely that Ser-473 kinase will be the same protein
as the hydrophobic motif kinase phosphorylating Thr-444 in
NDR1. For similar reasons, it is also improbable that NDR1
could be targeted by atypical PKCs such as PKC/ (which
curiously possess a phosphate-mimicking, negative-charge
glutamate residue in place of Ser/Thr at their hydrophobic
motif, making them independent of an upstream kinase), as
was postulated for conventional and novel PKCs such as
PKC, PKC, or PKC, and p70S6K (40–42). Finally, al-
though precedents for the autophosphorylation at hydropho-
bic site also exist (e.g. PKCII, Ref. 43), as mentioned above,
we have unambiguously ruled out this alternative for NDR1.
We observed that both autophosphorylation of NDR1 on
Ser-281 as well as phosphorylation by an upstream kinase on
Thr-444 are Ca2-dependent processes. In this context, it
should be noted that OA, which induces phosphorylation on
both sites, was reported, in addition, or because of its inhibitory
effect on protein phosphatase 2A, also to increase the intracel-
lular Ca2 concentration. This occurs by at least two mecha-
nisms: activation of L-type Ca2 voltage-dependent channels
(44) or release of intracellular Ca2 stores (45). This fact im-
plies that OA not only stimulates NDR1 directly through re-
lieving the protein phosphatase 2A-mediated inhibition of
phosphorylation of NDR1, but it also may activate NDR1 indi-
rectly, through some Ca2-dependent signaling pathways.
Combining the in vitro and in vivo data we gathered in this
work, the Ca2 dependence of autophosphorylation of NDR1 on
Ser-281 can be explained readily by requirement of NDR1 for
Ca2/S100B to autophosphorylate efficiently. Indeed, the T74A
mutant deficient in binding to S100B also displayed a strongly
diminished autophosphorylation rate on Ser-281 in vivo. On
the other hand, the Ca2 dependence of NDR1 phosphorylation
on Thr-444 appears to be mediated by a Ca2-dependent ki-
nase. However, because the T74A mutant showed a compro-
mised ability to become phosphorylated on Thr-444 as well, it
might also be possible that the N-terminal domain of NDR1,
together with Ca2/S100B, can in part be responsible for the
Ca2 dependence of Thr-444 phosphorylation, e.g. through tar-
geting an upstream kinase to NDR1.
In this report, we defined NDR1 as a new member of a broad
group of Ca2-regulated protein kinases which currently com-
prises proteins as different as CaM and CaM kinases, twitchin/
titin giant kinases, conventional PKCs, and to some extent also
mitogen-activated protein kinases, PKA, PKB, and PKG (46).
We characterized the molecular mechanism for activation of
NDR1 by Ca2 consisting of Ca2/S100B-induced autophospho-
rylation of NDR1 on the activation segment residue Ser-281
and phosphorylation of hydrophobic motif site Thr-444 by a
Ca2-dependent upstream kinase. The exact nature of the ac-
tivatory Ca2 signals as well as the identity of upstream kinase
and downstream targets of NDR1 still awaits elucidation but
will eventually provide insights into the physiological function
of this enzyme and the corresponding signaling pathway.
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NDR (nuclear Dbf2-related) kinase belongs to a family
of kinases that is highly conserved throughout the eu-
karyotic world. We showed previously that NDR is reg-
ulated by phosphorylation and by the Ca2-binding pro-
tein, S100B. The budding yeast relatives of Homo sapiens
NDR, Cbk1, and Dbf2, were shown to interact with Mob2
(Mps one binder 2) and Mob1, respectively. This interac-
tion is required for the activity and biological function
of these kinases. In this study, we show that hMOB1, the
closest relative of yeast Mob1 and Mob2, stimulates NDR
kinase activity and interacts with NDR both in vivo and
in vitro. The point mutations of highly conserved resi-
dues within the N-terminal domain of NDR reduced
NDR kinase activity as well as human MOB1 binding. A
novel feature of NDR kinases is an insert within the
catalytic domain between subdomains VII and VIII.
The amino acid sequence within this insert shows a
high basic amino acid content in all of the kinases of
the NDR family known to interact with MOB proteins.
We show that this sequence is autoinhibitory, and our
data indicate that the binding of human MOB1 to the
N-terminal domain of NDR induces the release of this
autoinhibition.
NDR1 kinase belongs to a highly conserved family of kinases,
a subclass of the AGC family of protein kinases (1, 2). The NDR
family consists of the mammalian protein kinases NDR1 and
NDR2, Drosophila melanogaster NDR, Caenorhabditis elegans
SAX1, mammalian, D. melanogaster and C. elegans large tu-
mor suppressor kinases, Neurospora crassa COT1, Ustilago
maydis UKC1, Saccharomyces cerevisiae Cbk1, Dbf2, and
Dbf20, Schizosaccharomyces pombe Orb6 and Sid2, and several
plant kinases (1, 2). These kinases share a high sequence
conservation, and some possess conserved functions, mainly
involving regulation of cell morphology and the cell cycle
(2–15).
The kinase domain sequence of NDR is related to that of
other members of the AGC group of kinases, e.g. protein ki-
nases A, B, C, and G, PRK, p70S6K, p90RSK, and phosphoinosit-
ide-dependent kinase 1 (1). NDR contains all 12 subdomains of
the kinase catalytic domain as described by Hanks and Hunter
(16). However, the catalytic domains of all of the members of
the NDR family are interrupted by an insert of 30–60 amino
acids between subdomains VII and VIII. This inserted se-
quence is not well conserved but is always rich in the basic
amino acids, arginine and lysine. The catalytic domain insert
has been shown to act as a non-consensus nuclear localization
signal in the case of NDR1. NDR1 localizes predominantly to
the nucleus in COS-1 cells, whereas mutant NDR1 with a
deletion in the insert is localized to the cytosol (17). An addi-
tional special feature of the NDR family of kinases is a highly
conserved N-terminal domain. In the case of NDR1, this do-
main consists of 81 amino acids and encompasses a region
predicted to form an amphiphilic -helix that binds to the
EF-hand Ca2-binding protein, S100B (18). Finally, the C-
terminal extension of NDR kinase contains a broadly conserved
hydrophobic motif phosphorylation site that is an important
regulatory site within the AGC group of kinases (19).
NDR kinase is efficiently (20–100-fold) activated upon treat-
ment of cells with the protein phosphatase 2A inhibitor, oka-
daic acid (OA). OA treatment induces the phosphorylation of
the activation segment site, Ser-281, and the hydrophobic motif
site, Thr-444 (20). We have shown that Ser-281 is autophos-
phorylated, whereas Thr-444 is targeted by an as yet uniden-
tified upstream kinase. Both sites are crucial for NDR activity
in vivo and in vitro. NDR activation is Ca2-dependent as
shown by the treatment of COS-1 cells with the Ca2 chelator,
BAPTA-AM, which abolishes NDR activation. It has been
shown that the EF-hand Ca2-binding protein, S100B, binds to
the N-terminal domain of NDR in vivo and in vitro and that
Ca2/S100B activates NDR in vitro. S100B induces increased
autophosphorylation on Ser-281. During investigations of the
mechanism of S100B-induced autophosphorylation, a third au-
tophosphorylation site, Thr-74, in the N-terminal domain was
discovered (21). This site is also crucial for NDR activation,
because its mutation to alanine affected NDR activity in vivo.
The results of several recent studies indicate a novel con-
served signaling pathway involving NDR kinase family mem-
bers. It has been shown in D. melanogaster that NDR geneti-
cally interacts with FURRY, a 300-kDa protein of unknown
function (22). In S. cerevisiae, the FURRY relative, Tao3/Pag1,
lies on the Cbk1 pathway. Furthermore, Tao3/Pag1 and Cbk1
interact physically and their localization is interdependent
(23). In S. pombe, the FURRY-like protein, Mor2/Cps12, inter-
acts physically with Orb6, the S. pombe NDR orthologue (24).
The FURRY-like proteins are conserved in mammals, and thus,
it is likely that other proteins interacting genetically and/or
physically with S. cerevisiae Cbk1 or Dbf2 also play a role in
the NDR kinase family pathway in higher eukaryotes. Most of
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these proteins are fairly well conserved throughout evolution.
S. cerevisiae Mob1 is a member of the mitotic exit network
(25, 26). Dbf2 associates with Mob1, and Mob1 is required for
phosphorylation and activation of Dbf2 (27). S. cerevisiae
Mob2, a close relative of Mob1, is a member of the Cbk1 path-
way. Mob2 is required for the biological function of Cbk1 in the
mother/daughter separation after cytokinesis and maintenance
of polarized cell growth. Mob2 associates physically with Cbk1,
and Cbk1 kinase activity is dependent on Mob2. Furthermore,
Mob2 and Cbk1 show interdependent localization (28, 29). Sim-
ilarly, S. pombe Mob2 interacts physically with the protein
kinase Orb6 and is required for Orb6 function in the coordina-
tion of cell polarity with the cell cycle (30). Multicellular organ-
isms possess highly conserved MOB proteins. hMOB1 shares
a sequence identity/similarity of 50/65% with S. cerevisiae
Mob2 and of 57/78% with S. pombe Mob1. The human MOB
protein family consists of two almost identical proteins,
hMOB1 and hMOB1 (NCBI accession numbers Gi8922671
and 27735029), sharing a sequence identity/similarity of 95/
97%; a more distantly related protein, hMOB2 (NCBI accession
numbers Gi38091156), that is 41/60% identical/similar to
hMOB1; three other related proteins, hMOB3 , , and 
(Gi18677731, 41350330, and 3809115), with an identity/simi-
larity of 50/73% to hMOB1; and the weakly similar protein,
phocein (Gi41349451), that is 24/45% identical/similar to
hMOB1. Because the nomenclature of MOB proteins in the
data bases is rather confusing, we use the above terminology
based on homology as also proposed recently by Stravridi et al.
(31). To date, no functional domains have been identified in the
MOB proteins and the hMOB proteins have no known func-
tions. It has been shown that the MOB relative, phocein, inter-
acts with the protein phosphatase 2A regulatory subunit, stria-
tin, and with proteins involved in vesicular traffic (32, 33).
Here, we characterize the interaction of hMOB1, the closest
relative of yeast Mob1 and Mob2, with human NDR kinase. We
show that hMOB1 binding is dependent on the N-terminal do-
main of NDR and that hMOB1 stimulates NDR kinase activity
both in vivo and in vitro. Furthermore, we show that a basic
sequence within the insert in the catalytic domain of NDR has an
autoinhibitory function and that hMOB1 may stimulate NDR
activity by releasing the autoinhibitory effect of this sequence.
EXPERIMENTAL PROCEDURES
Cell Culture—COS-1 cells were maintained in Dulbecco’s modified
Eagle’s medium containing 10% fetal calf serum, 100 units/ml penicil-
lin, and 100 g/ml streptomycin. Cells were transfected at the subcon-
fluent stage with FuGENE 6 transfection reagent (Roche Applied Sci-
ence) according to the manufacturer’s instructions. In some
experiments, the cells were treated for 60 min with 1 M OA in 0.1%
N,N-dimethylformamide or 50 M BAPTA-AM in 0.1% Me2SO 48 h
after transfection.
Plasmids—Mammalian expression vector pCMV5 encoding HA-
tagged NDR1 was described previously (21). pCMV5-hMOB1 was
constructed by PCR using the Image clone 4854541 (BG 754693) as
template and the primers 5-GGG GTA CCA CCA TGG AAC AGA AAC
TCA TCT CTG AAG AGG ATC TGA GCT TCC TCT TCA GCA GCC
GCT C-3 and 5-GCT CTA GAC ATT TAT CTG TCT TTT GAT CCA
AGT TTC TCT ATT AAT TCT TGA AGA GG-3 and subcloned into the
KpnI and XbaI sites of the vector. pGex2T-hMOB1 was constructed by
PCR using the primers 5-CGG GAT CCA GCT TCC TCT TCA GCA
GCC GCT C-3 and 5-CCG CTC GAG CAT TTA TCT GTC TTT TGA
TCC AAG TTT CTC TAT TAA TTC TTG AAG AGG-3 and subcloned
into the BamH1 and XhoI sites of the vector. For the bacterial produc-
tion of the NDR protein kinase, NDR2 was fused to a capsid-stabilizing
protein of lambdoid phage 21 (SHP).2 The cloning details and vector
maps are available upon request. pCMV5 HA-NDR1 and pSHP-NDR2
point mutations were generated from wild-type vectors using the
QuikChange site mutagenesis protocol (Stratagene) and the appropri-
ate primers (primer sequences are available upon request). The se-
quences of all of the plasmids were confirmed by DNA sequencing.
Antibodies—Phosphorylated anti-Ser-281 and anti-Thr-444 antibod-
ies were as described previously (21). Phosphorylated anti-Thr-74 rab-
bit polyclonal antiserum was raised against the synthetic peptide,
AHARKET(PO4)EFLRLK. The 12CA5 (HA) and the 9E10 (Myc) mono-
clonal antibody hybridoma supernatants were used for detection of
HA-NDR and Myc-hMOB1. Anti-GST-NDR polyclonal antibody was as
described previously (17).
Western Blotting—To detect HA-NDR, SHP-NDR, and Myc-hMOB1,
samples were resolved by 10 or 12% SDS-PAGE and transferred to
polyvinylidene difluoride membranes. Membranes were blocked in
TBST (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween 20)
containing 5% skimmed milk powder and then probed overnight at 4 °C
with anti-GST NDR rabbit polyclonal antibody, 12CA5 (HA) mono-
clonal antibody supernatant, 9E10 anti-Myc monoclonal antibody su-
pernatant, anti-Thr-444P, anti-Ser-281P, or anti Thr-74P. Bound anti-
bodies were detected with horseradish peroxidase-linked secondary
antibodies, or Myc-hMOB1 in HA immunoprecipitations were detected
with horseradish peroxidase-conjugated protein A/G and ECL.
Bacterial Expression of Human GST-fused hMOB1 and Human
SHP-fused NDR2—XL-1 Blue Escherichia coli was transformed with
the pGEX-2T-hMOB1 plasmid. Mid-logarithmic phase cells were in-
duced with 0.1 mM isopropyl -D-thiogalactopyranoside overnight at
20 °C. Bacteria were disrupted using a French press in the presence of
1 mg/ml lysozyme, and the fusion proteins were purified on glutathione-
agarose. SHP-NDR2 wild-type and mutant plasmids were transformed
into XL-1 Blue E. coli, and the protein was produced as described for
GST-hMOB1 and purified on nickel-nitrilotriacetic acid-Sepharose.
HA-NDR Kinase Assay—Transfected COS-1 cells were washed once
with ice-cold phosphate-buffered saline and harvested in 1 ml of ice-cold
phosphate-buffered saline containing 1 mM Na3VO4 and 20 mM -glyc-
erol phosphate before lysis in 500 l of IP buffer (20 mM Tris-HCl, pH
8.0, 150 mM NaCl, 1% Nonidet P-40, 10% glycerol, 1 mM Na3VO4, 20 mM
-glycerol phosphate, 1 M microcystin, 50 mM NaF, 0.5 mM phenyl-
methylsulfonyl fluoride, 4 M leupeptin, and 1 mM benzamidine). Ly-
sates were centrifuged at 20,000  g for 20 min, and duplicate aliquots
(250 g) of the supernatant were precleared with protein A-Sepharose
for 60 min and mixed subsequently for 3 h at 4 °C with 12CA5 antibody
prebound to protein A-Sepharose. The beads were then washed twice
with IP buffer, once for 10 min with IP buffer containing 1 M NaCl,
again for 10 min with IP buffer, and finally twice with 20 mM Tris-HCl,
pH 7.5, containing 4 M leupeptin and 1 mM benzamidine. Thereafter,
the beads were resuspended in 30 l of buffer containing 20 mM Tris-
HCl, pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 100 M [-
32P]ATP
(1,000 cpm/pmol), 1 M cAMP-dependent protein kinase inhibitor
peptide, 4 M leupeptin, 1 mM benzamidine, 1 M microcystin, and 1 mM
NDR1 substrate peptide (KKRNRRLSVA). After a 60-min incubation at
30 °C, the reactions were processed as described previously (21).
SHP-NDR Kinase Assay—1 g of purified recombinant SHP-NDR
wild type and mutants (without further treatment or pre-autophospho-
rylated in the presence of 10 M GST-hMOB1 or GST) were assayed in
a 30-l reaction mixture containing 20 mM Tris-HCl, pH 7.5, 10 mM
MgCl2, 1 mM dithiothreitol, 100 M [-
32P]ATP (1,000 cpm/pmol), and
1 mM NDR1 substrate peptide (KKRNRRLSVA). After incubation at
30 °C, the reactions were processed and kinase activity was determined
as described for the HA-NDR kinase assay.
Immunoprecipitations—COS-1 cells transfected with HA-NDR wild
type or mutants and Myc-hMOB1 were harvested as described above.
Cell lysate protein (0.5 mg) was precleared with protein A- or G-
Sepharose and mixed subsequently for 3 h at 4 °C with 12CA5 antibody
prebound to protein A-Sepharose or with 9E10 antibody prebound to
protein G-Sepharose. The beads then were washed twice with IP buffer,
once with IP buffer containing 1 M NaCl, once again with IP buffer, and
finally twice with 20 mM Tris-HCl, pH 7.5, containing 4 M leupeptin
and 1 mM benzamidine. Samples were resolved by 12% SDS-PAGE, and
Myc-hMOB1 and HA-NDR were detected by Western blotting.
GST Pull-down Assay—25-g aliquots of GST or GST-hMOB1 were
incubated with glutathione-Sepharose for 2 h at 4 °C. The beads were
washed three times with Tris-buffered saline, and then 5-g aliquots of
SHP-NDR wild type or mutants were added and incubated for 3 h at
4 °C. The beads were washed five times with Tris-buffered saline and
resuspended in 30 l of 1 SDS sample buffer, and the samples were
resolved by 12% SDS-PAGE. NDR bound to GST-hMOB1 was detected
by Western blotting.
2 P. Forrer, C. Chang, D. Ott, A. Wlodawer, and A. Plu¨ckthun, sub-
mitted for publication.
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RESULTS
hMOB1 Activates NDR—Previous work by other groups has
shown in yeast that Mob1 and Mob2 are required for the
activity of the NDR-related kinases Dbf2 and Cbk1, respec-
tively (26, 27). To test whether hMOB1 also plays a role in NDR
activation, we co-transfected Myc-hMOB1 or the empty vector
with HA-NDR1 into COS-1 cells. The cells were treated with
the protein phosphatase 2A inhibitor, OA. To date, OA is the
only known potent activator of NDR in vivo (20, 21) and it has
been shown that yeast Mob1 becomes phosphorylated after OA
treatment (27). The kinase activity of immunoprecipitated HA-
NDR1 was stimulated 35-fold by a 45-min treatment of 1 M
OA (Fig. 1A). Co-expression of Myc-hMOB1 induced an addi-
tional 2–3-fold increase in NDR kinase activity (Fig. 1A). At the
45-min OA time point, HA-NDR1 co-expressed with Myc-
hMOB1 was stimulated 100-fold compared with the control.
This indicates a role for hMOB1 in NDR activation. To test
whether hMOB1 acts directly on NDR, we performed in vitro
kinase assays of bacterially expressed SHP-NDR2 in the pres-
ence of GST-hMOB1 or GST. We used NDR2 for in vitro exper-
iments, because it can be readily produced in sufficient
amounts. NDR2, which is 86% identical to NDR1, has been
shown to be regulated in the same way as NDR1 (34). Further-
more, we confirmed with NDR1 produced in Sf9 cells that
wild-type NDR1 behaves in vitro similar to NDR2 with respect
to hMOB1 (data not shown). GST-hMOB1 stimulated SHP-
NDR2 autophosphorylation 2-fold (data not shown). Further-
more, SHP-NDR2, which was pre-autophosphorylated in the
presence of GST-hMOB1, has up to a 6-fold higher kinase
activity against the NDR substrate peptide than SHP-NDR
pre-autophosphorylated in the presence of GST (Fig. 1B). These
results show that hMOB1 has a direct positive effect on NDR
kinase activity. We tested the effect of hMOB1 on the phospho-
rylation state of the NDR phosphorylation sites Thr-74, Ser-
281, and Thr-444 (Thr-75, Ser-282, and Thr-442 in the case of
NDR2; the phosphorylation sites of NDR2 were recognized by
phosphospecific antibodies generated against the correspond-
ing phosphorylation sites of NDR1). SHP-NDR2 phosphoryla-
tion on the autophosphorylation sites Ser-282 and Thr-75 was
slightly increased, whereas Thr-442 of SHP-NDR2, which is
known to be targeted by an upstream kinase in vivo, showed no
autophosphorylation (Fig. 1B).
hNDR1 Interacts with hMOB1—To investigate whether
hMOB1, the closest relative of yeast MOB2 and MOB1 in
mammals, is able to interact with NDR1, epitope-tagged NDR1
and hMOB1 were co-transfected into COS-1 cells. In co-immu-
noprecipitation experiments of Myc-hMOB1 with HA-NDR1
(Fig. 2A) as well as those of HA-NDR with Myc-hMOB1 (Fig.
2B), hMOB1 associated with NDR1. The protein level of Myc-
hMOB1 was dramatically increased upon OA stimulation,
whereas Myc-hMOB1 transfected without NDR1 was present
at similar levels in OA-treated and OA-untreated cells. We did
not address the molecular basis of this phenomenon. The ki-
nase-dead mutant with the mutated catalytic lysine in the ATP
binding site, K118A, was still able to interact with hMOB1
after OA stimulation (Fig. 2A). Thus, the interaction was not
dependent on NDR kinase activity. Furthermore, we tested
whether the two important in vivo phosphorylation sites of
NDR, Ser-281 and Thr-444, as well as a recently identified in
vitro autophosphorylation site, Thr-74, play a role in NDR-
MOB interaction. The NDR mutants S281A and T444A still
interacted with hMOB1 after OA stimulation, whereas the
T74A mutant showed almost complete absence of interaction
with hMOB1 (data not shown).
NDR-hMOB1 Interaction Depends on OA-induced Modifica-
tion on hMOB1, whereas Phosphorylation of NDR Is Not Re-
quired—Myc-hMOB1 interacted with HA-NDR1 in OA-treated
COS-1 cells, but it was not clear whether OA acted just by
increasing the Myc-hMOB1 protein level or whether OA-in-
duced modification of NDR1, hMOB1, or both promoted the
interaction. To address this question, we transfected HA-NDR1
and Myc-hMOB1 separately into COS-1 cells and stimulated
them with 1 M OA or left them unstimulated. We then pooled
the lysates (NDR1  OA with hMOB1  OA) and immunopre-
cipitated with -HA antibody. In the two combinations contain-
ing Myc-hMOB1 of OA-treated cells, Myc-hMOB1 strongly as-
sociated with HA-NDR, regardless of whether the HA-NDR
was expressed in OA-treated or unstimulated cells. Myc-
hMOB1 from unstimulated cells showed only a weak interac-
tion with HA-NDR from both unstimulated and OA-stimulated
cells (Fig. 2C). Thus, OA-induced phosphorylation of NDR is
not required for interaction but hMOB1 modification is neces-
sary. Furthermore, GST-hMOB1 was phosphorylated by im-
munoprecipitated HA-NDR. The phosphorylation of GST-
hMOB1 increased 3–4-fold when HA-NDR was immuno-
precipitated from OA-stimulated COS-1 cells. However, the
phosphorylation of GST-hMOB1 was also observed when ki-
nase-dead HA-NDR was immunoprecipitated (Fig. 2D). We
conclude that a kinase that co-immunoprecipitates with NDR
is able to phosphorylate hMOB1.
FIG. 1. hMOB1 stimulates NDR kinase activity. A, HA-NDR was
cotransfected with Myc-hMOB1 or the empty vector and treated for the
indicated times with 1 M OA. 12CA5 immunoprecipitates were then
assayed for kinase activity. Also shown is the expression of HA-NDR
and Myc-hMOB1 in the total cell lysates. B, GST-hMOB1 or GST was
added to bacterially expressed SHP-NDR2, and autophosphorylation
reactions were performed for the indicated times. After autophospho-
rylation, half of the reaction was added to a mixture containing
[32P]ATP and NDR substrate peptide to perform kinase assays. The
other half was stopped with SDS sample buffer and resolved on a 10%
SDS gel for Western blots with phosphospecific antibodies. wt, wild
type; IP, immunoprecipitate.
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The Highly Conserved N-terminal Domain of NDR Is Re-
quired for Kinase Activation—The N-terminal regulatory do-
main of NDR kinase is highly conserved in the closest relatives
of NDR throughout the eukaryotic world (Fig. 3A). Several
residues are completely invariant throughout evolution from
single cell organisms to humans. This prompted us to test the
functional significance of these residues with respect to NDR
kinase activity. Mutations of the highly conserved residues
induced strong inhibition of OA-stimulated kinase activity
(Fig. 3B). The first part of the N-terminal domain covering
amino acids 1–33 and containing a predicted -sheet in hNDR
proved to be important for kinase activation. The deletion of
the first 30 amino acids completely abolished kinase activation
(data not shown). The point mutations in this region strongly
reduced kinase activity. The mutation of Thr-16, Glu-18, and
Glu-28 reduced activity to 40%, whereas the mutation of
Lys-24 and Tyr-31 reduced activity to 20%. Mutation to ala-
nine of Arg-41, Arg-44, or Leu-48, all of which lie in a predicted
first -helix covering the amino acids 40–55 and are situated
close together on the same side of the predicted -helix, re-
duced kinase activity to below 20% of wild-type activity. Mu-
tation of the residues in a predicted second -helix situated in
the previously described S100B binding region of NDR and
covering amino acids 60–80 also led to the inhibition of kinase
activity. Mutation of Lys-72, Glu-73, Thr-74, Arg-78, and
Leu-79 to alanine reduced kinase activity to 20% or lower.
Taken together, the results imply that the high conservation of
the N-terminal domain in the following termed SMA (S100B
and MOB Association) domain is due to an absolute require-
ment of the conserved residues for proper kinase function,
either by ensuring the correct structural conformation of the
protein or being directly involved in binding to interacting
proteins.
The SMA Domain Is Required for NDR-MOB Interaction—
Thr-74, which was previously shown to be important for NDR
kinase activity and interaction with S100B, also turned out to
be required for NDR-hMOB1 interaction in COS-1 cells. There-
fore, we investigated the involvement of the conserved residues
of the SMA domain in NDR-hMOB1 interaction. Co-transfec-
tion of HA-tagged NDR mutants and Myc-hMOB1 and subse-
quent co-immunoprecipitation of Myc-MOB with HA-NDR re-
vealed that several of the conserved residues important for
kinase activation are also required for NDR-hMOB1 interac-
tion (Fig. 4, A–C). Tyr-31, Arg-41, Thr-74, and Arg-78 seem to
be absolutely required for interaction, whereas the Lys-24,
Arg-44, and Leu-79 mutants displayed reduced interaction.
Only three of the mutants with a strongly reduced kinase
activity (Arg-48, Lys-72, and Glu-73) showed no decrease in the
ability to bind hMOB1.
Tyr-32 of NDR2 Kinase Is Essential for Activation by hMOB1
in Vitro—The residues Tyr-31, Arg-41, Arg-44, Thr-74, and
Arg-78 of NDR1 were shown to be important for kinase activa-
tion and interaction with hMOB1 in COS-1 cells. We examined
whether these residues are involved directly in the interaction
of NDR and hMOB1 or indirectly by influencing interactions
with other proteins in the cells. We used bacterially produced
SHP-NDR2, wild type, and the mutants Y32A, R42A/R45A,
E74A, T75A, and R79A (corresponding to the NDR1 mutants
Y31A, R41A/R42A, E73A, T74A, and R78A) together with GST-
hMOB1 protein to perform in vitro kinase assays to measure
the direct effect of hMOB1 on NDR kinase activity (Fig. 5A).
The mutation of Glu-74, a residue that affects kinase activity
but not interaction with hMOB1 in COS-1 cells, led to a reduc-
tion in kinase basal activity in vitro. This very highly conserved
Glu-74 seems to have an important intrinsic role for the func-
tion of NDR kinase, although it is not involved in the binding to
FIG. 2. NDR interacts with hMOB1. A and B, wild type (wt) and
kinase-dead (kd) HA-NDR and Myc-hMOB1 were co-transfected into
COS-1 cells, and the cells were treated with OA prior to lysis. A,
HA-NDR was immunoprecipitated, and the co-immunoprecipitated
Myc-hMOB1 was detected. B, Myc-hMOB1 was immunoprecipitated,
and the co-immunoprecipitated HA-NDR was detected. C, HA-NDR
and Myc-hMOB1 were transfected separately into COS-1 cells, and
the cells were treated with OA or solvent alone prior to lysis. Lysates
of OA-stimulated and OA-unstimulated cells containing HA-NDR1
and lysates of OA-stimulated and OA-unstimulated cells containing
Myc-hMOB1 were combined. HA-NDR was immunoprecipitated from
these combined lysates, and co-immunoprecipitated Myc-hMOB1 was
detected. D, HA-NDR wild-type and the kinase-dead mutant K118A
were transfected into COS-1 cells, and the cells were treated for 60
min with 1 M OA or the solvent alone prior to lysis. HA-NDR was
immunoprecipitated from 1 mg of lysate protein. HA-NDR kinase
reactions were performed for 2 h with 10 M GST-hMOB1 or GST
instead of the NDR substrate peptide. The reactions were resolved on
a 10% SDS-PAGE, and the incorporated 32P was visualized with a
PhosphorImager.
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hMOB1. The mutation of residues Arg-42 and Arg-45, which lie
on the same side of a predicted -helix and whose mutation
affects NDR-hMOB1 interaction as well as kinase activation in
COS-1 cells, led to a reduction in kinase activity in vitro but did
not completely abolish the activation by hMOB1. NDR with
mutated Tyr-32 showed an intact basal kinase activity but was
not activated by hMOB1 in vitro at all, pointing to an impor-
tant role for this residue in the direct interaction with hMOB1.
The activation of the T75A and the R79A mutants by hMOB1
was not different to wild-type NDR, suggesting that Thr-75 and
Arg-79 are not directly involved in binding to hMOB1 and do
not affect the kinase activity of NDR per se. Furthermore, the
pull-down assays showed that NDR2 with mutated Tyr-32 does
not bind to hMOB1, whereas the binding of NDR2 with mu-
tated Arg-42 and Arg-45 is not abolished (Fig. 5B).
The Insert in the Catalytic Domain Acts as an Autoinhibitory
Sequence—A common feature of the NDR family of kinases is
an insert in the catalytic domain of 30–60 amino acids between
subdomains VII and VIII. The insert sequence is not highly
conserved but contains in all cases many positively charged
amino acids. Therefore, we tested the importance of these pos-
itive residues for NDR activity and NDR-hMOB1 interaction.
Mutating the amino acid sequence 265KRKAETWKRNRR276 to
amino acid sequence 265AAAAETWAANRR276 increased both
the kinase activity and phosphorylation of Thr-74, Ser-281, and
Thr-444 in COS-1 cells (Fig. 6, A and B) but did not affect
NDR-MOB binding (data not shown). To test whether this
insert sequence has an autoinhibitory function, we produced
recombinant SHP-NDR2 insert mutant and tested its in vitro
activity. NDR with the mutated insert sequence had a 4–6-fold
FIG. 3. The N-terminal SMA domain of NDR is essential for kinase activity. A, alignment of the N-terminal domain of NDR and its
relatives. Numbering is based on NDR1. B, relative kinase activities of HA-NDR1 point mutants from OA-stimulated COS-1 cells. The kinase
activities of HA-NDR and the indicated mutants were measured. The data are a summary of three experiments (mutant amino acids 16–31, 40–60,
and 61–79). NDR wild type was stimulated 20–30-fold by OA in these experiments. The activities of the NDR mutants were compared with the
activity of wild-type NDR in each experiment. Similar expression levels of NDR wild type (WT) and mutants were confirmed in each experiment
by HA-Western blotting. H.s, H. sapiens; D.m., D. melanogaster; C.e., C. elegans; S.p., S. pombe; S.c., S. cerevisae, A.t., A. thaliana; N.c., N. crassa;
U.m., U. maydis.
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elevated basal kinase activity, similar to hMOB1-stimulated
NDR2, proving that the insert sequence is autoinhibitory.
Moreover, NDR2 with a mutated autoinhibitory sequence (AIS)
was only slightly (1.5-fold) stimulated by hMOB1. Further-
more, we examined the effect of the combined mutation of
Tyr-32 and the AIS. The mutation of Tyr-32, which abolishes
the binding of hMOB1 to NDR, did not affect the activity of the
AIS mutant NDR2, and the AIS Y32A mutant was not acti-
vated by hMOB1 (Fig. 6C). Altogether, these results indicate
that hMOB1 binding induces the release of the autoinhibition
caused by the AIS.
The Ca2 Chelator BAPTA-AM Reduces NDR-MOB Interac-
tion in Cells, but the Action of hMOB1 on NDR in Vitro Is
Ca2-independent—Previously, we showed that treatment of
COS-1 cells with the Ca2 chelator BAPTA-AM reduces OA-
induced NDR kinase activation (21). Therefore, we tested
whether the treatment of COS-1 cells with BAPTA-AM influ-
ences NDR-hMOB1 interaction. In co-immunoprecipitation ex-
periments of Myc-hMOB1 with HA-NDR of BAPTA- and OA-
treated cells, BAPTA-AM reduced NDR-hMOB1 interaction
corresponding to the observed reduction in NDR kinase activa-
tion (Fig. 7A). Therefore, we tested whether Ca2 influences the
action of hMOB1 on NDR in vitro. The addition of Ca2 to NDR
in vitro kinase assays in the presence or absence of GST-hMOB1
had no effect on NDR kinase activity (Fig. 7B). Thus, Ca2 has no
direct influence on NDR-hMOB1 interaction.
DISCUSSION
We found that NDR kinase is activated by and interacts with
hMOB1 in vitro and in COS-1 cells. MOB proteins, similar to
NDR family kinases, are highly conserved throughout the eu-
karyotic world. hMOB1 is the closest relative of yeast Mob1
and Mob2. The yeast NDR family kinases, Dbf2 and Cbk1,
were both shown to interact with yeast Mob1 and Mob2. The
finding that hMOB1 activates and interacts with NDR sup-
ports the existence of a highly conserved signaling pathway.
The interaction of NDR and hMOB1 in COS-1 cells increased
when the cells were treated with OA. We have shown that the
interaction of NDR1 and hMOB1 in cell lysates depends on an
OA-induced modification of hMOB1 but not that of NDR. A
possible explanation for this is that hMOB1 is sequestered by
interaction with another protein and hMOB1 is released upon
OA treatment and interacts with NDR. Therefore, the observed
activation of NDR by OA may not be due solely to the direct
inhibition of Ser-281 and Thr-444 dephosphorylation and acti-
vation of the pathway leading to Thr-444 phosphorylation but
also to an increase in hMOB1 interaction with NDR. The ob-
served phosphorylation of GST-hMOB1 by immunoprecipi-
tated wild-type and kinase-dead HA-NDR1 suggests that OA
stimulates a kinase that phosphorylates hMOB1 and is in a
complex with NDR. It is conceivable that this phosphorylation
is responsible for the binding of NDR to hMOB1 in COS-1 cells.
There is now a need to identify the phosphorylation sites on
hMOB1 and the kinase that phosphorylates hMOB1. We
showed previously that NDR activation depends on Ca2 (21).
The treatment of COS-1 cells with the Ca2 chelator
FIG. 4. The SMA domain of NDR is required for NDR-hMOB1
interaction. HA-NDR N-terminal point mutants and Myc-hMOB1
were co-transfected into COS-1 cells that were treated with OA prior to
lysis. HA-NDR mutants were immunoprecipitated, and co-immunopre-
cipitated Myc-hMOB1 was detected. A, point mutants of amino acids
16–31. B, point mutants of amino acids 40–60. C, point mutants of
amino acids 61–79. wt, wild type; IP, immunoprecipitate.
FIG. 5. Influence of SMA domain mutants on the in vitro kinase
activation of NDR by hMOB1 and the NDR-hMOB1 interaction.
A, 1 g of wild-type SHP-hNDR2 and the indicated mutants was pre-
autophosphorylated in the presence of 10 M GST-hMOB1 or GST for
2 h. The reactions were subsequently mixed with [-32P]ATP and NDR
substrate peptide and incubated for 60 min to determine the NDR
peptide kinase activity. B, 25 g of GST or GST-hMOB1 was incubated
with 20 l of glutathione-Sepharose for 2 h at 4 °C. The beads were
washed three times with Tris-buffered saline, and 5 g of SHP-NDR
wild type (wt) and mutants then was added and the mixture was
incubated for 3 h at 4 °C. The beads were washed five times with
Tris-buffered saline and resuspended in 30 l of 1 SDS sample buffer,
and the samples were resolved by 12% SDS-PAGE. Bound NDR was
detected by Western blotting using the anti-NDR antibody.
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BAPTA-AM led to a decrease in NDR-hMOB interaction. How-
ever, Ca2 had no effect on hMOB1-stimulated NDR activity in
vitro. Therefore, Ca2 may be required for MOB modification in
vivo but it plays no role in the direct activation of NDR by
MOB.
Several residues within the N-terminal SMA domain of NDR
are important for NDR-hMOB1 interaction and for the kinase
activation in vivo. On the other hand, only one of these resi-
dues, Tyr-32, proved to be important for interaction with and
activation by hMOB1 in vitro. In contrast, it has been shown by
NMR studies that Xenopus laevis MOB1 interacts with a syn-
thetic peptide covering the S100B binding region of NDR (35).
This region also contains residues Thr-74 and Arg-78, which
are important for NDR activation and interaction with hMOB1
in vivo. Furthermore, the previously resolved crystal (31) and
NMR (35) structures of hMOB1 and X. laevis MOB1, respec-
tively, revealed that MOB1 has a negatively charged and ex-
posed potential interaction surface. Thus, it is likely that pos-
itively charged residues of the NDR SMA domain such as
Arg-78 are involved in the interaction with hMOB1 but that its
mutation is not sufficient to disrupt the interaction with NDR
under in vitro conditions. The residues Arg-41 and Arg-44,
which lie on the same side of a predicted -helix, may also
participate in the interaction, but their mutation is not suffi-
cient to disrupt the interaction in vitro. However, the mutation
of Tyr-32 might disrupt the overall structure of the SMA do-
main, thereby disabling the interaction with hMOB1, or Tyr-32
of NDR might interact directly with hMOB1.
Although the sequence of the insert in the kinase catalytic
domain between subdomains VII and VIII is not well conserved
between NDR and the yeast kinases Cbk1 and Dbf2, they all
have a sequence with a high basic amino acid content. Because
this sequence is located just in front of the activation segment
phosphorylation site, the question of whether it has a regula-
FIG. 6. Mutation of the insert in the catalytic domain activates
NDR kinase. A, kinase activity of HA-NDR insert mutant. The amino
acid sequence 265KRKAETWKRNRR276 was mutated to 265AAAAET-
WAANRR276. HA-NDR, wild-type (wt), and insert mutant were ex-
pressed in COS-1 cells, and the cells were treated with OA or solvent
alone as indicated. HA-NDR was immunoprecipitated, and NDR kinase
activity against the NDR substrate peptide was measured. B, Western
blots showing the expression levels (anti-HA Western blot) and the
phosphorylation states of Thr-74, Ser-281, and Thr-444. C, in vitro
kinase activity of NDR insert mutant. 1 g of SHP-NDR2 wild-type
mutant (WT), insert mutant (AIS), and insert mutant with mutated
Tyr-32 (AIS Y32A) were pre-autophosphorylated in the presence of 10
M GST-hMOB1 or GST for 2 h. Reactions were mixed with [-32P]ATP
and NDR substrate peptide and incubated for 60 min to determine NDR
kinase activity.
FIG. 7. Ca2 depletion of COS-1 cells reduces NDR-hMOB1 in-
teraction, but Ca2 has no direct role in NDR-hMOB1 interac-
tion. A, HA-NDR1 and Myc-hMOB1 were co-transfected into COS-1
cells and the cells treated with BAPTA-AM and OA or the solvents
alone as indicated. HA-NDR was immunoprecipitated, and the co-im-
munoprecipitated Myc-hMOB1 was detected. The kinase activity of the
HA-NDR immunoprecipitates was measured in a peptide kinase assay.
B, 1 g of SHP-NDR2 was pre-autophosphorylated for 2 h in the
presence of 10 M GST-hMOB1 or GST at 0, 10, 100, and 1000 M Ca2.
Zero Ca2 was achieved by the addition of 2 mM EGTA to the kinase
reactions. The reactions were subsequently mixed with [-32P]ATP and
NDR substrate peptide and incubated for an additional 60 min to
determine the peptide kinase activity of NDR.
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tory role arises. Mutation of the basic residues in this insert led
to kinase activation both in cells and in vitro, showing that the
sequence acts autoinhibitory. When NDR with mutated AIS
was mutated on Tyr-32, a residue essential for NDR-hMOB1
interaction, unstimulated kinase activity was not affected. This
points to a new mechanism of kinase activation in which the
binding of MOB may induce a conformational change that leads
to the release of the autoinhibition caused by the AIS. Crystal-
lographic studies of MOB-bound and MOB-unbound NDR
would be required to test this model. It is noteworthy that the
phosphorylation of the hydrophobic motif site Thr-444 of the
NDR AIS mutant in COS-1 cells also increased. Thus, the release
of autoinhibition also facilitated phosphorylation by the hydro-
phobic motif upstream kinase. In accordance with this finding,
it was suggested previously that the binding of yeast Mob1 to
Dbf2 enables the Ste20-like kinase, Cdc15, to phosphorylate
Dbf2 (27).
It has been shown that the autoinhibitory sequence acts as a
nuclear localization signal in COS-1 cells in the case of NDR1
(17). In yeast, Mob2 is important for the localization of the NDR
relative, Cbk1 (28, 29). It is possible that the conformational
change induced by hMOB1 also influences NDR localization,
and this will be addressed in future studies. It will also be
interesting to examine whether other members of the MOB
family (hMOB1  and , hMOB2, and hMOB3 , , and ) act
as kinase activators in vivo. During the preparation of this
article, it was reported that hMOB2 interacts with NDR1 and
NDR2 from Jurkat cells and that hMOB2 stimulates NDR
kinase activity (36).
S100B, a previously described activator of NDR, is constitu-
tively bound to NDR in cells independent of OA stimulation
(21). S100B may constitutively maintain the correct conforma-
tion of the SMA domain. It has been shown recently that the
NDR-derived S100B-binding peptide adopts its helical confor-
mation after binding to S100B (37). Thus, a high concentration
of S100B in certain cell types (for example, melanoma cells
(18)) may lead to constitutively elevated NDR activity. In con-
trast, MOB proteins may transmit a signal by fluctuation of the
MOB protein level during the cell cycle as is reported for S.
cerevisiae Mob1 (38) and/or by post-translational modification
of MOB that promotes the interaction with NDR as we have
suggested for the mechanism of OA-induced NDR kinase
activation.
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